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Chemotaxis is a fundamental process involved in a diverse range of biological phenomena 
such as nutrient finding in unicellular organisms, development and morphogenesis of 
multicellular organisms, wound healing and immune response. It is also related to a number 
of diseases including immunological disorders and cancer metastasis. It is a complex cellular 
process which is composed of several steps including signal detection and amplification, cell 
polarisation and cytoskeleton reorganisation. There are several signal transduction pathways 
working in parallel to control chemotaxis, which involve a multitude of regulatory factors 
and effectors modulating the cytoskeletal dynamics. The final outcome is actin 
polymerisation at the leading edge, depolymerisation at the trailing edge and myosin II 
filament assembly and contraction in the back of the cell, which together drive the directional 
cell movement in the direction of the chemotactic gradient.  
One of the poorly understood aspects of the chemotactic response is a biphasic character of 
the chemoattractant-induced actin polymerisation. The two temporally distinct phases of 
actin polymerisation reveal very different characteristics and regulation, but the exact 
mechanisms responsible for these differences have not been determined.  
We have taken advantage of recent advances in a quantitative proteomic technique and 
adapted the SILAC experimental approach to analyse the fast translocation dynamics of 
proteins associated with a crude cytoskeleton preparation after stimulation with the 
chemoattractant in Dictyostelium discoideum. These experiments detected, among many 
other proteins, a wide range of cytoskeletal components including structural constituents, 
actin binding proteins and regulatory factors associated with the cortical cytoskeleton. The 
SILAC results provide valuable quantitative information about the translocation dynamics for 
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hundreds of cytoskeletal components in the same experiment. Most of those proteins follow 
the generic biphasic profile of enrichment reflecting actin dynamics, but subsets of proteins 
show specific incorporation during only one of the two phases of actin polymerisation. We 
identify several positive regulators of actin polymerisation showing enrichment specific to 
the first phase of chemotactic response and other regulatory components incorporated to the 
cytoskeleton exclusively during the second phase of cAMP-induced actin polymerisation. 
Detailed analysis of the major structural components of the actin cytoskeleton reveal that 
about 25% of the primary actin nucleator – Arp2/3 complex, incorporated to the cortex 
during the first phase, do not trigger formation of a new filament.  
In order to verify the proteomic analysis 55 known cytoskeletal proteins, which showed 
strong enrichment in the SILAC experiments, were selected for tagging with GFP followed 
by in vivo fluorescence microscopy imaging. Their analyses served as positive controls 
validating the translocation dynamics patterns measured with the SILAC experiments and 
also provided further detailed spatio-temporal characterisation of the cAMP-mediated protein 
translocation. Regulatory factors involved in the first phase of actin polymerisation can be 
classified into two groups exhibiting distinct incorporation dynamics detected by TIRFM 
imaging. The first group includes DocA, DocB and GacR proteins, which show very rapid 
and transient translocation to the cortex and are most likely involved in the earliest events 
following cAMP stimulation. The second group, which is composed of Roco7, PakB, XacB 
and GacA proteins, shows slower enrichment and longer occupancy at the cortex. TIRFM 
analysis also led to characterisation of a new class of cytoskeletal components, which bind 
exclusively to the pre-existing actin filaments and do not associate with the structures formed 
during response to cAMP stimulation. These proteins, which include MhcA, ZizA, RapGAP1 
and two novel cytoskeletal components, translocate only to the inner cortex upon cAMP 
stimulation and are likely involved in regulation of the actin depolymerisation phase.  
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In order to identify novel components of the cytoskeleton 54 uncharacterised proteins 
showing response to cAMP stimulation in the SILAC experiments, were cloned and tagged 
with GFP. Most of those proteins showed specific localisations to various cellular 
compartments including the nucleus, contractile vacuoles and various types of vesicles. 12 of 
the selected proteins showed colocalisation with the cortical structures and clear translocation 
in response to cAMP stimulation. A small number of these proteins contain actin binding 
domains identified by sequence homology analysis, but none of them were previously 
characterised. These novel cytoskeletal components need to be further investigated in order 
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1.1. Dictyostelium discoideum as an ideal model 
organism to investigate chemotaxis 
 
Chemotaxis, the directed movement up or down a chemical concentration gradient of a 
chemoattractant/repellent, is an essential process which plays a crucial role in a multitude of 
biological responses and organisms. In single celled organisms it is involved in many aspects 
of survival such as nutrient sourcing, avoidance of predators and finding optimal 
environmental conditions. In higher organisms it plays major roles during development by 
guiding cells in different tissues to their destination, especially during gastrulation [1]. 
Chemotaxis of axonal growthcones is also critical for the correct wiring of the nervous 
system in the growing embryo [2]. In adult life chemotaxis plays important roles in processes 
responsible for tissue maintenance and repair, wound healing and angiogenesis [3]. 
Chemotaxis is essential for a proper functioning of many cell types in the immune system, 
such as neutrophils and macrophages, which circulate between vascular and lymphatic 
systems and migrate toward the sites of infection or inflammation guided by 
chemoattractants [4, 5].  
Due to its involvement in this diverse range of physiological functions, aberrations in 
chemotaxis are linked to development and progression of several disorders such as asthma, 
arthritis and other chronic inflammatory diseases [6-9]. Improper cell migration is also the 
primary cause of one of the most severe pathological phenomena, which is the cancer 
metastasis [10, 11]. This process occurs when the cancer cells in the primary tumour mutate 
genes involved in the control of the cell movement. Some of those cells will acquire the 
ability to invade into the surrounding tissues and also penetrate into the vascular system and 
spread around the whole organism, generating secondary tumours [12].  
 
- 10 -
Because of this great importance in development and disease, chemotaxis has been a subject 
of extensive research for a few decades, yet there are still many aspects of this process that 
are not fully understood.  
Since chemotaxis is such a fundamental process, it was developed and optimised very early 
in the evolution of life in ancient unicellular eukaryotes. Once established, this process was 
highly conserved throughout the evolution of higher organisms, and the principal 
mechanisms controlling chemotactic cell movement are virtually identical in all the 
eukaryotes from simple amoebas to mammalian cells such as leucocytes, especially 
neutrophils [13]. This universal character allows us to investigate this process in a simple 
model organism and then translate the results of this research into understanding the basis of 
development and disease in humans. 
 
Dictyostelium discoideum is a simple organism, which was proven to be a powerful system 
for investigating mechanisms of eukaryotic chemotaxis and other cytoskeletal functions. In 
fact many of the regulatory components, including Roco proteins [14, 15], and signalling 
pathways, such as phospholipase A2 [16, 17], mediating chemoattractant-induced motility in 
eukaryotes have been described in this experimental system. Also many cytoskeletal 
proteins, such as coronins [18], were first identified in Dictyostelium cells.  
Dictyostelium discoideum is a social amoeba, which spends most of its life as a single cell 
organism feeding on bacteria in the soil. Dictyostelium cells chase bacteria by chemotaxing 
towards folic acid secreted by those prokaryotes. When the cells divide and multiply they 
start to deplete their food source and eventually starve. Starvation triggers a fascinating 
developmental process leading to aggregation of cells to form a motile slug and transform 








Aggregation initiates by individual cells starting to secrete cAMP (cyclic AMP), which is a 
primary chemoattractant used during the remainder of the developmental process. Other cells 
in close proximity detect this signal and respond by moving in the direction of its source and 
by synthesizing and secreting more cAMP themselves [19]. This in turn is then detected by 
other cells. This process results in the formation of periodic waves of cAMP travelling 
through the cell mass from the aggregation centre outward, which guide the cells towards the 
aggregation centre. Up to several hundred thousand cells aggregate during this process by 
chemotaxing to cAMP, initially individually and later in streams formed by many cells 
connected in a head-to-tail manner. They form a multicellular mound, which transforms into 
a slug and which moves to the surface of the soil by a phototactic process. The cells continue 
to move in response to spiral cAMP waves initiated at the tip  [20].  
Dictyostelium cells differentiate during the developmental process and form two major types 
of cells, prespore and prestalk, which have very different functions and fates. Prestalk cells 
drive the developmental process at the multicellular level and they eventually form the stalk 
Figure 1. The lifecycle of Dictyostelium discoideum.  Vegetative cells are spread uniformly while feeding 
on bacteria (on the left). Upon food source depletion they starve and start aggregating into multicellular 
mounds. These structures are transformed into motile slugs (in the middle) which migrate out before 
developing into a mature fruiting body (on the right). During development cells undergo differentiation into 
prestalk and prespore cell types which are sorted into different compartments of the multicellular structures 
and play different roles during the entire developmental process. 
 
- 12 -
of the fruiting body and die. Prespore cells on the other hand, only follow the guidance 
provided by the prestalk cells and slowly switch off their metabolism, preparing to form 
spores, which will go to the next generation [21].  
This simple developmental process places the social amoebas on the threshold of the 
transition between unicellularity and multicellularity. The mounds and slugs formed during 
development are not true multicellular organisms, since their morphogenesis depends on cell 
aggregation rather than cell division. In this sense, it may be more adequate to describe those 
multicellular stages as superorganisms, similarly to social insects like ants or termites. There 
are several parallel characteristics between those different groups of organisms. Both 
aggregates of social amoebas and colonies of social insects are formed by closely related, 
fully independent individuals, which lose their own identity and are willing to sacrifice their 
lives for the sake of the entire superorganism. In both of those systems there is a 
specialisation of individuals to perform different functions, which in amoebas involves 
different genetic programs and cellular composition, while in insects it involves differential 
development and morphology. The collective behaviour of those superorganisms is 
controlled by self-organising emergent processes, which give them capabilities far exceeding 
the summed potential of all the components acting independently.  
Dictyostelium cells use chemotaxis during their whole life cycle, which means that they are 
very motile and have highly developed cytoskeletal machinery. The complexity of the actin 
cytoskeleton and the signalling pathways regulating it in Dictyostelium is comparable with 
that of mammalian leucocytes and other highly motile cells [22]. This organism is 
biochemically and genetically tractable. Most of the molecular genetic techniques, such as 
homologous recombination, insertional mutagenesis and RNA interference are available and 
highly efficient in this system. The Dictyostelium discoideum genome has been sequenced 
and is being annotated [23], which enables all the high-throughput genomic, transcriptomic 
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and proteomic analysis to be performed. All those characteristics make this model organism a 
perfect system to use for investigation of chemotaxis and cytoskeletal dynamics.  
 
1.2. Principles of chemotactic movement 
 
The dynamic process of chemotactic movement can be divided into several interconnected 
events such as directional sensing, signal amplification, cell polarisation and force generation 
driving the motility [24, 25]. It has been proposed that the directional sensing of the 
chemoattractant coupled with the signal amplification and transduction acts as a compass 
guiding cells towards the source of stimulus [26].  
Directional movement requires a defined cell polarity with differential organisation of the 
cortical cytoskeleton at two distinct cellular poles. This polarised morphology and 
localisation of cytoskeletal components is necessary for performing distinct functions at the 
front and back of moving cells [24].  
Actin polymerisation occurs at the leading edge of chemotaxing cells, where it drives the 
membrane protrusions. The exact mechanism of actin based force generation is not fully 
understood, but the best model describing this process involves an actin polymerisation based 
Brownian ratchet [27]. During movement the cell needs to contract its uropod in order for it 
to follow the protruding front. This process is driven by the contraction of the actin 
meshwork through the action of myosin II filaments, which are localised predominantly at 
the back and sides of polarised cells [28, 29]. This actin-based molecular motor generates 
contractile force by sliding along actin filaments in an MgATP dependent manner [30].  
 
- 14 -
At the same time the cell needs to establish new connections to the substrate at the leading 
edge in order to gain traction and brake the cell-substrate contacts at the rear to allow uropod 







There are several mechanisms regulating this polarised localisation and activation of 
different cytoskeletal components leading to F-actin driven pseudopod formation at the front 
and myosin II mediated contraction at the back of the cell [32, 33]. These mechanisms 
include positive feedback-loops, which help to maintain the established polarisation and 
ensure the persistence of cellular movement [34].  
 
Figure 1.1. Basic principles of cellular motility. Directional movement requires a polarised distribution of the 
cytoskeletal components. Actin polymerisation drives pseudopod formation at the leading edge, while myosin 
II filaments generate contractile force at the back mediating uropod retraction. During the whole process cell 
needs to establish new attachment points at the front and disassemble the ones at the rear. Arrows indicate the 
direction of movement (Based on Fukui et al., 1987). 
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1.3. Components of the cytoskeleton 
 
The cortical actin cytoskeleton is made of a dense network of actin filaments. Each of those 
filaments is asymmetric and contains a fast growing barbed end and a slow growing or 
shrinking pointed end. ATP-bound actin monomers are incorporated into the existing 
filaments and due to their intrinsic ATPase activity they hydrolyse ATP into ADP + Pi [35]. 
ATP hydrolysis coupled with the delay in Pi dissociation acts as a molecular clock 
determining the age of the filament and regulates the kinetics of disassembly and the 
association of interacting proteins [36].  
These cortical actin structures are generated by nucleation processes driven primarily by the 
Arp2/3 complex [37]. This highly conserved complex was first purified from Acanthamoeba 
[38] and has since emerged as a major eukaryotic actin nucleator of the branched networks of 
actin filaments at the cortex [39].  
The Arp2/3 complex is a stable assembly of 7 subunits including two actin-related proteins, 
Arp2 and Arp3, which function as an initiation point for the new filament formation [40, 41]. 
This protein complex binds to the side of an existing actin filament and triggers elongation of 
a new filament at a roughly 70° branch angle [42]. These two processes of filament-
branching and nucleation are tightly coupled [43, 44]. This means that this complex can only 
generate new filaments as branches emerging from the existing filaments, leading to the 
formation of a highly branched network of cross-linked actin filaments [45, 46] (Fig. 1.2.). 
The Arp2/3 complex possesses very little activity on its own and needs to be activated by the 
nucleation promoting factors (NPFs) in order to perform its function [44, 47]. Some of the 
most prominent and best characterised NPFs are proteins belonging to the WASP (Wiskott – 








catalytic WCA domain composed of WH2 (WASP-homology 2) motif responsible for 
binding actin monomer (G-actin) and a Central and an Acidic region involved in interaction 
with the Arp2/3 complex [50, 51]. The most basic model of the WASP-mediated Arp2/3 
Figure 1.2. General scheme of the branched network of actin filaments at the cortex. New filaments are 
generated by the Arp2/3 complex binding to the side of existing filaments and nucleating a branch emerging at 
a 70° angle to the mother filament. Filaments are growing at the barbed ends by incorporating G-actin until 
cupped by the Cap32/34 complex, which is inhibited by PI(4,5)P2 at the membrane. A dense network of the 
branched filaments drives broad membrane protrusions, while filaments assembled into tight bundles by the 
bundling proteins generate narrow finger-like extensions. Bipolar myosin II filaments bind to different parts of 
the cortical actin meshwork and generate contractile force by moving along F-actin and decreasing the 
distance between those two regions. Actin filaments are being depolymerised by ADFs at the pointed ends.
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activation is that the WCA domain delivers actin monomer to form a trimer with Arp2 and 
Arp3 subunits, which functions as a nucleus for the new filament [39, 52]. 
In a resting condition the WASP family proteins are present in a closed inactive 
conformation, in which the catalytic domain is inhibited by the interaction with GBD 
(GTPase Binding Domain) [53, 54]. This autoinhibitory conformation is disrupted by the 
interaction with activated Rho GTPases allowing the initiation of the Arp2/3-mediated actin 
polymerisation [55, 56]. This regulatory mechanism couples the WASP-dependent activation 
of the Arp2/3 complex to the signal transduction pathways that couple the detection of a 
chemoattractant gradient to localised cytoskeletal dynamics [57]. 
The Arp2/3 complex generates actin filaments with free fast growing barbed ends, which 
then elongate in an autocatalytic manner [58]. This filament elongation continues until 
inhibited by the capping protein binding to the barbed end [59]. One of the most significant 
capping proteins responsible for the majority of the barbed end capping activity in 
Dictyostelium cells is the heterodimeric Cap32/34 complex [60, 61]. This factor is inhibited 
by phosphatidylinositol (4,5) bisphosphate (PI(4,5)P2) present in a great abundance on the 
inner leaflet of the cell membrane, and thus protects the very peripheral actin filaments from 
being capped [59, 62].  
 
The mechanical properties and the metabolism of the actin cytoskeleton are modulated by a 
big collection of actin binding proteins (ABPs). These effectors control the turn-over cycle of 
actin networks, regulate their organisation and apply tension, which are required for the 
diverse actin-driven cellular functions [63]. The regulation of various mechanical properties 
is mediated, among others, by cross-linking proteins forming a loose network of actin 
filaments, bundling proteins generating a tight bundle, factors anchoring filaments to the 
membranes and actin based motors. The major regulators of actin dynamics and turn-over 
include nucleating factors, depolymerising factors, proteins capping actin filaments and 
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proteins sequestering G-actin or regulating ADP/ATP exchange in those monomers [64]. The 
ABPs can be divided into 7 major groups, based on their functions (Table 1.1.). However this 
arbitrary classification does not always reflect the biological complexity, since many proteins 
are exhibiting several activities and belong to more than one group [63]. One such example is 
cofilin, which can bind both actin monomers and filaments and mediates both 


















All of those classes of factors play important roles in the regulation of the actin cytoskeleton 
functions. They are the final effectors of the signalling pathways controlling actin dynamics. 
Various ABPs can recognise different binding sites present on the surface of actin filaments, 
 
1. Monomer binding proteins sequester G-actin and prevent its conversion to F-
actin (e.g., thymosin) or catalyse exchange of ADP to ATP (e.g., profilin).  
 
2. Actin depolymerising factors promote conversion of F-actin to G-actin 
preferentially at the pointed end of the filaments containing ADP-bound actin 
subunits (e.g., cofilin). 
 
3.  Actin capping proteins bind to the free ends of the filaments and inhibit their 
further elongation. They can cap the pointed ends (e.g., tropomodulin) or the 
barbed ends (e.g., Cap32/34, CapZ) of actin filaments. 
 
4. Filament severing proteins bind to the sides of actin filaments and cut them into 
two separate pieces (e.g., gelsolin, severin). 
 
5. Cross-linking proteins contain more than one binding site for F-actin and lead to 
the formation of three-dimentional actin filament networks and filament bundles 
(e.g., villin, fimbrin). 
 
6. Stabilising proteins bind to the side of actin filaments and prevent their 
depolymerisation (e.g., tropomyosin). 
 
7. Motor proteins use actin filaments as a track for movement. They are involved in 
trafficking and force generation (e.g., myosin family proteins). 
Table 1.1. Basic classification of the actin binding proteins. Based on their activity, ABPs can be divided into 7 
groups of factors performing different functions in the regulation of the actin cytoskeleton. Some of the ABPs 
exhibit several activities and belong to few groups at the same time. 
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but most of those components have to compete with several other proteins binding to the 
same region of F-actin [67]. 
 
One of the most important processes during cell movement is a contractile force generation, 
which is mediated by one of the ABPs group of motor proteins. Conventional filamentous 
myosin II is the major member of this family driving this process of force generation [68]. 
Myosin II is a hexamer consisting of 2 myosin heavy chains (MHC), 2 regulatory light chains 
(RLC) and 2 essential light chains (ELC) [69-71]. These myosin II complexes spontaneously 
assemble into bipolar filaments, which is the only form in which they can perform their 
cellular functions (reviewed  in [72]). 
Myosin II filament assembly in Dictyostelium is negatively regulated through MHC 
phosphorylation by MHC kinases (MHCKs) [73], and induced by dephosphorylation 
performed by MHC phosphatase PP2A [74]. Dictyostelium myosin II filaments are 
assembled in the cytosol and then translocated to the cortex by two separate and independent 
mechanisms [75]. Myosin II function and motor activity in Dictyostelium are controlled by 






1.4. Regulation of chemotaxis 
 
1.4.1. Ras GTPases 
 
The Ras superfamily of small GTPases is present in all eukaryotes and plays a key role in a 
regulation of a wide range of cellular processes including proliferation [80], differentiation 
[81], cell polarity [82] and motility [83, 84] and subcellular trafficking [85, 86].  
These proteins act as molecular switches cycling between active GTP-bound and inactive 
GDP-bound states [87]. This activation/inactivation cycle is controlled by specific regulatory 
factors (Fig. 1.3.). Activation is mediated by GEFs (Guanine-nucleotide Exchange Factors), 
which promote dissociation of the GDP allowing binding of GTP and transition to the active 
state [88, 89]. Inactivation is directed by GAPs (GTPase-Activating Proteins), which 
stimulate the intrinsic GTPase activity leading to GTP hydrolysis into GDP [90, 91]. 
Additional regulation comes from GDIs (GDP-Dissociation Inhibitors), which can lock 
GTPases in an inactive GDP-bound state and inhibit activation by GEFs [92]. Only activated 
small GTPases can interact with downstream effectors and regulate their function. This 
simple and easily controlled mode of action makes small GTPases extremely versatile 
components of various signal transduction pathways [93]. 
The Ras superfamily can be divided into five broad subfamilies: Ras, Rho, Ran, Rab and Arf 
[94]. The Ras and Rho subfamilies, which are involved in the regulation of the cytoskeleton 
are overrepresented in Dictyostelium relatively to the small genome size of this organism 
[95]. Two members of the Ras subfamily, RasC and RasG, play a central role in the 
regulation of chemotaxis and development in Dictyostelium [96, 97]. These two proteins are 
acting directly downstream of the G-protein-coupled cAMP receptor and activate several 
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signalling pathways controlling chemotactic movement and cAMP relay response. They 
exhibit certain overlap in function, but RasG was shown to be more important in chemotaxis 





Members of the Rho subfamily are specialised regulators of the actin cytoskeleton functions, 
working as a components of the signalling pathways downstream of RasG and RasC [99]. 
The Rho subfamily can be further divided into three major groups called Rac, Rho and 
Cdc42. Among 18 Rho GTPases identified in Dictyostelium 7 are classified as members of 
the Rac subfamily based on the phylogenetic analysis, while the rest do not belong to any of 
those groups. There are no clear homologs of Rho and Cdc42 proteins in Dictyostelium, 
which suggests that they diverged later in evolution [100, 101].  
The Rho GTPases are regulated by a surprisingly large number of factors in Dictyostelium. 
There are 42 proteins containing Rho GEF domain, 43 with Rho GAP domain and 3 proteins 
containing both, encoded in the Dictyostelium genome. Additionally there are 8 proteins 
belonging to the Dock180/Zizimin-related unconventional family of Rho GEFs identified in 
Figure 1.3. Regulation of small GTPases. Inactive GDP-bound small GTPases (blue) are activated by GEFs, 
which catalyse exchange of GDP into GTP. This exchange is inhibited by GDIs. Active GTP-bound form (red) 
can interact with downstream effectors and mediate the regulatory function. The intrinsic GTPase activity is 
greatly enhanced by GAPs leading to GTP hydrolysis and transition to the inactive state.  
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this organism [100]. This relatively big number of regulatory factors involved in the 
cytoskeletal functions is related to the complexity of the microfilament apparatus and the 
requirement for highly diverse and complex cellular functions during the Dictyostelium life 
cycle. It also suggests considerable redundancy in this highly important regulatory system.  
 
1.4.2. Directional sensing and cell polarity 
 
Chemotaxis is a complex cellular process involving several signalling pathways with a 
variety of regulatory steps, signal amplification and very precise fine tuning enabling 
response to a very shallow gradients on the edge of physical limits of detection [102-104].  
The initial step is the binding of the chemoattractant to cell surface receptors, which then 
transduce this signal via G proteins to a complex network of signalling pathways, resulting in 
a gradient of cellular components [105]. There is a big collection of proteins and molecules 
that specifically localise to the front or to the back of cells moving in the gradient of 
chemoattractant (reviewed in [102]). Factors showing increased localisation to the front 
include phosphatidylinositol 3 kinase (PI3K) and its product phosphatidylinositol (3,4,5) 
trisphosphate (PI(3,4,5)P3) [106]; furthermore PI(3,4,5)P3 binding proteins such as CRAC 
[107], PKB/Akt [108], Rho GEFs and others described below. Components found at the back 
and sides of chemotaxing cells include PTEN [109], ACA [110] and others (Fig. 1.4.).  
This internal gradient is translated into coordinated remodelling of the cytoskeleton and leads 
to the formation of actin filaments in the front, which drives the extension of filopodia and 
pseudopodia [111], and myosin thick filaments at the back of the cell [75], which inhibit 
pseudopodia formation and drive uropod retraction [112]. The final outcome is cell 






Cytoskeleton reorganisation at the front of the cell is driven by the Arp2/3 dependent 
autocatalytic polymerisation of actin filaments and actin dependent inhibition of myosin II 
filament assembly [114, 115]. Localised stimulation of Dictyostelium cells with 
chemoattractant results in activation of Ras and PI3K signalling leading to actin 
polymerisation and newly polymerised actin results in further recruitment of PI3K signalling 
which in turn triggers more actin polymerisation forming a positive feed-back loop [34, 116-
118]. At the same time activated Ras stimulates signalling pathways that locally activate 
MHC kinase A, which results in phosphorylation of the myosin II heavy chain and 
disassembly of myosin filaments at those sites in Dictyostelium [75, 119].  
Both of those events fit in the LEGI (Local Excitation Global Inhibition) model, which 
explains regulation of actin cytoskeleton by local activation of polymerisation at the front of 
polarised Dictyostelium cells and global inhibition at the rest of cell surface [26, 120]. On the 
Figure 1.4. Spatial localisation of different 
proteins in polarised cell. cAMP receptor cAR1 
is distributed uniformly but gradient of external 
cAMP is translated into localised production of  
PI(3,4,5)P3 by PI3K at the front of the cell, 
which determinates localization of proteins 
containing PH domain. PI(3,4,5)P3 gradient is 
formed and maintained by the specific 
localisation of PI3K to the front and PTEN to 
the back and sides of the cell. This leads to 
spatially determined rearrangements: actin is 
being polymerised at the front while myosin 
filaments assembled at the back. 
Actin polymerisation process is amplified by a 
positive feedback loop, which stabilizes 
initiated pseudopodia. At the same time actin 
polymerisation and the positive feedback loop 
that it triggers lead to the inhibition of myosin 
filament assembly at the front of the cell. 
(Based on Manahan et al., 2004) 
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contrary, myosin II filament assembly is globally activated and only locally inhibited at the 
front of the Dictyostelium cells [15, 77, 121], which complements the regulation of actin 
cytoskeleton, since myosin II filaments at the cell cortex suppress actin-driven protrusions 
[113].  This model predicts different diffusion rates of factors mediating global and local 
response. For example cGMP which is a small and highly diffusible molecule, leads to global 
activation of myosin II filament assembly and therefore inhibition of actin-based 
pseudopodia [122, 123], while local activation of actin polymerisation and myosin II 
disassembly is mediated by local accumulation of PI(3,4,5)P3 and several proteins at the sites 
of activation in Dictyostelium cells [103, 124, 125].   
The localisation and functional role of PI(3,4,5)P3 and the mode of cell movement may differ 
depending on the strength of the gradient that the Dictyostelium cells are exposed to. In 
shallow gradients of chemoattractant PI(3,4,5)P3 is almost uniformly distributed along the 
cell membrane, while in the steep gradients it is strongly localised at the leading edge [126]. 
Detailed analysis of phenotypes exhibited by various Dictyostelium mutants in PI3K 
signalling revealed that in shallow gradients PI(3,4,5)P3 plays more global role of increasing 
the frequency of new pseudopodia formation rather than their localisation [127]. These and 
other observations resulted in a model of chemotaxis, in which pseudopodia are constantly 
produced spontaneously in random directions, similarly to the random motion observed in 
the absence of chemoattractant stimulation [128, 129]. In these models the steering process is 
thought to be a separate event mediated by other pathways, which stabilise and maintain only 
those pseudopodia pointing in the direction of the gradient while retracting the others [130]. 
On the other hand, in steep chemoattractant gradients PI(3,4,5)P3 is almost exclusively 
localised to the leading edge of Dictyostelium cells, where it plays more direct role in 
mediating the chemotaxis, by driving localised production of new pseudopodia in the 




1.4.3. Signal transduction pathways 
 
Dictyostelium can detect several chemoattractants like cAMP, folic acid or lysophosphatidic 
acid (LPA), with cAMP being the major signalling molecule during development. Cyclic 
AMP is detected by a family of serpentine G-protein-coupled receptors (GPCRs) cAR1 – 4 
[131]. Binding of cAMP triggers the activation and dissociation of heterotrimeric G proteins 
into cytosolic Gα-GTP subunits and membrane bound Gβγ subunits, both of which can 
regulate a diverse set of downstream effectors [116, 132].  
The main signal transduction pathway from cAMP GPCRs goes through Gβγ subunits via 
Ras GEFs to Ras GTPases. The Ras superfamily of small G proteins and especially members 
of the Rho family within this superfamily as described earlier, are the major regulators of 
cytoskeletal dynamics in eukaryotic cells and play substantial role in chemotaxis [98, 116, 
117]. Different Ras GEFs (e.g., GefR, GefA) activate different Ras GTPases (e.g., RasG, 
RasC) which then activate several signalling pathways leading in parallel to the effectors in 
the cytoskeleton (Figures 1.5. and 1.6.).  
The first pathway discovered to play a crucial role in Dictyostelium chemotaxis was class I 
phosphatidylinositol 3 kinase (PI3K) signalling [106]. Upon cAMP stimulation RasG is 
locally activated, which then recruits PI3K to the membrane. PI3K phosphorylates PI(4,5)P2 
to form PI(3,4,5)P3 leading to local accumulation of this molecule at the membrane. At the 
same time PI(3,4,5)P3 is degraded to PI(4,5)P2 by a membrane bound phosphatase – PTEN 
[125]. Therefore dissociation of PTEN from the membrane at the site of cAMP stimulus is a 
necessary step in order to efficiently accumulate PI(3,4,5)P3. Evidence has been presented 
that this dissociation event is driven by a cAMP activated phospholipase C (PLC) activity, 
which hydrolyses PI(4,5)P2 to form diacylglycerol (DAG) and inositol(1,4,5) triphosphate 
(IP3) [133]. PI(4,5)P2 is not only a substrate for PI3K and a product of PTEN but it is also an 
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important factor regulating PTEN binding to the membrane [134]. This binding may depend 
on PI(4,5)P2 both directly and indirectly, since PTEN binds to PI(4,5)P2 via several charged 
residues at its N terminus, but this alone is not sufficient to drive PTEN localisation. 
Therefore other mechanisms, which are yet unknown, must take part in this process but could 








Figure 1.5.  The general overview of the signalling pathways triggered by cAMP in Dictyostelium.  
Binding of cAMP to cAR1 leads to dissociation of G protein which then activates Ras proteins and also 
PLC. Ras signalling leads directly or indirectly to activation of several pathways transducing the signal to 
the cytoskeleton in parallel. TORC2 mediates both cAMP relay response and actin polymerisation; PLC, 
PTEN and PI3K contribute to PI(3,4,5)P3 signalling which is the central factor in chemotaxis. PLA2  is a 
parallel pathway to PI3K and can control chemotaxis in the absence of PI(3,4,5)P3. sGC is another parallel 
pathway that can alone mediate chemotaxis in highly polarised cells. It generates two independent signals by 
binding to the actin filaments at the front where it regulates formation of new pseudopodia and production 
of cGMP which globally promotes myosin filament assembly. Rap1 activates MHCK which inhibits myosin 
filaments assembly at the front. 
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The mechanism of PLC activation is not fully understood but it is mediated by the Gα2 at the 
site of cAR1 stimulation [136]. This activation leads to local degradation of PI(4,5)P2 and 
dissociation of PTEN from the membrane. The remaining pool of PI(4,5)P2 is sufficient as a 
substrate for PI3K and at the absence of PTEN an effective accumulation of PI(3,4,5)P3 can 
be achieved. The proper level of PLC activity is necessary for building a functional gradient 
of PI(3,4,5)P3 during chemotaxis. Mutants lacking PLC activity are unable to accumulate 
PI(3,4,5)P3 at the front of the cell and exhibit chemotaxis defects, while overexpression of 
PLC leads to global dissociation of PTEN from the membrane and PI(3,4,5)P3 production, 
which also disrupts PI3K signalling and chemotaxis in Dictyostelium [133, 135].  
PI(3,4,5)P3 is a key player in the regulation of chemotaxis. Local accumulation of this 
molecule in the membrane can alone drive the pseudopodia formation and protrusion by 
stimulating actin polymerisation [137]. Accumulation of PI(3,4,5)P3 at the leading edge and 
building a steep gradient of PI(3,4,5)P3 within the cell is crucial for efficient chemotaxis and 
is a major characteristic of polarised cells [33, 125]. PI(3,4,5)P3 acts as a binding site for 
proteins containing PI(3,4,5)P3 specific Plekstrin Homology (PH) domains and therefore 
mediate their translocation to the membrane after cAMP stimulation. There is a great variety 
of proteins binding to PI(3,4,5)P3, which play part in different aspects of chemotaxis and the 
cAMP relay response. One of those proteins is CRAC (Cytosolic Regulator of Adenylyl 
Cyclase) which regulates activation of ACA (Adenylyl Cyclase of Aggregation stage) and 
mediates signalling to cAMP relay response [107, 110]. There is a multitude of PH domain 
containing proteins which lead to activation of actin polymerisation or contribute to 
cytoskeleton structure and dynamics in other way. Many Rac GEFs and also Rac GAPs, bind 
to PI(3,4,5)P3 and regulate Rac GTPases – a subfamily within Rho family involved in 
regulation of the actin cytoskeleton [99, 100, 138].  
Rac small G proteins directly activate Scar/WAVE complex and WASP protein, two main 
NPFs acting on the Arp2/3 complex, which is a key nucleator of actin polymerisation [41, 
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48]. Scar/WAVE is inhibited by other components of the complex – PIR121 and Nap, and 
after Rac activation it is released from these interactions and can bind Arp2/3 and trigger 
actin polymerisation [139]. WASP is present in an inactive form due to auto-inhibition, 
which is released after conformational change mediated by binding of activated RacC, 
allowing activation of the Arp2/3 complex [49, 52, 56]. Each of those factors activates the 
Arp2/3 complex in a different context and leads to formation of different actin based 
structures. The Scar/WAVE complex induces formation of pseudopodia and lamellipodia – 
broad membrane protrusions filled with dense meshwork of branched actin filaments [139, 
140], while the WASP protein is involved in clathrin based endocytosis and vesicle 
trafficking [50, 141]. Some of the other proteins that bind to PI(3,4,5)P3 and regulate actin 
cytoskeleton are: PhdA a PH domain containing adaptor protein regulating filamentous actin 
(F-actin) localisation and organisation [106], PDKa, Akt/PKB and PKBA protein kinases 
involved in signal transduction to both actin and myosin cytoskeleton [140, 142] and PAKa 
which regulates assembly of the myosin thick filaments [72]. 
 
There is an intrinsic positive feedback loop in the PI3K signalling, which leads to strong 
signal amplification and maintenance of the polarisation at the leading edge. The model of 
this feedback loop is based on the ability of PI3K to bind to newly polymerised, ATP-rich 
actin filaments. Once activated PI3K pathway leads to formation of new actin filaments, 
which then recruit more PI3K to the site of activation [126, 143]. Ras signalling is also 
involved in this feedback loop. Even though activation of Ras is PI3K and F-actin 
independent, it is strongly amplified by factors contributing not only to PI3K signalling but 
also to other pathways regulated by Ras [117, 140, 143]. The result of this feedback loop is 
strong amplification of the initial signal, which maintains the persistence of chemotactic 
response and enables detection of very shallow gradients, which is enhanced by the 
localisation of  PTEN at the sides and back of chemotaxing cells through a mechanism 
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described above. Both of these mechanisms help to establish and maintain an internal 
gradient of PI(3,4,5)P3 and other factors between the front and the back of chemotaxing cells, 
which is translated into organised response to chemoattractant stimulation [144]. 
Even though PI(3,4,5)P3 plays a central role in the chemotactic response it is not essential for 
this process. Mutant lacking all five genes encoding class I PI3 kinases in Dictyostelium as 
well as PTEN still exhibit good chemotaxis in steep gradients of cAMP with orientation 
efficiencies close to that of wild type, however they move at reduced speed [145]. This 
suggests that at least one other pathway acting in parallel with PI3K can independently drive 
chemotactic movement. Two research groups using two different approaches found that 
phospholipase A2 (PLA2) plays a role of additional compass in chemotaxis and is required for 
directed cell movement in the absence of PI3K signalling [16, 17].  
The mechanism of PLA2 pathway is not well understood. PLA2 is a cytosolic enzyme that 
cleaves the second acyl chain in phospholipids (PLs) and forms lysoPLs and free fatty acids 
(FFA) such as arachidonic acid (AA) [17]. The mediator of PLA2 signalling in chemotaxis is 
unknown but AA is one of the candidates, another possible factor is lysophosphatidic acid 
(LPA) – a product of further processing of lysoPL. The mechanism of PLA2 activation is also 
unsolved, but it must go through cAR1 and therefore is probably dependent on a G protein 
signalling pathway [146]. PLA2 activity is dependent on Ca²⁺ signalling, which is controlled 
by IP3 and the IP3 receptor [147]. IP3 is a product of PLC which is a regulator of PI(3,4,5)P3 
signalling as described before, and therefore it could be a point of crosstalk between the two 
pathways. But Ca2+ signalling is not entirely dependent on PLC activity since there are other 
sources of IP3 in the cell and plc-null mutants have close to wild type levels of  IP3 [146].  
The PLA2 and PI3K pathways act in parallel to regulate chemotaxis and either one of them is 
sufficient to generate chemotactic movement, while cells lacking both of those pathways 
cannot move up gradients of cAMP [16, 17]. But this is still not the end of the story. It was 
recently shown that inhibition of both PLA2 and PI3K blocks chemotaxis completely only in 
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unpolarised not fully developed cells after 4-5 h of pulsing with cAMP. If the cells are 
developed for longed time, 7-9 h, they become highly polarised and establish stable internal 
gradients of many cellular components. These cells are able to move in gradient of cAMP 
after inhibiting both the PLA2 and PI3K pathways [148]. This implies existence of a third 
pathway that could independently drive the chemotactic response, present only in polarised 
cells. It was determined that soluble guanylyl cyclase (sGC) is responsible for this rescue of 
chemotaxis defect in polarised cells [148]. Further investigation revealed that sGC signalling 
has an interesting bipolar character. sGC protein localises to the front of chemotaxing cells 
where it binds to F-actin and regulates dynamics and orientation of pseudopodia formation. 
On the other hand the product of sGC catalytic activity – cGMP, regulates myosin assembly 
and motor activity at the back of the cell [76, 148]. Myosin assembly and activity is regulated 
by cGMP which activates cGMP binding protein C (GbpC) that initiates myosin filaments 
translocation to the cortex. GbpC also phosphorylates myosin light chain kinase A (MLCK-
A) which activates myosin motor activity in the acto-myosin filaments and generates driving 
force for uropod retraction during cell movement [72]. Interestingly mutants lacking only 
catalytic activity of sGC could still induce chemotaxis to some extent, while catalytically 
active sGC lacking ability to bind to F-actin could not, indicating that actin binding  is 
required for the primary function of sGC in chemotaxis [148]. 
Another component contributing to the complexity of the whole system is Target Of 
Rapamycin Complex 2 (TORC2). This complex consists of the TOR protein, which is highly 
conserved in evolution and contains structural similarities to the PI3 kinase family, Ras 
interacting protein 3 (RIP3), Pianissimo (Pia) and few other proteins [149]. TORC2 is 
activated after cAMP stimulation by Ras pathway via RIP3 [150] and then phosphorylates 
several proteins involved in signal transduction to chemotaxis. TORC2 regulates cAMP relay 
response since it is an essential component for ACA activation both directly and indirectly 
through PKB [149]. The major contribution of TORC2 signalling to the cytoskeleton 
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regulation is through activation of protein kinases B – PKBA and PKBR1 at the leading edge 
[151]. PKBA binds to PI(3,4,5)P3 and activates another PI(3,4,5)P3 bound kinase – PAKa 
which regulates the myosin cytoskeleton. PKBR1 is constitutively bound to the membrane 
and after activation by TORC2, phosphorylates downstream effectors such as Rac GEFs and 









Myosin II filaments localised at the cortex of the cell inhibit formation of pseudopodia,  
Figure 1.6. Detailed model of signal transduction pathways from cAR1 to the cytoskeleton. Separate pathways 
are indicated by different colours of the background. 
Ras GTPases are master regulators of signalling in chemotaxis. They independently activate PI3K, TORC2, sGC 
and Rap1 pathways. Activation of PLC is mediated by Gα subunit, the mechanism of PLA2 activation remains 
unknown. PI3K, PTEN and PLC all contribute to the formation of PI(3,4,5)P3 gradient, which is the major factor 
in chemotaxis. It is a binding site for the PH domain containing proteins, and therefore mediates their 
localisation to the front of the cell. Rac GEFs bind to PI(3,4,5)P3 and locally activate Rac GTPases, which 
trigger WASP and Scar activity, the main regulators of the Arp2/3 complex. This leads to actin polymerisation 
and formation of pseudopodia. There is a positive feedback loop between Ras, PI3K and actin polymerisation 
shown as green triangle. TORC2 is a regulator of ACA and also regulates cytoskeleton by acting on PKB’s. sGC 
mediates two independent signals to actin at the front by binding to F-actin, and to myosin at the back by 
producing cGMP. GpbD contains GEF domain which activates Rap1 and leads to myosin filament disassembly 
at the front, mediated by MHCK-A activity.  
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therefore in order to generate new protrusions at the leading edge myosin filaments need to 
be disassembled at the front of chemotaxing cell [68]. This process is mediated by Rap1 
GTPase which is rapidly activated by GEF domain of GbpD at the leading edge upon cAMP 
stimulation. Activated Rap1 binds and activates Phg2 kinase, which then phosphorylates 
myosin heavy chain kinase A (MHCK-A) that leads to inhibition of myosin filament 
assembly at the front [116]. 
All the pathways described here form a highly complex network of regulation of chemotaxis. 
Studying roles of different components and mechanisms acting in separate pathways is 
difficult because of their redundant character. There are still many parts of the system that 
need to be covered with extensive analysis and presumably also novel functional components 
remain to be discovered. 
 
 
1.5. Biphasic character of cAMP-induced actin 
polymerisation 
 
Stimulation of cells with cAMP results in two temporally distinct phases of actin 
polymerisation (Fig. 1.7. B). The first phase is very rapid and peaks at about 5 s after 
stimulation at room temperature and 10 s at 12°C. This phase is not dependent on PI3K 
activity and it leads to uniform actin polymerisation at the cortex, which is followed by a 
phase of rapid actin depolymerisation [152]. During this rapid phase of actin polymerisation 
cells stop moving and soon after the depolymerisation phase, they retract all their 





Figure 1.7. Two phases of actin polymerisation in response to cAMP stimulation. A) Confocal images of the 
cell expressing RFP-lifeact F-actin probe stimulated with cAMP at room temperature. B) Phalloidin assay 
analysis of actin dynamics after cAMP stimulation at 12°C. The graph shows the relative F-actin abundance. It 
is a representation of 16 separate measurements.  
The first uniform burst of actin polymerisation peaks at about 10 seconds after stimulation at 12°C. During the 
second phase actin polymerisation is localised to generated protrusions. It shows much slower kinetics and 
lower amplitude, peaking between 2-3 min after cAMP stimulation at 12°C.  
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driven by myosin II mediated contraction. The F-actin level goes back to almost 
prestimulation level after the depolymerisation phase is finished and then slowly increases 
during the second long-lasting phase of polymerisation. The second phase, which peaks at 
around 2-3 min at 12°C, is dependent on PI3K/PTEN activity. During this phase actin 
polymerisation becomes confined to pseudopodia, which are extended at the front of moving 
cells [152]. This phase leads to pseudopodia formation and therefore drives the actual 
chemotactic movement. 
Both of those phases are dependent on Arp2/3 activity since mutants with disrupted function 
of this complex have strongly decreased response in each of those two phases [153]. The 
fact, that both phases of actin polymerisation require the Arp2/3 complex, but only the 
second phase is dependent on PI3K signalling, suggests that there have to be diverse paths of 
signal transduction and regulatory factors involved in each of those phases.  
The mechanisms regulating the actin polymerisation during the second phase have been 
relatively well characterised and are closely related to the mechanisms involved in the 
random motion in the absence of chemoattractants [26, 143]. However the exact mechanisms 
leading to the activation of actin polymerisation during the first phase, as well as the 
regulation of the depolymerisation phase, have not yet been described. 
This biphasic nature of chemoattractant-induced actin polymerisation is a universal 
characteristic, which can be detected with certain variability in both Dictyostelium amoebas 
and human cells such as neutrophils and fibroblasts [154]. The physiological relevance of 
this feature is not fully understood. It is thought that such temporal differentiation of actin 
polymerisation response could enhance spatial detection of stimulation source. In natural 
conditions cells might be exposed to oscillatory chemoattractant stimulation such as the 
periodic waves of cAMP during Dictyostelium development. In these conditions the 
travelling wave of stimulus will induce the first rapid response with a spatio-temporal 
gradient at the cortex. The actin polymerisation will first occur at the side of the cell that first 
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experiences the chemoattractant, which might leave some biochemical trace indicating the 
direction of the source. This type of behaviour can be observed by looking at actin dynamics 
at streaming Dictyostelium cells, but it cannot be detected during uniform cAMP stimulation.  
 
1.6. Experimental approach for investigating 
function and regulation of the cytoskeleton during 
chemotaxis 
 
There are two main approaches to identify components involved in any biological process 
and to study mechanisms functioning in it. The first one is a genetic approach, which can be 
applied in a forward or reverse manner. Forward genetics is used for identification of factors 
playing role in the process analysed. It is always based on some form of mutagenesis 
followed by screening for mutants displaying mutant phenotypes in the process of interest. 
Usually the most challenging part of this approach is the identification of mutations 
responsible for the observed phenotypes. Reverse genetics is useful for discovering function 
of a certain component by introducing a disruption or various mutations to the gene of 
interest and analysing the effects of those manipulations. Both of those techniques are 
extensively used in many fields of biological research including the investigation of 
chemotaxis. 
The major limitation of these approaches is the redundancy of function exhibited by the 
components involved in the process analysed. Disruption of a single factor will generate only 
a very limited phenotype, since its function can be often provided by other redundant 
components. This often causes a necessity to introduce several disruptions simultaneously, in 
order to detect a clear phenotype.  
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This limitation in utilising the genetic approach has proven to be of a crucial significance in 
the chemotactic research. Many of the molecules involved in the cytoskeletal dynamics are 
known to have redundant functions and to be somehow able to substitute for each other. This 
redundancy of certain factors as well as the parallel regulation of the whole process by 
independent signalling pathways makes this system surprisingly adaptive and resistant to 
disruption by genetic modifications, as is to be expected of process crucial for life. There are 
very few essential components of this system, which could not be deleted, such as major 
subunits of the Arp2/3 complex [153]. From the list of all the mutants ever analysed, that had 
single cytoskeletal factors knocked-out, only a relatively small proportion was displaying 
severe defects in chemotaxis. These severe defects usually affect cells lacking factors that act 
at the initial stages of the signal transduction, upstream of the multiple parallel pathways, 
such as car1 [131] or rasG null cells [155]. Most of other mutants with disruptions of further 
downstream signalling factors such as GEFs and GAPs, or effectors like many ABPs, had 
only minor aberrations, slightly decreased motility rates or even no observable phenotypes at 
all. Some mutants lacking the whole signalling pathway involved in the regulation of the 
cytoskeleton could still perform efficient chemotaxis, such as cells lacking all the genes for 
PI3K’s and PTEN [17, 145, 156]. 
 
Another approach of identifying components and their functions is a proteomic analysis. This 
biochemical approach also comes in a variety of forms and has its own limitations. The major 
difference of this technique, compared to the one previously described, is that it does not 
need to disturb the process in order to investigate it. Proteomic analysis can be performed in 
a wild type system, which allows us to observe the biological processes the way they really 
work in native conditions. This approach can detect various aspects of protein dynamics, 
changes in protein abundance and protein-protein interactions. It can determine the 
composition of various cellular structures and protein complexes. The great advantage of 
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proteomic analysis is the ability to analyse many factors involved in a certain process during 
a single experiment. The major limitation of this approach is that, although it can be used to 
analyse dynamics and interactions, it cannot determine the function of analysed proteins, 
which needs to be investigated in follow up experiments. Both genetic and proteomic 
methods are highly complementary.  
 
1.6.1. Mass spectrometry-based proteomics 
 
Mass spectrometry (MS) is an analytical method used for a very precise measurement of the 
molecular mass of the analysed sample. There are different types of measuring instruments, 
such as time-of-flight (TOF), Orbitrap or quadrupole mass analysers, which can be used for 
various applications including analysis of biomolecules. This technology has emerged as a 
central tool for in-depth characterisation of proteins in biological systems. A wide range of 
MS-based experimental strategies have been developed and successfully applied in different 
fields of proteomic research having a great impact on the life sciences in general [157].  
The field of proteomic research has experienced a true revolution in the last decade. Due to 
remarkable advances in MS technology the MS-based proteomics has evolved from mainly 
qualitative analytical tool into a truly quantitative method [158]. During this time we could 
observe constant increase in precision and sensitivity of mass spectra acquisition, which 
allowed in-depth analysis of highly complex protein samples. This has been driven mainly by 
development of the Orbitrap technology by Alexander Makarov [159]. This new type of mass 
analyser operates by trapping ions in a stable orbit around a spindle-like electrode inside an 
outer barrel-like electrode. The ions orbiting the central electrode also oscillate along its axis 
in the electric field. The mass-to-charge (m/z) ratios are obtained by Fourier transforms of 
the frequencies of those axial oscillations measured for all peptide ions. Since the frequency 
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of ion axial oscillations can be measured very precisely, the corresponding m/z values are 
also determined with extremely high precision and accuracy [160]. It also generates a very 
high mass spectrometric resolution which allows distinguishment and precise quantification 
of peptides with very small differences in m/z ratio values. Another advantage of the 
Orbitrap in the proteomic research is the large dynamic range of ion abundance in which it 
can operate. All of those qualities are very important for the analysis of complex biological 
samples [161]. This technology has become a powerful tool which allowed development of a 
truly quantitative MS-based proteomics bringing it to a whole new level. 
In MS-based proteomics proteins can be characterised by their unique mass which depends 
on their amino acid composition (“top down” proteomics). This approach is however 
challenging because the mass difference between proteins with similar composition is small 
comparing to their total mass and also because entire proteins are difficult to measure [162]. 
This is why in most applications proteins are first digested with proteases such as trypsin, and 
the derived peptides are then analysed (“bottom up” proteomics).  
Mass spectrometer cannot measure the peptide mass directly but only its mass-to-charge 
ratio. In order to calculate the mass of those molecules we need to determine the charge state 
of the ions by analysing their isotopic distribution peaks. Since stable heavy carbon isotope 
13C contributes to about 1.1% of all the natural carbon on Earth it is always present in large 
biomolecules which contain hundreds if not thousands of carbon residues. Each peptide is 
therefore present in several isotopic forms containing either 0 or 1 or 2 etc. of 13C isotopes 
and the mass difference between the neighbouring forms is exactly 1Da (Fig. 1.8. [MS] and 
Fig. 3.2. A,B). We can determine the charge state of each peptide ion since it is directly 
related to the distance between different isotopic forms on the m/z scale. For example if the 
distance between different isotopic forms is 1 mass unit on the m/z scale the peptide ion has 




A modern MS-based proteomics provides a variety of applications for different aspects of 
proteomic analysis. Apart from basic protein sequence identification, mass spectrometry is 
used for mapping and detailed characterisation of post-translational modifications (PTMs) 
which play a key role in the regulation function and turn-over of proteins [163]. This 
technique serves as an exceptional tool for studying signal transduction pathways and 
complex networks of protein regulation by analysing dynamics of protein phosphorylation 
[164] and other PTMs such as acetylation [165], ubiquitination [166], SUMOlylation [167] 
and others [168, 169]. Mass spectrometry is also widely used for identification of both stable 
and transient protein-protein interactions [170-172] and subunits of protein complexes [173, 
174] or even analysis of protein composition and turn-over in different organelles and 
cellular compartments [175, 176]. 
The quantitative character of modern MS-based proteomics allows for all those analysis to be 
performed in a quantitative manner revealing the dynamics of the underlying regulatory 
networks. It also enables studying dynamic changes of protein abundance during cell cycle 
[177], development [178] or any other biological processes, and also during response to 
various stimulations and treatments tested in the experimental system [179, 180].  
The difficulty in reliable quantification of peptides in any MS measurement comes from the 
fact that the signal intensity of a peptide ion does not always reflect the peptide abundance in 
the analysed sample. This is caused by the variability in ionisation efficiency between 
different peptides and also by the influence of other ions in the sample on the measured 
intensity of a particular peptide ion. A reliable quantification requires therefore a good 
internal standard in the sample to normalise quantitative variability between different MS 
measurements. An ideal internal standard should have identical chemical and physical 
properties to the analysed molecule. The best solution is to have for each peptide a separate 
internal standard made from peptide with identical sequence but labelled with different stable 
isotopes allowing for distinguishment of the two species on MS. This has led to the 
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development of several techniques for peptide labelling with stable isotope tags both in vitro 
and in vivo.  
The in vitro labelling is done by chemical modifications of proteins or peptides leading to 
incorporation of stable isotopic tags onto selected sites. There are several different methods 
which use different types of tags with various isotopic labelling and specificity of reactive 
groups (reviewed in [181]). The advantage of chemical labelling is that it can be performed 
on any type of protein sample including tissue biopsies and body fluids. The disadvantage is 
that the analysed sample and the internal standard have to be processed individually and are 
mixed together at the late stage before the MS measurement, which can lead to quantitative 
variability affecting the final results. 
The in vivo labelling involves metabolic incorporation of stable heavy isotopes into proteins 
of cells grown in special media containing those isotopes. This can be done by growing 
bacteria or yeast cells in media containing nitrogen source with 15N isotopes, which will be 
incorporated into all the amino acids, or by growing cell cultures or even whole organisms on 
media containing essential amino acids labelled with 13C and 15N. The approach of metabolic 
incorporation has the great advantage that the proteins are tagged in the very early stages. 
This allows for the samples to be mixed with internal standards at the cell level or straight 
after the lysis, which reduces the variability caused by sample preparation and yields highly 
accurate quantification. The disadvantage is that it can only be used for systems, which can 
be grown on a defined media, which excludes human or environmental samples.  
Stable Isotope Labelling by Amino acids in Cell culture (SILAC) is a straightforward 
approach for labelling the whole proteomes by metabolic incorporation of essential amino 
acids from the culture medium into the newly synthesised proteins. After a minimum of five 
cell doublings all the proteins are labelled with ‘heavy’ forms of lysine and arginine 
containing 13C and 15N stable isotopes. By choosing various forms of labelled amino acids up 
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to three different cell populations can be generated, which can be subjected to various 
treatments and then analysed simultaneously in a single MS measurement [182].  
Labelling proteins with ‘heavy’ forms of lysine and arginine is compatible with tryptic digest 
during downstream sample preparation. Since trypsin cleaves proteins only after lysine and 
arginine residues, all the peptides generated by this enzyme will have at least one labelled 
amino acid (some will have more than one due to missed cleavage sites). This means that all 
the peptides in the analysed sample will be present in both ‘light’ and ‘heavy’ forms, one of 
which will serve as an internal standard and will allow for precise quantification.  
Even though MS technology is rapidly improving and already allows for in-depth analysis of 
highly complex samples, the level of complexity and dynamic range of protein samples from 
the whole cell lysate or even a particular purified cellular fraction is still too large to allow 
comprehensive coverage of the whole proteome. In order to decrease this complexity and 
dynamic range and therefore increase the protein detection, samples need to be divided into 
fractions. This can be performed at a protein level by using one dimensional SDS-PAGE 
when proteins are separated according to their size. Gel lanes containing separated proteins 
are then cut into individual fractions and the tryptic digest is performed in-gel and followed 
by peptide extraction [183]. Other ways of sample fractionation can be performed on the 
peptide level using OFFGEL electrophoresis [184] or anion exchange (SAX) or cation 
exchange (SCX) columns [185, 186] for peptide separation according to their isoelectric 
points. 
Even such fractionated samples represent a highly complex mixture of peptides which cannot 
be analysed simultaneously in MS. This is why in modern proteomics mass spectrometers are 
coupled with liquid chromatography (LC) columns which separate all the peptides usually by 
reverse-phase chromatography. Peptides need to be ionised and transferred into the gas phase 
before entering mass spectrometer. The most common method used for performing both of 
those tasks in proteomics is electrospray ionisation (ESI) [187] developed by John Fenn who 
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was awarded a share of the Nobel Prize in Chemistry in 2002 for this invention. Peptides are 
eluted from the LC column with a very low flow and continuously enter the electrospray 






The challenges of modern proteomics generate requirement for the usage of complex tandem 
mass spectrometers as core instrumentation. These machines are composed of several 
different mass analysers and ion traps, which select and manipulate peptide ions for m/z ratio 
measurement and sequence determination. Peptide ions are precisely controlled inside the 
vacuum of a mass spectrometer by static and dynamic electromagnetic fields. Individual 
peptide ions can be selected by quadrupole mass analysers which tune the electromagnetic 
Figure 1.8. A general workflow scheme in MS-based proteomics. The analysed sample containing a mixture 
of different proteins (e.g. cell lysate, cellular fractions or purified complexes) is subjected to a digest with 
proteolytic enzyme such as trypsin. Generated peptides are separated on a liquid chromatography (LC) column 
just before entering the mass spectrometer via electrospray ionisation (ESI). Peptide ions are analysed by a 
tandem mass spectrometer containing at least two mass analysers, the most advanced instruments include an 
Orbitrap mass analyser shown on the graph. During analysis two types of mass spectra are generated for each 
peptide ion - MS for the whole peptide and MS/MS for its degradation products. Both of them are used for 
downstream data analysis including identification and quantitation of analysed peptides.  
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field so that only ions with a particular m/z ratio can pass through. Selected peptide ions can 
then be captured in a field of a linear or three dimensional ion traps where they can be 
accumulated [188, 189]. After a certain accumulation a cloud of selected peptide ions can be 
injected into the Orbitrap mass analyser on a stable orbit around inner electrode for a very 
accurate m/z ratio measurement. In another round of tandem mass spectrometry a sequence 
of selected peptide ion is determined. For this purpose peptide ions are subjected to some 
form of fragmentation, usually by collision with an inert gas such as helium at low pressure, 
which is called collision-induced dissociation (CID). Peptides usually break along the 
backbone and the m/z ratios of the fragmentation products called MS/MS can be used for 
sequence determination by matching the masses of fragments and the entire peptide with the 
database of all the known protein sequences from the analysed specie [190]. 
MS-based proteomic analysis generate enormous amount of raw data containing MS and 
MS/MS spectra for all the peptides detected in each sample. These data need to be processed 
by specialised software which will identify and quantify proteins based on several detected 
peptides. One example of such software package is MaxQuant - an open source program 
developed in the Mann Lab [191]. 
 
The aim of this study is to adapt this technique of quantitative proteomic analysis to 
investigate the dynamics of fast protein translocation to the cytoskeleton after 
chemoattractant stimulation. This type of analysis could bring new insight into the 
mechanisms regulating cytoskeletal dynamics during chemotaxis and elucidate the 
differential regulation of the two phases of actin polymerisation. I also want to discover 
novel and uncharacterised proteins which are expected to be identified with this approach 
and to start to define their role in the regulation of the cytoskeleton. 
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1.6.2. In vivo fluorescence microscopy 
 
Since proteomic analysis can only be applied to a whole cell population it will always 
generate averaged data from the entire analysed population. In order to gain further insight 
into function and regulation of proteins on cellular level the proteomic approach needs to be 
complemented with other methods. 
The best way to investigate subcellular localisation and dynamic behaviour of proteins, such 
as trafficking or stimulation induced translocation, is by using in vivo fluorescence 
microscopy [192]. In this technique a protein of interest is tagged with a fluorescent protein 
(FP) and expressed in cells or organisms of interest [193]. This is usually done by cloning a 
gene encoding the selected protein into a vector containing a coding sequence of fluorescent 
protein directly upstream or downstream of the insertion site. Expression of such a construct 
will lead to formation of a fusion protein with FP tag at the N- or C-terminus. 
Fluorescent proteins like all fluorophores can be excited by absorbing a photon. The exited 
state is very transient and the absorbed energy is either dispersed in a non-radiative way or 
emitted as another photon. Due to energy dissipation during a short life-time of the excited 
state, the emitted photon has lower energy and therefore longer wavelength than the 
excitation photon. This means that the light emitted by any fluorophore can be detected and 
measured independently from the light used for excitation [194].  
The first fluorescent protein discovered was a green fluorescent protein (GFP) which was 
isolated from the jellyfish Aequorea victoria by Osamu Shimomura in 1962 [195]. It took 
another 30 years before the gene encoding the GFP was cloned [196] and demonstrated to 
create fluorescence in other organisms [197, 198]. After that point the GFP was extensively 
studied and started being used as a tool in molecular biology.  
Even though the wild type GFP can generate fluorescence in other organisms it has several 
disadvantages for the practical use as a fluorescent molecular tag. These include a dual 
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picked excitation spectrum with a major peak at 395 nm, a low fluorescence quantum yield 
and low photostability and also poor folding at 37°C. A single point mutation (S65T) was 
found to dramatically improve the spectral characteristics of the GFP by shifting the 
excitation spectrum to a single peak at 488 nm while keeping the emission spectrum peak at 
509 nm [199]. Eventually all of these qualities were significantly improved by directed and 
random mutagenesis [200]. After obtaining the crystal structure of the GFP [201, 202] the 
crucial information about the chromofore formation and neighbouring residues was provided, 
which allowed for directed engineering of the fluorescent properties of this protein [203]. All 
these genetic modifications of the GFP led to formation of several different derivatives with 
various spectral characteristics and other specialised features. Some of those mutants have 
shifted excitation and emission spectra which include blue fluorescent proteins (BFPs) cyan 
fluorescent proteins (CFPs) and yellow fluorescent proteins (YFPs) [200, 203]. Other 
derivatives include super-fast folding fluorescent proteins [204, 205], photoactivatable 
fluorescent proteins [206-208] and few others [209-211], which can all be used for various 
specialised applications. In 2008 Martin Chalfie, Osamu Shimomura and Roger Y. Tsien 
were awarded a Nobel Prize in Chemistry for their discovery and development of the GFP. 
Several other fluorescent proteins from different aquatic organisms were isolated and 
characterised, many of which were also engineered to improve their qualities such as 
brightness, photostability and folding and to reduce their tendency for oligomerisation [212]. 
The whole process of developing GFP derivatives and isolating other fluorescent proteins 
resulted in formation of a wide range of FPs with different excitation and emission peaks 
spread over the whole spectrum of visible light (Fig. 1.9.). All these proteins have different 
characteristics such as brightness, photostability, expression levels, folding efficiency, 





       
Up to three different FPs can be used simultaneously for multiple labelling of different fusion 
proteins in single cell line, which can be then all imaged independently with hardly any 
cross-talk between the channels [213-215]. This gives a great opportunity to investigate 
colocalisation and interaction of different proteins within a cell.  
Figure 1.9. Excitation (A) and emission (B) spectra of some of the available fluorescent proteins (FPs) used 
in fluorescence microscopy. Different FPs can be used simultaneously for multicolour labelling of proteins. 
The most common combination for double labelling is GFP / RFP and for triple labelling CFP / YFP / RFP. 
BFP – blue fluorescent protein; CFP – cyan fluorescent protein; GFP – green fluorescent protein; YFP – 
yellow fluorescent protein; RFP – red fluorescent protein. 
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In parallel to the development of fluorescent proteins various techniques in fluorescence 
microscopy were developed and optimised allowing for quantitative analysis and high 
resolution imaging of cellular structures and processes. The majority of fluorescence 
microscopes in life sciences operate in the Epi-illumination mode in which the excitation 
light passes through the objective lens which is also used to collect the emitted fluorescence. 
In this method most of the excitation light is transmitted through the specimen and does not 
enter the microscope which improves the signal-to-noise ratio of the detected image. The 
reflected fraction of the excitation light, which reaches the objective together with the 
emitted light, is filtered out using dichroic mirrors and emission filters before the detector.  
The most basic design is a wide-field epifluorescence microscope, which collects the emitted 
light from the whole thickness of the illuminated specimen. This means that an image of 
visualised structures is always blurred by the light coming from outside of the focal plane. 
The contribution of out-of-focus light leads to decrease of image clarity and contrast which is 
most apparent when using objectives with high resolving power. Different ways of dealing 
with this problem have been developed. One approach is to collect wide-field images and 
then modify them by using complex computational algorithms which is commonly known as 
deconvolution process. A nonrestorative or 2D deconvolution improves contrast by removing 
out-of-focus light form the images while a restorative or 3D deconvolution requires several 
images from different focal planes of the sample to actually reassigns light to its proper place 
of origin [216].  
Another approach is to collect high contrast images by using more advanced microscope 
designs. The most common technique developed to obtain high contrast images is Confocal 
Laser Scanning Microscopy (CLSM). The key feature of a confocal microscope is a 
controlled and highly limited depth of focus which allows accusation of images from selected 
focal plane without the background created by the out-of-focus light. In the confocal 
microscopy the excitation light is transmitted through the specimen and illuminates 
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fluorophores in its entire depth similarly to the wide-field microscopy. The major difference 
is that the emitted light collected by the objective lens passes through an aperture with very 
small diameter which allows only the light from selected focal plane to reach the detector and 
obstructs all of the out-of-focus light [217, 218]. This technique can obtain images of very 
high contrast and high resolution and can also be used to generate a 3D image of the analysed 
structures [219, 220]. The disadvantage of this method is a relatively high exposure of the 
specimen to the excitation light which leads to increased photobleaching and phototoxicity 
and which is related to the fact that only small fraction of the emitted light is used to create 
an image while the rest of generated illumination still causes the negative effects.  
Few other techniques in fluorescence microscopy were developed to minimise the 
photobleaching and phototoxicity while obtaining high contrast images. These techniques 
utilise sophisticated optical designs to create a thin plane of light used for selective local 
illumination of the specimen instead of the global excitation by transmitted light. One 
example of such method is a Digital Scanned Laser Light-sheet Microscopy (DSLM) 
developed by Philipp Keller, which uses a light-sheet for optical sectioning of the specimen 
[221]. This type of fluorescence microscopy generates images with very high signal-to-noise 
ratio and it can be applied for large specimens such as a whole zebrafish developing embryo 
[222]. 
Another technique which uses a different kind of restrictive illumination is a Total Internal 
Reflection Fluorescence Microscopy (TIRFM) developed by Daniel Axelrod [223]. TIRFM 
uses an evanescent wave created during total internal reflection of the laser light at the glass-
water interface to selectively excite fluorophores in a restricted region immediately adjacent 
to this interface (Fig. 1.10.). The evanescent light wave decays exponentially from the 
interface and can therefore penetrate only a very thin region of about 200 nm into the 
specimen which means that the images obtained by the TIRFM contain essentially no 
background coming from deeper structures [224]. This specialised type of fluorescence 
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microscopy is therefore particularly useful for investigating the dynamics of events occurring 
at the cell membrane such as exocytosis [225] and the cell cortex including different aspects 







In this study I used the Confocal Scanning Laser Microscopy and the Total Internal 
Reflection Fluorescence Microscopy to visualise the in vivo dynamics of selected proteins 
which were detected by the quantitative proteomics analysis as factors responding to the 
chemoattractant stimulation. 
Figure 1.10. Total Internal Reflection Fluorescence Microscopy (TIRFM). Excitation laser light is projected 
at a low angle to the cover glass and totally internally reflected at the glass-water interface. During this 
process an evanescent wave is formed which penetrates about 200 nm into the specimen. This forms a very 
spatially restricted illumination zone which leads to selective excitation of only those fluorophores which 
are present at the membrane and periphery of the cortex of visualised cells. Deeper structures such as nuclei 
do not get illuminated. 
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Developmental Buffer (DB) : 
5 mM KH2PO4 5 mM Na2HPO4, 2 mM MgSO4, 0.4 mM CaCl2, pH 6.2. 
 
Stimulation Buffer (SM) : 
5 mM KH2PO4 5 mM Na2HPO4, 2 mM MgSO4, pH 6.2. 
 
Lysis Buffer (1x) : 
20 mM HEPES pH 7.4, 2 mM EGTA pH 8, 2 mM MgCl2, 0.2% Triton X-100, 1x Complete 
EDTA-free Protease Inhibitors cocktail (Roche, 11873580001). 
 
Fixing Lysis Buffer (1x) : 
20 mM HEPES pH 7.4, 2 mM EGTA pH 8, 2 mM MgCl2, 0.2% Triton X-100, 1% 
formaldehyde. 
 
Wash Buffer : 
100 mM HEPES pH 7.4, 2 mM MgCl2, 1x Complete Protease Inhibitors cocktail (Roche). 
 
Sample Buffer (SB, 1x) : 




Urea Buffer (UB, 1x) : 
100 mM Tris pH 8, 1% SDS, 2 M urea, 4.5% glycerol, 0.02% bromophenol blue. 
 
H-50 Transformation Buffer : 
20 mM HEPES pH 7, 50 mM KCl, 10 mM NaCl, 1 mM MgSO4, 5 mM NaHCO3, 1 mM 
NaH2PO4, pH 7. 
 
2.2. SILAC protocol 
 
2.2.1. Cell stimulation and lysis conditions 
 
Two cultures of Dictyostelium AX2 cells were grown in suspension on a horizontal shaker 
rotating at 170 rpm in a defined SIH medium (Formedium, SIH0310) until the populations 
went through 6 cell doublings. One population was grown in a light medium with all standard 
amino acids and the other population was grown in a heavy medium, in which standard K0 
L-lysine and R0 L-arginine were substituted with K8 L-lysine (U-13C6, 98%; U-15N2, 98%) 
and R6 L-arginine (U-13C6, 98%) labelled with stable isotopes of carbon 13C and nitrogen 
15N (Cambridge Isotope Lab, CNLM-291, CLM-2265). 
Cells were harvested at the density of 5x106 cells/ml, washed twice with Development Buffer 
(DB) and resuspended in DB at the density of 1x107 cells/ml. Cells were developed on a 
rotary shaker for 5 hours by pulsing with 30 nM final concentration of cAMP at 6 min 
intervals. Developed cells were washed once with Stimulation Buffer (SM) containing 1 mM 
EGTA in order to dissociate calcium dependent cell clusters formed during development, 
then once with pure SM and resuspended at the final density of 2x107 cells/ml in a pre-cooled 
to 12°C SM containing 3 mM caffeine to inhibit endogenous cAMP oscillations. 
 
- 52 -
Both heavy and light cell populations were kept on the rotary shaker in a thermostat at 12°C 
in the cold room for 20 min. The light cells were transferred to the 50 ml falcon tube with 
small magnetic bead and placed in a water bath adjusted to 12°C on a magnetic stirrer in the 
cold room. The cell suspension was stirred at about 300 rpm and 500 µl samples were 
transferred into 2 ml tubes containing 500 µl of ice cold 2x Lysis Buffer placed on a rotary 
horizontal mixer (IKA, Vibrax VXR) rotating at 1500 rpm.  
Samples were taken before the stimulation and after adding one pulse of cAMP at 500 µM 
final concentration at 6 time points: 4s, 10s, 20s, 60s, 120s and 180s. The initial one second 
time point was taken separately by adding 500 µl of unstimulated cells into 2 ml tube 
containing 5 µl of 50 mM cAMP and after one second adding 500 µl of ice cold 2x Lysis 
Buffer. The heavy cells lysate was prepared by mixing 5 ml of unstimulated heavy cells 
suspension with 5 ml of ice cold 2x Lysis Buffer in a 14 ml falcon tube and vortexing for 20 
s. One ml of this lysate was transferred into each tube containing previously prepared lysates 
of stimulated light cells. Mixed lysates were centrifuged for 2 min at 20,000 g at 2°C and the 
supernatants were discarded. Pellets were resuspended in 1 ml of ice cold Wash Buffer and 
transferred into 1.5 Protein LoBind tubes (Eppendorf, 2243108-1) and then centrifuged again 
in the same conditions. Final pellets were frozen and kept at -20°C until further processing. 
 
2.2.2. Sample preparation 
 
Frozen pellets (~7 µl) were thawed and resuspended in 12 µl of 1.5x Turbo DNase buffer 
containing 1x Complete EDTA-free Protease Inhibitors cocktail (Roche, 11873580001) with 
2 units of  Turbo DNase (Ambion, AM2238) and were incubated at 37°C for 30 min. 
Samples were then mixed with 7 µl of 4x Sample Buffer (SB) and boiled at 96°C for 6 min. 
After cooling down to room temperature and short spinning, 3 µl of fresh 1 M iodoacetamide 
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(Sigma, I1149) were added to the samples which were then incubated at room temperature in 
the dark for 30 min. After this alkylation step samples were mixed with 10 µl of 4x Urea 
Buffer (UB) to obtain the final sample volume of ~40 µl.  
Samples were run in NuPAGE 4-12% gradient bis-tris gels (Invitrogen, NP0335BOX). The 
gels were stained with Novex colloidal blue staining kit (Invitrogen, LC6025) for 4 hours in a 
sterile 14 cm tissue culture dish. After staining and washing the gels, sample lanes were cut 
into 12 fractions with a single use scalpel blades No.24 (Swann-Morton, 0211). Actin and 
myosin II bands were cut into individual fractions and the rest of the protein bands were 
divided into 10 fractions of similar sizes. Each gel fraction was further cut into cubes of 
about 1x1 mm and transferred into individual 1.5 ml Protein LoBind tube.  
 
2.2.3. In-gel digest and peptide extraction  
 
Gel pieces were washed with 500 µl of 40 mM NH4CO3 (Sigma, A6141) and mixed on a 
horizontal mixer at 1500 rpm for 15 min. 500 µl of CH3CN (Sigma, A3396) was added and 
samples were incubated at 45°C for 2 hours with periodic mixing. Supernatant was discarded 
and 250 µl of CH3CN was added to dehydrate the gel pieces for 10 min. Supernatant was 
discarded and gel pieces were dried in a vacuum centrifuge (Thermo Scientific, Savant 
SPD131DDA) for 10 min. 
Dried gel pieces were covered with 50 µl of 40 mM NH4CO3 containing 10 µg/ml of Trypsin 
Gold (Promega, V5280) and incubated at room temperature for 30 min to rehydrate. Between 
30 and 100 µl of 40 mM NH4CO3 was used to cover the gel pieces completely. Samples were 
incubated at 37°C overnight.  
Peptides were extracted with equal volumes (80-150 µl) of 50% CH3CN / 0.1% 
trifluoroacetic acid (TFA, Sigma 299537) by incubating at 45°C for 3 h with periodic mixing 
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on a rotary horizontal mixer at 1500 rpm. Supernatants were transferred to fresh Protein 
LoBind tubes and 400 µl of 50% CH3CN / 0.1% TFA was added to the gel pieces. Samples 
were again incubated at 45°C for 2 h with periodic mixing and supernatants were transferred 
to the tubes from the previous step. Combined supernatants containing extracted peptides 
were evaporated in a vacuum centrifuge at 45°C until fully dry.  
Dried peptides were resuspended in 15 µl of 0.1% TFA and purified using ZipTip C-18 
peptide purification microcolumns (Millipore, ZTC18S096). Each sample was analysed by 
100 min run on the LTQ Velos Orbitrap Mass Spectrometer (Thermo Scientific). 
 
2.3. Cross-linked SILAC protocol 
 
All the cell growth and development conditions were the same as in the standard SILAC 
protocol described above. 
In the cross-linked version of the SILAC protocol the Lysis Buffer contained formaldehyde 
(Sigma, 25.254-9) at the final concentration of 1%. Instead of collecting one 500 µl sample 
for each time point, the stimulation of light cells was repeated 4 times and 125 µl samples 
were collected for each time point from each stimulation and lysed with equal volume of ice 
cold 2x Fixing Lysis Buffer. The lysates of corresponding time points from all 4 stimulation 
series were combined and kept on ice for 30 min. The heavy cells lysate was prepared as 
described above, but with Fixing Lysis Buffer and was incubated on ice for 30 min before 
mixing with the combined lysates of the stimulated light cells. 
After centrifugation, the pellets were washed two times with 1 ml of Wash Buffer and 
transferred into 1.5 ml Protein Lo-bind tubes before freezing. 
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Samples were treated with DNase as described above. For the reversal of formaldehyde 
cross-linking samples were boiled with SB at 99°C for 40 min. After this step samples were 
processed as described above for the standard SILAC protocol. 
 
2.4. Data analysis 
 
Raw mass-spec data were processed using MaxQuant software developed by Jurgen Cox et 
al. in the Mann Lab, Max Planck Institute for Biochemistry, Martinsried [191]. MaxQuant 
version 1.0.13.13 was used to quantify peptide peaks and protein Light/Heavy (L/H) ratios, 
and Mascot Daemon (Matrix Science) version 2.3.2 was used to identify peptides.  
Data were analysed with the following variable modifications: Oxidation (M); Acetylation 
(N-term); Phosphorylation (S,T,Y); and one fixed modification: Carbamidomethylation (C). 
Maximum Posterior Error Probability (PEP) for each peptide was set at 0.05 and all the other 
settings were set as default. Protein L/H ratios were quantified, based on a minimum of two 
peptides per time point, using razor and unique peptides. 
Detected proteins were annotated in Excel with Gene Ontology (GO terms) and protein 
information obtained from the DictyBase web page (http://dictybase.org/Downloads/). 
Detections were filtered so that only proteins that had ratios present in at least four out of 
eight time points per experiment were selected for further analysis. 
Each protein’s series of unnormalised L/H ratios in each experiment were first normalised to 
their average and then two separate experiments were merged by averaging those ratios for 
each time point of each protein. Standard errors were calculated for each value. Those protein 
ratios series from two merged experiments were then normalised to the pre-stimulation time 
point for each protein separately. Standard errors were recalculated for each time point as a 
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square root of sum of squares of the standard errors calculated previously for this time point 
and the pre-stimulation time point. When the protein had no ratio present in the pre-
stimulation time point the ratios from the other time points were left normalised to the 
average with their original standard errors. Unnormalised L/H ratios series from the cross-
linked SILAC experiment were normalised to the pre-stimulation time point for each protein.  
These final protein L/H ratios series normalised to the pre-stimulation time point were 
analysed by clustering using a Cluster3 software created by Michiel de Hoon, University of 
Tokyo [229] and based on the earlier Cluster software developed in the Eisen Lab, University 
of California, Berkeley. We were using City-Block distance as a similarity metric and an 
average linkage as a clustering method. Clustering results were represented in the form of 
heat maps with the Java TreeView software developed by Alok Saldanha [230], Stanford 
University School of Medicine. 
 
2.5. Phalloidin actin polymerisation assay 
 
To measure the actin polymerisation in response to cAMP stimulation we used a modified 
version of the method previously described by Kim et al. from the Devreotes Lab [231]. 
Cells grown in HL-5 medium were harvested at the density of 4x106 cells/ml and were 
developed and stimulated as described before for the SILAC experiment. Stimulation was 
performed at 12°C water bath in the cold room. 200 µl samples were collected twice before 
the stimulation and every 5 s after cAMP stimulation for the first 30 s and then in various 
time points up to 4.5 min. Samples were lysed with equal volumes of ice cold 2x Fixing 
Lysis Buffer containing 1 µM Phalloidin – TRITC (Sigma, P1951). Lysates were mixed on a 
horizontal mixer at 700 rpm in the dark for 2 h at RT or overnight in the cold room. Samples 
were centrifuged at 20,000 g at 10°C for 10 min and the supernatants were discarded. In 
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order to extract the phalloidin 500 µl of methanol was added to the samples which were then 
mixed at RT on a horizontal mixer at 1000 rpm in the dark for 1 h. Samples were centrifuged 
at 20,000 g at RT for 2 min and two replicas of 200 µl for each time point were transferred to 
a 96-well microtiter plate with flat transparent bottom. Rhodamine fluorescence was 
measured using microtiter plate fluorometer (Anthos2001, Anthos Labtech) with 540 nm 
excitation filter and 575 nm emission filter.  
 
2.6. Molecular cloning 
 
2.6.1. Vectors for protein GFP tagging and overexpression 
 
We have adapted the comprehensive system of extrachromosomal expression vectors for 
Dictyostelium discoideum developed by Douwe Veltman et al. in the van Haastert Lab, 
University of Groningen [232]. Two vectors with G418 selection cassette, pDM317 with N-
terminal GFP tag and pDM323 with C-terminal GFP tag, were modified to fit the particular 
needs of design for this study. Multiple Cloning Site (MCS) on those vectors was modified 
by adding AgeI (ACCGGT) restriction site between the two existing sites for BglII 
(AGATCT) and SpeI (ACTAGT). At the same time the linker fragment between the insert 
and the C-term GFP tag on pDM323 was extended from 4 amino acids (ThrSerSerGly) to 8 
amino acids (ThrSerAlaGlyAlaSerSerGly). 5 amino acids linker (SerGlyLeuArgSer) on 
pDM317 was not modified. These modifications were made by inserting short fragments of 
dsDNA with cohesive ends compatible with BglII and SpeI restriction sites present on the 
vectors. These fragments of dsDNA were generated by aligning two oligos mixed in 
equimolar ratios. Fragment inserted into the MCS of pDM317 was formed from 18 base long 
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oligos: GATCTGCTACCGGTAGTA and ACGATGGCCATCATGATC. Fragment inserted 
into the pDM323 vector was made from 30 base oligos: GATCTGCAACCGGTAGTA-
CTAGTGCAGGAG and ACGTTGGCCATCATGATCACGTCCTCGATC.  
After these steps both vectors were further modified by inserting expression cassette 
containing mRFPmars-Lifeact (RFP-lifeact) actin probe construct into the NgoMIV 
restriction site. First RFP-lifeact probe was generated by inserting dsDNA fragment formed 
from 61 base oligos, GATCCATGGGTGTTGCTGATTTAATTAAAAAATTTGAATCAA-
TTTCAAAAGAAGAAA and GTACCCACAACGACTAAATTAATTTTTTAAAGTTAG-
TTAAAGTTTTCTTCTTTGATC, into the BglII and SpeI sites on pDM318 with N-term 
mRFPmars tag. The whole expression cassette with act15 promotor, RFP-lifeact construct 
and act8 terminator was amplified by PCR using high fidelity KOD polymerase (Novagen, 
71086) with primers intoducing NgoMIV restriction sites at the ends of the cassette. PCR 
product was purified using PCR clean-up kit (Qiagen, 28106), digested with NgoMIV 
restriction enzyme (NEB, R0564), and purified again. This construct was ligated using T4 
DNA ligase (NEB, M0202) into modified pDM317 and pDM323 vectors digested with 
NgoMIV and dephosphorylated with Antarctic Phosphatase (NEB, M0289). This insertion of 
a second expression cassette into the plasmids is a part of the whole vector system design, 
allowing coexpression of two tagged proteins from a single vector, which ensures similar 
expression levels in each cell [232]. The final vector based on the pDM323 was called 
pDG600 and the vector based on the pDM317 was called pDG700. 
 
2.6.2. Cloning procedures 
 
Genes selected for cloning were amplified from genomic DNA by PCR using KOD 
polymerase and primers which introduced restriction sites at the ends of the PCR products. 
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Each forward primer contained restriction site for BglII or one of the enzymes generating 
compatible cohesive ends: BamHI and BclI. Several genes which had all of those sites 
present were cloned using AgeI site on the vectors. Those genes were amplified with forward 
primers containing recognition sequence for AgeI or XmaI which generates compatible 
cohesive ends. Reverse primers were carrying restriction sites for SpeI or XbaI or NheI. All 
the restriction sites on the primers were flanked with 5 base fragments to allow efficient 
digest of the PCR products. Primers were designed to have the annealing temperature of 
54°C. Initially all the genes were amplified using standard PCR conditions with 24 cycles, 
annealing temperature of 50°C, annealing time of 15 s, extension temperature of 68°C and 
extension time of 40s/kb. Reactions which did not yield sufficient amount of product or 
which  generated additional non-specific products were further optimised using gradient PCR 
with annealing temperatures between 45°C and 60°C with 3°C steps. For a few genes the 
number of cycles was increased up to 28. Reactions were performed in 50 µl with 30 ng of 
genomic DNA and 0.5 unit of KOD polymerase in Eppendorf Mastercycler ep Gradient S. 
 
PCR products were purified with PCR clean-up kit (Qiagen, 28106) using QG buffer instead 
of PB buffer to ensure total protein denaturation and prevent potential cohesive ends 
degradation by any remaining polymerase proofreading activity. Purified samples were 
digested simultaneously with two restriction enzymes appropriate for each construct’s 
design. After restriction digest samples were purified again with the same method as before 
and the DNA concentration was measured with NanoDrop ND 1000 spectrophotometer 
(Thermo Scientific). These final samples were ligated into pDG600 and pDG700 vectors.  
Vectors were prepared by digesting first with SpeI (NEB, R0133) for two hours at 37°C, then 
the enzyme was heat inactivated at 80°C for 20 min and then the vectors were incubated with 
BglII (NEB, R0144) or with AgeI (NEB, R0522) for two hours at 37°C. After the digests 
vectors were dephosphorylated with Antarctic Phosphatse (NEB, M0289) at 37°C for 30 
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min, which was then heat inactivated at 70°C for 5 min, and samples were purified using 
PCR clean-up kit. 30 ng of plasmid DNA was mixed with approximately two molar excess of 
insert DNA in 5 µl samples. Ligations were performed using 0.5 unit of T4 DNA ligase 
(NEB, M0202) at 16°C overnight and the whole sample volumes were used for 
transformation of chemo-competent DH5 E. coli cells.  
Initially 6 clones from each transformation were checked by colony PCR and if none of them 
was positive another 12 clones were screened. If the second round of screening failed to 
detect positive clones the ligation was repeated. Constructs generated on pDG600 were tested 
using insert forward primer and GFP reverse primer and constructs on pDG700 were tested 
with GFP forward primer and insert reverse primer. Whenever available, two positive clones 
for each construct were purified from bacteria using Plasmid Miniprep kit (Qiagen, 27106). 
Constructs were validated by restriction analysis with two sets of enzymes: BglII/HindIII and 
BamHI/SpeI.  
 
2.7. Dictyostelium cells transfection 
 
AX2 cells were grown in a shaking culture in HL-5 medium up to 4x106 cells/ml. Cells were 
harvested by centrifugation at 600 g for 2 min, washed two times with H-50 buffer and 
resuspended in H-50 buffer at the density of 5x107 cells/ml. 100 µl of this cell suspension 
was mixed with 1 µg of plasmid DNA and transferred to an ice cold 0.1 cm electroporation 
cuvette. Cells were electroporated with two 0.65kV pulses at 25 µF capacitance with 5 
seconds interval. Cuvettes were incubated on ice for 5 min and the cells were transferred to 
6-well culture plates with 4 ml of HL-5 medium with Ampicillin and Streptomycin or to 10 
cm Petri dishes with 10 ml of HL-5 medium with antibiotics. Selection drug G418 was added 
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6-18 hours after transfection to a final concentration of 30 µg/ml. Cells were grown for at 
least 4 days after transfection before being used for in vivo imaging. 
 
2.8. In vivo fluorescence microscopy 
 
About 5x106 cells from each strain were collected and washed twice with 1 ml of DB in 2 ml 
tubes and resuspended in 0.5 ml of DB. Cells were developed in the dark during 5 hours of 
starvation in 2 ml tubes on a horizontal mixer at 300 rpm. After development cells were 
washed once with SM containing 1 mM EGTA then with DB and resuspended in 0.5 ml of 
DB with 3mM caffeine. 100 µl of these cell suspensions were transferred to separate 
chambers of 8-chambered cover glass (Nunc, 155411) and mixed with additional 250 µl of 
DB with 3 mM caffeine. Cells were kept in the dark for 10 min to settle and attach to the 
bottom and were then used for imaging with confocal and Total Internal Reflection 
Fluorescence (TIRF) microscopy. During each imaging session cells were stimulated by 
adding 50 µl of 4 mM cAMP to the chamber. 
 
2.8.1. Confocal microscopy 
 
Confocal microscopy was performed using Leica DM IRBE confocal laser scanning 
microscope with 100x objective. GFP was exited with 488 nm laser and the light emitted 
from this protein was collected between 500 - 540 nm. mRFPmars was exited with 543 nm 
laser and the emitted light was collected at 580 - 640 nm. Both channels were scanned at one 
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frame per second (fps) with 800 Hz scanner speed and 512x512 pixel resolution and the light 
was detected by a photo multiplier tube. 
Confocal images were quantified by ImageJ software by selecting a region of interest (ROI) 
covering a fragment of cell cortex and reslicing the average signal intensity of those ROI as a 
function of time. The intensity profile was generated giving a temporal dynamics for both 
GFP and RFP signals within this fragment of the cortex.  
 
2.8.2. TIRF microscopy 
 
Total Internal Reflection Fluorescence microscopy was performed using Nicon Eclipse Ti 
TIRF microscope with 100x objective. GFP was exited with 488 nm laser and the emitted 
light was filtered through a 500-530nm filter. mRFPmars was exited with 594 nm laser and 
the emitted fluorescence was filtered through a 600 – 630 nm filter. Both channels were 
detected by a CCD camera with various exposure times between 50 – 300 ms at 1024x1024 
pixels resolution. When only green channel was imaged, pictures were collected at a constant 
rate of 2 fps. When both channels were analysed the image collection speed was limited by a 
filter changing mechanism which performed with a variable efficiency and resulted in a 
variable intervals of 2.5 – 4 seconds between the frames. 
TIRFM imaging sequences captured only for GFP fluorescence with constant rate of 2 fps 
were quantified using ImageJ and Time Series Analyser plug-in with ROIs selected in the 




3. Proteomic analysis of the cytoskeleton 
 
3.1. Experimental approach 
 
I have adapted the generic SILAC protocol [182] to analyse fast protein translocation to the 
cytoskeleton insoluble fraction upon cAMP stimulation (Fig. 3.1.). The cytoskeletal fractions 
from various time points after cAMP stimulation were prepared using protocol based on the 
standard cytoskeleton purification procedure. Triton X-100 insoluble fractions were 
separated by centrifugation and briefly purified with a single washing step. Samples prepared 
in this way are composed of acto-myosin filaments with all the proteins attached to them, but 
also other cellular structures resistant to lysis in those conditions, such as the nuclei. This 
method relies on a fast cell lysis stopping all the biochemical reactions by diluting the 
necessary cytosolic factors, and on maintaining protein-protein interactions during the entire 
process of sample preparation. In the course of method development I performed three pilot 
SILAC experiments with various modifications in preparation and buffer composition. I also 
analysed kinetics of the cell lysis in various conditions by measuring changes in light 
scattering after adding the lysis buffer to the cell suspension (data not shown). Several 
modifications to the protein Sample Buffer and the final sample preparation were tested to 
establish the best procedure of efficient sample solubilisation and separation on the SDS-
PAGE. The lysis conditions were optimized to decrease the delay in cell lysis and the 
cytoskeleton purification procedure was shortened to a minimum and performed at 0°C. 
Stimulation with cAMP was performed at 12°C in order to slow down the response allowing 
reproducible capturing of the first phase of actin polymerisation. The final working protocol 
is described in detail in the Materials and Methods chapter. 
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Two independent experiments were analysed and the results were combined. All the 
proteomic data presented in the heat-maps are protein L/H ratios averaged from two 
experiments and normalised to pre-stimulation levels. Original data from each experiment are 





In order for the SILAC experiment to succeed cells need to incorporate ‘heavy’ forms of 
lysine and arginine provided in the SILAC medium into their proteins. In optimal conditions 
after five cell doublings in the ‘heavy’ SILAC medium about 97% of all the lysine and 
arginine residues in the entire proteome should contain the labelled forms of those amino 
acids. Therefore one of the most important controls of the SILAC procedure performed at the 
initial stages of the protocol development was the analysis of incorporation efficiency of the 
‘heavy’ amino acids into the proteome of Dictyostelium cells. Cytoskeleton fraction from the 
‘heavy’ cell population grown in a shaking culture for five cell doublings was analysed 
separately and the results were used to determine the incorporation efficiency (Fig. 3.2.). 
Figure 3.1. SILAC experimental workflow. ‘Light’ cells were stimulated with cAMP and lysed at various 
time points with Triton X-100 lysis buffer. ‘Heavy’ cells were lysed without stimulation and served as an 
internal reference of protein abundance in each time point of stimulated population. Insoluble fractions were 
fractionated by SDS-PAGE and digested with trypsin. Extracted and purified peptides were analysed by the 
LTQ Velos Orbitrap MS. Data were processed with the MaxQuant software. The final protein dynamics 
patterns were clustered and represented in the form of heat maps. 
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Figure 3.2. Results from the labelling efficiency control. A) Mass spectrum (MS) of a SILAC pair of a peptide 
containing a single lysine residue (ALHLFGPTLGYFGEAK ) with H/L ratio value of 29.7. B) MS of a SILAC 
pair of a peptide containing a single arginine residue (AAITNDFIGSEIR ) with H/L ratio value of 51.9. Blue 
brackets indicate isotopic distribution peaks belonging to the ‘light’ forms and red brackets to the ‘heavy’ forms. 
C) Unnormalised ratio H/L distribution of the 616 detected proteins. Ratio H/L values indicate labeling 
efficiency of the proteins, e.g. H/L ratio 4 corresponds to 80% of labeling efficiency and H/L ratio 9 corresponds 
to 90% labeling efficiency. D) Labelling efficiency groups of all the detected proteins. The range of labelling 
efficiency indicates the contribution of ‘heavy’ forms of lysine and arginine incorporated into the proteins.  
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The Ax2 axenic strain of D. discoideum used in this study is auxotrophic for both lysine and 
arginine [233] and I observed efficient incorporation for each of those amino acids. Examples 
of mass spectra for one peptide containing a single lysine residue and one containing a single 
arginine residue are presented in Figure 3.2. A and B. The H/L ratio values of those peptides 
correspond to the labelling efficiency of about 97% and 98% respectively.  
A general ratio H/L distribution of entire proteins indicates a wide range of labelling 
efficiencies for different proteins (Fig. 3.2. C). While most of the 616 detected proteins fall in 
the range of H/L ratio value between 6 and 20 which corresponds to 85-95% labelling 
efficiency (about 66% of all the proteins) there are some that are labelled with lower than 
75% efficiency and some that are labelled with almost 99% efficiency. In total more than 
60% of all the proteins are labelled with higher than 90% efficiency and about 85% of all the 
proteins show labelling efficiency above 85% (Fig. 3.2. D).  
There are several reasons for this relatively big variability in the extent of ‘heavy’ amino 
acids incorporation between different proteins. One factor might be simply a measurement 
error which will most likely affect the low abundant proteins represented by very few 
peptides. Another more specific factor might be a variable protein turn-over rate. Proteins 
with high turn-over rates and short lifetime will go through more generation cycles than the 
number of cell doublings and will be therefore labelled with higher efficiency than the most 
stable proteins with slow turn-over rates. But even the proteins with turn-over rate as slow as 
the pace of the cell cycle should be labelled with efficiency exceeding 95% after 5 cell 
doublings. A variable cell doubling time within one cell population might therefore be the 
most important factor responsible for the presence of proteins labelled with low efficiency. 
Even though the total cell count indicates 5 cell doublings of the whole population it is likely 
that some cells will undergo more than 5 doublings while others will divive more slowly. 
This slowly dividing fraction of the cell population might potentially maintain certain 
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proteins with significantly lower incorporation factor than the rest of the population, which 
could affect the final H/L ratio value for those proteins.  
Nevertheless the final result with the average labelling efficiency for the whole sample of 
93% is satisfactory. Even the proteins exhibiting low incorporation of ‘heavy’ amino acids of 
around 80% can still provide informative and fairly quantitative results. In my experimental 
design ‘heavy’ cell population serves as an internal reference in the SILAC experiments. 
Levels of the labelled proteins remain constant in all the time points while only the ‘light’ 
forms of the proteins change their abundance levels. The final L/H ratio values from all the 
time poins are then normalised to the prestimulation time point. 
Table 3.1. shows how different labelling efficiencies will affect the SILAC results including 
initial unnormalised ratios and final ratios normalised to the prestimulation time point (t0).  It 
is noticeable that the normalisation to the prestimulation time point abolishes most of the L/H 
ratio variabilities coming from differential labelling efficiency of the ‘heavy’ forms.  Low 
labelling efficiency of proteins in the ‘heavy’ population leads to overestimation of 
unnormalised ratios but underestimation of the L/H ratios after normalisation to t0. There is 
surprisingly little difference between the final normalised L/H ratios quantified for proteins 
with high and low labelling efficiencies of the ‘heavy’ form. A three fold increase of the 
‘light’ form normalised to 1 : 1 proportion at the prestimulation time point would be detected 
as 2.8 fold enrichement for protein labelled with 90% efficiency at the ‘heavy’ population 
and as 2.6 fold enrichment for protein showing 75% labelling efficiency (Tab. 3.1.).  
This shows that the accuracy of the SILAC ratios quantification is affected by the labelling 
efficiency lower than 95% but this is a relatively mild effect not exceeding the biological or 
technical variability and the obtained results can still be analysed in a quantitative manner.  
Another factor which needs to be considered during setting up a SILAC procedure is a 
potential metabolic transition of ‘heavy’ arginine into proline. This would lead to generation 







significantly the outcome of the experimental results. This issue was addressed by analysing 
one of the SILAC experiments with variable modifications including labelled forms of 
proline P(5) and P(6). The obtained results indicated that this transition process is essentially 
not occurring in the analysed cells. There were 37 labelled residues of proline detected in 
total which corresponds to only 0.11% of 33,589 proline residues found in the entire 
experiment. The abundance levels of those few ‘heavy’ prolines detected were so low that 
the H/L ratios for those modified peptides were usually not available or very small and it was 
very difficult to find their peaks at the mass spectra (data not shown). 
Table 3.1 Effects of various labeling efficiencies on the SILAC ratio quantification in the experimental design 
used in this study. Decreased labeling efficiency of the ‘heavy’ form used as an internal control, leads to 
overestimation of detected unnormalised L/H ratios and underestimation of L/H ratios after normalization to 
the prestimulation time point. All the calculations assume 1 : 1 proportion of ‘light’ and ‘heavy’ forms in the 
prestimulation time point.  
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3.2. General protein detection  
 
Total protein detection from the SILAC experiments included about 2500 proteins. Around 
30% of those proteins were detected only in one or two time points and were therefore not 
informative. After filtering out the proteins with detection lower than 4 time points, there 
were about 1800 proteins left, which were detected with a minimum of 2 peptides/protein in 
each time point. Proteins were annotated with Dictyostelium Gene Ontology Annotations and 
divided into several groups based on the Cellular Component information (Fig. 3.3). There 
were more than 200 cytoskeletal proteins which formed a 11% fraction of all the identified 
proteins. Nuclear proteins had slightly higher contribution of 12% while 5 other protein 
groups: phagocytic vesicle, centrosome/microtubules, membrane, mitochondria and 
ribosomes formed smaller fractions of 2-7%. Other characterised proteins which did not have 
any Cellular Component annotation were put together in a group called ‘other’, which 
contained one third of all the proteins detected. Second biggest protein group called 
‘unknown’, which covered almost one quarter of all the proteins detected, was made up from 
proteins of unknown function. These proteins are predicted from the DNA sequence and 
some of them have protein domains identified by homology analysis, but they were never  
characterised and do not have individual names other than the gene/protein IDs. 
The general overview of proteins identified in the SILAC experiments shows that 
cytoskeletal proteins form relatively small portion of all the proteins detected in the insoluble 
cell fraction analysed. On the other hand out of the first 20 proteins with the highest detection 
intensity 5 were cytoskeletal factors, including actin, myosin II heavy chain and coronin A 
described later in detail. This indicates that the analysed samples were significantly enriched 
in the cytoskeletal fraction, but the exact enrichment factor could only be determined by 








There are few interesting facts to notice in this overview of identified proteins. The 
substantial part of the whole detection is formed by the nuclear proteins, which is caused by 
the fact that nuclei stay intact in the lysis conditions used and they get centrifuged and 
purified at least as efficiently as the cell cortex. Another big class of identified proteins are 
components of the ribosomal machinery, which suggests that the rough Endoplasmic 
Reticulum (ER) containing these macrocomplexes is also somewhat resistant to the lysis with 
Triton X-100 detergent and gets purified with other cellular structures. Presence of many 
putative membrane proteins in those samples also suggests that some membranous structures 
are preserved in this purification procedure. It is encouraging to notice that almost 25% of all 
the molecules identified, are the proteins of unknown function, since besides quantifying the 
translocation dynamics of the cytoskeletal proteins, one of the main goals of this research 
project was to identify novel cytoskeletal components. 
Results from two SILAC experiments were combined and these final protein L/H ratios 
series normalised to the pre-stimulation time point were analysed by clustering using a 
Figure 3.3. Protein detection in the SILAC experiments. Proteins were divided into 9 groups based on the 
Cellular Component information from Gene Ontology Annotations. Cytoskeletal proteins represent 11% of all 
the proteins identified. ‘Other’ represents characterized proteins with no Cellular Component information 
available. ‘Unknown’ represents  proteins of unknown function which have not yet been characterized. 
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Cluster3 software created by Michiel de Hoon, University of Tokyo [229]. The purpose of 
this step was to separate all the proteins into several groups of distinct translocation dynamics 
patterns. We were using hierarchical clustering with City-Block distance as a similarity 
metric and an average linkage as a clustering method. These clustering settings were found to 
generate the best grouping of proteins into clusters with similar dynamics patterns.  
Clustering results were represented in the form of heat maps with the Java TreeView 
software developed by Alok Saldanha, Stanford University School of Medicine [230]. 
 
3.3. Cytoskeletal proteins 
 
As mentioned earlier, a good factor indicating that the analysed fractions were enriched in 
the cytoskeletal factors, is that the two major structural constituents of the cytoskeleton,  
actin and myosin II heavy chain, were among the first four most abundant proteins detected.  
Dictyostelium genome contains 29 genes encoding actin proteins with amino acid identity 
greater than 83%. 17 of those genes encode identical proteins and another 3 have only few 
amino acid differences, while the rest are a bit more divergent [22]. This represents a big 
challenge for proteomic analysis, since the majority of those proteins will generate a pool of 
identical peptides, which will not be possible to allocate to a single protein, these are the 
razor peptides. Those actins that do have unique peptides generated in a tryptic digest will 
have only few of them and the quantification of protein ratios based on those few remaining 
unique peptides will be less reliable than the one based on all the data available. This is the 
reason why protein ratios were quantified using both unique and razor peptides.  
MaxQuant algorithms allocate the whole pool of razor peptides to a single protein which has 
the highest unique peptides intensity of all the proteins sharing this pool [191]. In these 
experiments all the actin razor peptides, which contained most of the actin peptides 
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altogether, were allocated to Act10 protein, which is therefore a representation of the total 
combined actin response to cAMP stimulation. It reaches a peak of the first phase at 4 s 
which lasts until 10 s at a level of about 2.3 L/H. It is followed by depolymerisation phase 
with the lowest point of 1.2 L/H at 60 s and then rises slowly reaching the highest point of 
the second phase with 1.7 L/H at 180 s. This is the basic actin dynamics which is in 
agreement with the data previously collected by phalloidin assay (Fig. 3.5. E).  
There were two other actins detected in at least 4 time points, Act17 and Act22, which were 
both quantified using only the few unique peptides available. Act17 shows higher amplitude 
in the first phase than Act10, but is not detected in the last two time points, while Act22 
shows a bit more noisy pattern than the whole group represented by Act10. This actin 
dynamics is by far the most commonly represented pattern which is shown in variable 
amplitude and sometimes slightly different timing by the whole variety of proteins and 
protein complexes. It is shared by structural components such as Arp2/3 complex, actin 
filaments effectors like bundling proteins and finally the regulatory factors including GEFs 
and GAPs (Fig. 3.4.). Another common profile of protein dynamics is the one represented by 
myosin II complex. It shows slight increase in the early time points followed by depletion at 
10 s and 20 s and then reaches the main peak of around 3 L/H in the last 3 time points, which 









Abbreviations of protein annotations used in the heat-maps: 
 
ABP – actin binding protein;     KIN – kinase; 
adpr – adaptor protein;      PHOS – phosphatase; 
bd – binding;      put – putative; 
con – containing;      pr – protein; 
cpx – complex;       reg – regulatory; 
dcp – domain containing protein;    rel – related; 
fam – family;       rep – repeat; 
gr – group;       sim – similar; 





 Figure 3.4. Protein dynamics of the cytoskeletal proteins. Only proteins with response higher then 1.5 L/H in a 
minimum of one time point after cAMP stimulation are presented.  
Cytoskeletal proteins showing strong response 
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3.3.1. Structural components of the cytoskeleton 
 
Proteins that follow actin dynamics most closely are the structural components of actin 
filaments. These include the major actin nucleator – Arp2/3 complex, at the pointed end and 
the capping protein – Cap32/34 complex, at the barbed end. All 7 components of the Arp2/3 
complex share the same actin-like pattern with certain variability in amplitude which is not 
reproducible between the two experiments and is most likely caused by the measurement 
errors rather than differential response (Fig. 3.5. B). It is therefore more appropriate to 
analyse the Arp2/3 complex as a single unity rather than each component separately (Fig. 
3.5. C). This primary nucleator of actin filaments has the same timing as actin dynamics but 
shows higher enrichment reaching more than 3 L/H during the first phase of actin 
polymerisation. It goes down to almost exactly pre-stimulation levels in the 60 s time point 
and then reaches similar levels as actin in the last two time points.  
Both components of the capping protein complex Cap32/34 also share virtually the same 
pattern, with variability not exceeding measurement error and should also be analysed 
together. This major inhibitor of the actin filaments elongation follows the actin dynamics 
much more closely than the Arp2/3 complex. It reaches almost the same levels in nearly all 
the time points except for 20 s, which is the beginning of depolymerisation phase, when 
Cap32/34 shows slower depletion rate than actin. It is interesting to notice that in the first 
phase the Arp2/3 complex shows much higher enrichment than the Cap32/34 and actin, while 
in the second phase all of those components share the same ratios.  
Myosin II complex reveals a biphasic response to cAMP stimulation as well, but with 
different timing and pattern than actin. It has a short and low first phase with a peak of 1.6 
L/H lasting from 1 s to 4 s followed by a disassembly phase when it goes down close to pre-









Figure 3.5. Protein dynamics of the major structural cytoskeletal components. (A) Heat-map representation of 
the L/H ratios for standard and cross-linked SILAC experiments. (B) Graph representation of the results from 
standard SILAC for all the components of protein complexes separately. Actin – red; Arp2/3 subunits  – green; 
Cap32/34 subunits – violet; myosin II subunits – blue. (C) Protein dynamics patterns from the standard SILAC 
experiment for the whole protein complexes, based on combined results from individual subunits. (D) Protein 
dynamics patterns from the cross-linked SILAC experiment for the whole protein complexes, based on combined 
results from individual subunits. (E) Actin dynamics in response to cAMP stimulation measured with phalloidin 
assay (red) and with SILAC experiment (green).  
Structural components of the cytoskeleton 
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of about 3 L/H, which stays constant in the following two time points. It is noticable that in 
the first phase of myosin II filaments assembly all three components of this protein complex 
show exactly equal levels of enrichment, as we would expect form a stable complex. On the 
other hand during the second phase of myosin response, essential light chain (ELC) shows 
higher L/H values than myosin heavy chain (MHC) and regulatory light chain (RLC) (Fig. 
3.5. B). Detailed examination of the results for the subunits of myosin II filaments from all 
the experiments performed revealed however that this tendency is not well reproducible 
between different biological replicas and is most likely an artefact caused by some form of 
variability or measurement error.  
All of these major structural proteins served as a good positive control of the response to 
cAMP measured in the SILAC experiments. These results confirmed that this method is 
capable of analysing protein translocation to the cytoskeleton for multiple proteins in a single 
experiment. Differences in L/H values between several subunits of a single protein complex 
indicate the accuracy levels and error range in the MS measurements. 
These controls were also used to validate the cross-linked SILAC with formaldehyde fixation 
during cell lysis. In this experiment all of those structural factors show the same type of 
dynamics patterns as in native lysis conditions, but with significantly lower amplitudes. Only 
the Arp2/3 complex reaches similar levels of enrichment as in the standard SILAC 
experiment with first peak around 2.8 L/H and the second peak of 1.6 L/H (Fig. 3.5. D). 
Actin and Cap32/34 complex again follow almost identical profile with the first peak at 10 s 
reaching 1.5 L/H and the second peak hardly noticeable. This generates even greater 
asymmetry between them and the Arp2/3 complex, which in this experiment shows higher 
levels of translocation in both phases of stimulation response.  
Myosin II complex shows the same biphasic response as in the standard SILAC experiment, 
but with lower amplitudes reaching 0.8 L/H level during disassembly phase and the second 
peak around 1.9 L/H at 2 min after cAMP stimulation. Possible reasons for the differences in 
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the protein dynamics amplitudes between standard and cross-linked SILAC experiments will 
be discussed later. 
 
3.3.2. Regulatory components of the cytoskeleton 
 
There is a big range of cytoskeletal regulatory factors detected in the SILAC experiments, 
including 14 small GTPases, 24 GEFs, 13 GAPs and a variety of protein kinases. GTPases 
such as RasG, which is known to be the master regulator of signalling pathways controlling 
the cytoskeleton [98], did not show any significant changes upon cAMP stimulation 
(Supplementary Materials). This is consistent with the notion that GTPases form only 
transient interactions with the downstream effectors. On the other hand proteins responsible 
for activation and inhibition of their activity, GEFs and GAPs respectively, did reveal 
temporal translocation to the insoluble fraction after chemoattractant stimulation (Fig. 3.6.).  
Most of the GEFs followed, with certain approximation, the general actin dynamics showing 
early and late peaks (Fig. 3.6. A). The ones that followed actin profile most closely were: 
ZizA, Roco5, GxcW, GxcDD, GxcA, GefD and DDB_G0280221. Due to low time resolution 
and relatively high noise fluctuations of those data, it is challenging to divide all the detected 
activators into unambiguous groups of factors playing major role in triggering the first phase 
and those responsible for induction of the late response to cAMP stimulation.  
There is a set of GEFs which show clear translocation in the early time points but are 
depleted during the second phase. These proteins which are most likely to be specifically 
involved in regulation of the first phase of actin polymerisation are: DocA, DocB, GefA, 
GefR, ZizC and GxcD. DocA and DocB are most significantly enriched in the first phase and 
most significantly depleted in the second phase within this group. Both of those proteins 
reach the highest point of their peaks in the earliest 1 s time point. This is a strong indication 
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that these two proteins might be among the earliest regulators to respond to cAMP 
stimulation. There is only one GEF – GxcQ, which has significantly higher enrichment in the 
second phase than in the first phase of actin response detected in the standard SILAC.  
The majority of GAPs also show enrichment in time points following cAMP stimulation. 
Some of them follow patterns similar to actin dynamics, but the resemblance is not as strong 
as for GEFs. RapGAP1 and Bub2 reveal highest similarity to actin profile, while GacHH has 
the strongest response from all the GAPs and if follows more myosin-like profile, reaching 
more than 4 L/H values in the last 3 time points.  
There were several other regulatory components sharing the common profiles of protein 
dynamics. Few PI3Ks were found to follow the generic actin profile, the strongest of which 
were PikA and PikF. Two kinases known to play roles in signalling to the cytoskeleton, p21-
activated protein kinase PakB and Tor, were detected. PakB, which binds to PI(3,4,5)P3, 
follows the general actin dynamics with amplitudes around 1.7 L/H (Fig. 3.4. and 4.17.). A 
Tor protein, component of a TORC2 complex playing a central role in one of the signalling 
pathways described earlier, follows a pattern closely correlated to myosin dynamics with a 















 Figure 3.6. Protein dynamics of the regulatory cytoskeletal components. (A) Profiles of all GEFs detected in 
standard SILAC experiment. (B) Profiles of all GAPs detected in standard SILAC experiment. 
Regulatory components of the cytoskeleton 
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3.4. Proteins from other cellular components 
 
Mixed composition of the analysed samples allowed us to look at the behaviour of proteins 
from various cellular components. Interestingly most of those proteins do show certain 
changes in abundance in response to cAMP stimulation. Some of them might represent just 
the stochastic fluctuations but some are clearly above the noise levels and reveal systematic 
changes across several time points. These protein groups will be only briefly described here, 
as they are not in the centre of interest of our analysis. Patterns of protein dynamics for each 
of the non-cytoskeletal groups are shown in Figures 3.7. and 3.8.  
There is a general systematic notion that most of the proteins are enriched after cAMP 
stimulation and only small proportion of molecules is depleted from the analysed fractions 
after stimulation. The dynamics patterns are always more reliable if they show persistence 
within few sequential time points, as this type of pattern is less likely to be caused by noise 
fluctuations. In other than cytoskeletal protein classes it is more common to see these 
persistent patterns in later time points, corresponding to the second phase of actin 
polymerisation. There are few examples of several proteins sharing the same common pattern 
of translocation dynamics, such as actin-like or myosin-like profile. One example is within 
phagocytic proteins where few of them share similar pattern of enrichment with a peak at 2 
min time point. There is also a group of several membrane proteins showing similar response 
to cAMP stimulation.  
Ribosomal proteins are an interesting example of this collective behaviour, as majority of the 
proteins in this class share very similar pattern of biphasic dynamics with peaks at 4 s and 2 
min and a dip at 10 s and 20 s time points (Fig. 3.8. top left). These patterns have rather small 
amplitude with the peaks reaching usually not more than 1.5 L/H levels, but it is interesting 
to see that this pattern resembles actin dynamics. It is not surprising that so many of the 
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ribosomal proteins share similar pattern, since they form a structurally integral complex, but 
the similarity of this pattern to the actin dynamics is not something to expect.  
One possible simple explanation for this observation is purely mechanistic and it requires 
assumption that rough ER stays intact during the lysis. With this assumption it is easy to 
imagine that sheets of this rough ER will be trapped in the cell cortex formed by the 
meshwork of actin and myosin filaments. This trapping and therefore purification of those 
structures will be more efficient when the cell cortex is thicker and denser, which is the result 
of actin polymerisation in response to cAMP. It is important to point out that thickness of the 
cell cortex will also affect the probability of cell shearing during the lysis and cells in the 
peaks of actin polymerisation will be more likely to stay intact and trap these structures 
within them. This mechanism of trapping big cellular structures by the cell cortex would 
explain the actin-like pattern of the components of these structures without their direct 
interaction with actin filaments. This example shows that we are dealing not just with a 
massive background of proteins from the whole cell but that this background can mimic the 
actual response we are measuring. 
There are many uncharacterised proteins that show interesting dynamics in response to 
cAMP stimulation sometimes reaching high amplitudes (Fig. 3.8. bottom left). Unfortunately 
these patterns are not very different from the ones displayed by many proteins from all the 
other protein groups. This characteristic of the background proteins showing response levels 
similar to the cytoskeletal proteins, makes it particularly difficult to screen for a novel 
cytoskeletal components from the vast number of unknown proteins. 
Even though the majority of detected proteins show changes after cAMP stimulation, not all 
the dynamics patterns are equally reliable. The level of confidence in the protein ratios 
present in the SILAC results is directly proportional to the detection level and the number of 
peptide counts, which these ratios are based on. The general notion is that the protein ratios 
based on fewer peptides have higher amplitudes and form noisy patterns, while the ratios 
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based on many peptides show smaller changes, but are more consistent and reproducible. 
This might be the reason why only small proportion of the proteins does not show any 
changes throughout the whole experiment. These are the factors which do not display any 
real translocation in response to cAMP stimulation and are at the same time abundant enough 
to be resistant to the noise fluctuations. The majority of low abundant proteins which do not 
respond to cAMP are affected by the measurement errors, which can generate big changes in 
the SILAC results. The dynamics patterns of some proteins can also be affected by other not 
specific processes, such as the cortex trapping mechanism proposed for the ribosomal 
proteins. 
It is therefore important to understand that not all the patterns of translocation dynamics 
detected with the SILAC approach can be interpreted in the same way. The results of 
analysed proteins need to be individually validated by the level of peptide detection and 




 Figure 3.7. Protein dynamics of proteins from different cellular components. Only proteins with maximum of 
one missing time point (gray) are represented. Series of protein L/H ratios are normalized to their prestimulation 




 Figure 3.8. Protein dynamics of proteins from different cellular components. Only proteins with response higher 
then 1.5 L/H in a minimum of one time point after cAMP stimulation were selected from the groups of unknown 
proteins and other known proteins.  
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3.5. Cross-linked SILAC experiment 
 
The proteomic approach to investigate fast protein translocation used in this study depends 
on maintaining protein-protein interactions throughout the course of sample preparation. In 
fact using this method for protein dynamics analysis is limited only to those proteins that 
bind directly or indirectly to the structural core of the cytoskeletal framework. This has been 
proven to work for a big range of cytoskeletal components, but there were also many known 
actin binding proteins that were missing in those experiments. Several important regulatory 
factors such as Scar and WASP proteins, direct activators of the Arp2/3 complex were not 
detected using the standard SILAC protocol. One explanation for their absence could be that 
they are present in very small amounts and avoid detection by being covered by more 
abundant molecules. The other and more likely explanation is that they form only transient 
and unstable interactions with the structural components of the cytoskeleton and dissociate 
from the insoluble fraction shortly after cell lysis.  
In order to preserve those easily lost proteins, several cross-linking factors compatible with 
downstream MS analysis were checked. The basic formaldehyde fixation followed by 
thermal reversal of the cross-linking was found to be the most efficient and practical. 
Another advantage of fixing the proteins during cell lysis was that the samples did not have 
to be processed as fast as possible. This allowed us to collect 4 separate stimulation series 
which were combined in order to average the variability in stimulation response and 
sampling errors.  
The total detection of the cross-linked SILAC was higher than in the standard experiment. 
There were about 300 new proteins detected out of which 90 were cytoskeleton related. 
There were also about 40 cytoskeletal proteins missing from the cross-linked SILAC 
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comparing to the previous results. In this chapter only the cytoskeletal components detected 
in the cross-linked experiment are described. 
Protein dynamics captured in the fixing conditions does not always correlate to the results 
from the native conditions. Only one third of the cytoskeletal proteins detected in both types 
of SILAC experiments, showed clearly reproducible dynamics patterns (Fig. 3.9.). This 
group contains all the structural proteins described before as positive controls of the response 
to cAMP stimulation. There are also many actin binding proteins and several regulatory 
factors which have similar dynamics in both experiments. Many of those proteins, which 
were sharing similar timing of the dynamics profile with the previous experiment, showed 
different amplitude levels in the peaks of incorporation. The general interpretation of this part 
of the cross-linked SILAC experiment is straightforward as it validates the results from the 
standard SILAC experiments. 
The remaining two thirds of the cytoskeletal proteins detected in this experiment, showed 
only weak correlation or even strong negative correlation with the previous results (Fig. 
3.10.). These proteins, which show lack of dynamics reproducibility between the two types 
of experimental preparations, are difficult to interpret and force us to question the reliability 
of this experimental procedure. There are several factors which might influence the outcome 
of the cross-linked SILAC experiment, such as the efficiency of formaldehyde cross-linking 
and its reversal.  
One possible explanation of such great variability between the results from those two types 
of sample preparation, is that formaldehyde fixation will have differential impact on various 
protein-protein interactions. Formaldehyde, which modifies mostly primary amines present 
on lysine and arginine residues, is a very small molecule and it forms only 1.2 Å bridge 
between the two cross-linked proteins. This means that only those protein-protein 
interactions, which contain lysine and/or arginine side chains in very close proximity, will be 







Figure 3.9. Comparison of protein dynamics detected in the standard SILAC (left column) and cross-linked 
SILAC (right column) experiments. Only cytoskeletal proteins showing correlation coefficient higher then 0.5 
between the patterns detected in both types of experiments are presented. 
Standard and cross-linked SILAC high correlation results 
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Proteins forming interactions which lack this characteristic will have their residues modified 
without forming cross-linking bridges. In those situations, such modifications will likely 
interfere with and potentially disrupt the protein-protein interactions they were meant to 
stabilise. If this explanation is true, then the proteins which can be efficiently cross-linked 
and preserved in the interactions they form, will show higher enrichment and more reliable 
dynamics in fixing conditions. All the other proteins, which could be rather disturbed than 
stabilised by formaldehyde modifications, should be analysed in native conditions. 
Unfortunately there is no simple way of predicting which proteins belong to each of those 
types. The only feature, which we can use to asses this issue, is the dynamics profile in each 
of those experiments. Assuming that the two most common profiles, actin-like and myosin-
like, are more likely to be representing a real protein dynamics than a stochastic noise, we 
can estimate a sort of weighting factor for the differing profiles. Following this logic, 
proteins which show pattern similar to actin or myosin dynamics only in one type of SILAC 
experiment, while the other type gives rather incoherent noisy pattern, the first profile is 
presumably a better representation of this protein’s real translocation dynamics. There are 
indeed many such examples among the proteins presented in Figure 3.10.  
AbpA, GefD and GxcDD are few examples of the proteins that follow the generic actin 
dynamics in the standard SILAC experiment, while being depleted after cAMP stimulation in 
the cross-linked preparation. There are also some proteins which reveal strong patterns only 
in the cross-linked SILAC, such as MyoI and GacA.  
Obviously this is a very arbitrary separation based on speculative assumptions and therefore 
cannot be treated with high dose of confidence. It is discussed in order to illustrate different 
aspects and complexity of the results obtained with both types of SILAC experiments. It is 
clear that the cross-linked SILAC cannot replace the standard experimental procedure, but it 









Figure 3.10. Comparison of protein dynamics detected in the standard SILAC (left column) and cross-linked 
SILAC (right column) experiments. Only cytoskeletal proteins showing correlation coefficient from 0.1 to -1 
between the patterns detected in both types of experiments are presented. 
Standard and cross-linked SILAC low correlation results 
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The most important contribution of the cross-linked type of sample preparation is detection 
of the proteins that were not found in the standard SILAC procedure. These proteins, which 
can only be detected in the fixing conditions, are most likely to belong to those factors which 
are efficiently cross-linked and stabilised by formaldehyde, which implies that their patterns 
are presumably more reliable. Many of those proteins show patterns with high correlation to 
the actin dynamics or myosin-like enrichment in the late response, with particularly big 
number of proteins showing translocation only in the last two time points (Fig. 3.11.). 
Some of the most interesting proteins to find here are two components of the Scar protein 
complex, ScrA and NapA, both of which follow biphasic actin dynamics. There are few other 
important factors which show resemblance to actin profile, such as component of TORC2 – 
RipA, or member of Ena/VASP family involved in actin cytoskeleton organisation – VasP. 
Another interesting observation is DocD protein, showing very little response in the first 
phase of actin polymerisation and strong enrichment in the late phase, which is very different 
from the dynamics detected proteinsly for DocA and DocB. There are several unconventional 
myosins detected only in the cross-linked SILAC, such as MyoB, MyoC, MyoE and MyoK, 
most of which are incorporated to the cytoskeleton in the later time points similarly to 
myosin II.  
There is a big group of proteins sharing a dynamics pattern which has not been represented in 
the standard SILAC experiment. These proteins show depletion in almost all the time points 
within first minute after cAMP stimulation and then show strong enrichment in the last two 
time points of 2 min and 3 min, corresponding to the second peak of actin polymerisation. 
This type of translocation pattern suggests a specific function in the second phase of actin 
response to cAMP stimulation, which involves pseudopod formation and uropod retraction. 
Proteins showing this type of dynamics include among others: Rho GTPase RacC, Rho GEF 






 Figure 3.11. Proteins detected only in the cross-linked SILAC experiment. Only cytoskeletal proteins with not 
more then one time point missing are presented. 
Proteins detected only with cross-linked SILAC 
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Cross-linked version of the SILAC experiment had significantly higher detection rate and 
provided complementary dataset to the one generated with the standard protocol. About one 
third of the proteins detected in this experiment, including all the major structural 
components, showed high correlation to the dynamics patterns measured in the standard 
SILAC. There were many cytoskeletal proteins detected only in this version of the 
experiment, some of which shared a new pattern of translocation dynamics with specific 
enrichment only in the second phase of actin polymerisation. 
 
3.6. Selection of proteins for tagging with GFP 
 
SILAC experiments provided large scale analysis of protein translocation dynamics in 
response to cAMP stimulation. Results from these experiments had to be validated by in vivo 
imaging of selected proteins tagged with GFP. This type of analysis is also the only way to 
confirm the cytoskeletal character of the unknown proteins which showed strong enrichment 
in the insoluble fraction after cAMP stimulation. For these purposes a group of 120 proteins 
was selected for cloning and tagging with GFP. About half of them were known cytoskeletal 
factors such as ABPs, GEFs and GAPs, and another half were proteins of unknown function.  
Known cytoskeletal proteins (Fig. 3.12.) were selected based on their dynamics patterns and 
also their function. Several ABPs such as AbpA, AbpB and coronins were chosen as positive 
controls to see how the proteomics data correlate with in vivo imaging analysis. Most of the 
GEFs and GAPs which showed strong response in the SILAC results were selected for 
cloning. Other regulatory proteins such as few PI3Ks and PakB were also selected. Couple of 
GTPases were selected even though most of them did not show any significant response to 
stimulation, but they were still interesting to investigate as major regulators of the 
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cytoskeleton. A number of other known proteins, not directly involved in organisation or 
regulation of the actin cytoskeleton, were selected due to their strong response or interesting 
dynamics patterns. These proteins include components of the clathrin endocytic pathway, 
subunits of vacuolar V-ATPase and few others. 
Unknown proteins were selected solely based on the translocation dynamics patterns from 
the standard SILAC experiment (Fig. 3.13.).  Proteins showing various types of patterns were 
chosen for cloning. Some followed basic actin dynamics while others showed enrichment 
mostly in the first or the second phase of actin polymerisation and few were most abundant in 
the time points corresponding to the actin depolymerisation phase. Selection of all those 
proteins was done with only the first standard SILAC data available. Some of the selected 
proteins did not show reproducible patterns in the second experiment, therefore after 
combining the results from both experiments, some profiles were no longer as strong or 
interesting as in the dataset used for selection. Some of the unknown proteins had various 
actin binding domains identified by sequence homology analysis. The type of those actin 
binding domains indicates the character of interaction with actin filaments, but it does not 
necessarily determine the function of those proteins. 
Decision for selecting this relatively big number of proteins for cloning and tagging with 
GFP was caused by the characteristics of the SILAC results. As described before, proteomic 
analysis of the cytoskeletal fractions reveal big background of proteins coming from other 
cellular compartments, which also show certain levels of enrichment after cAMP stimulation. 
This characteristic combined with relatively high noise fluctuations associated with 
measurements of protein abundance, made it very difficult to narrow down the selection to a 
small group of proteins most likely involved in the cytoskeleton dynamics. Instead, a wider 
range of unknown proteins was chosen for cloning, anticipating that big proportion of them 







Known proteins selected for cloning 
Figure 3.12. Known cytoskeletal proteins selected for tagging with GFP and in vivo imaging. Combined results 







Figure 3.13. Proteins of unknown function selected for tagging with GFP and in vivo imaging. Combined results 
from two standard SILAC experiments are presented. Proteins were chosen based solely on their dynamics 
pattern. 
Unknown proteins selected for cloning 
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To minimise the probability of GFP probe interfering with proteins’ function and 
localisation, each of the selected proteins was tagged with GFP on both C-terminus and N-
terminus separately. All of those GFP-tagged proteins were coexpressed with RFP-lifeact F-
actin probe to analyse their colocalisation with actin structures and correlation with timing of 
actin response. 
 In order to generate those constructs we have adapted a comprehensive system of 
extrachromosomal expression vectors for Dictyostelium discoideum developed by Douwe 
Veltman et al. in the van Haastert Lab, University of Groningen [232]. Two vectors 
containing G418 selection cassette, pDM317 with N-terminal GFP tag and pDM323 with C-
terminal GFP tag, were modified to fit the particular needs of design for this study. Multiple 
Cloning Site (MCS) on those vectors was modified by adding AgeI restriction site between 
the two existing sites for BglII and SpeI. At the same time the 4 amino acids linker fragment 
between the insert and the C-terminal GFP tag on the pDM323 was extended to 8 amino 
acids. These modifications were made by inserting short fragments of dsDNA with cohesive 
ends compatible with BglII and SpeI restriction sites, which were generated by aligning two 
oligos mixed in equimolar ratios. 
After these steps both vectors were further modified by inserting expression cassette 
containing RFP-lifeact F-actin probe construct into the NgoMIV restriction site. This 
insertion of a second expression cassette into the plasmids is a part of the whole vector 
system design, allowing coexpression of two tagged proteins from a single plasmid, which 
ensures that both of them are expressed on similar levels for colocalisation analysis [232]. 
The final modified vector based on the pDM323 was called pDG600 and the vector based on 











The final cloning efficiency was about 90%. From the initial 120 selected genes 109 were 
successfully cloned, out of which 103 were cloned into both vectors and 6 genes were present 
only on one of the two plasmids. The total number of 218 constructs was generated and 






Figure 3.14. Extrachromosomal expression vectors for GFP tagging and coexpression with RFP-lifeact probe for 
filamentous actin. Both GFP and RFP-lifeact expression cassettes contain act15 promoter and act8 terminator. 
A) pDG600 vector with C-terminal GFP tag. B) pDG700 with N-terminal GFP tag. 
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4. In vivo microscopy analysis of the 
cytoskeletal dynamics 
 
All the GFP-tagged proteins were first visualised using confocal microscopy with both GFP 
and RFP fluorescence captured at one frame per second. Cells were stimulated with cAMP 
during each imaging session and the actin polymerisation response was used as a time 
reference for GFP-tagged protein translocation.  
Proteins which showed strong colocalisation with the cortical actin structures were further 
analysed in greater detail with Total Internal Reflection Fluorescence Microscopy (TIRFM). 
In this type of fluorescence microscopy only a very thin layer of the cell cortex is illuminated 
just up to about 200 nm above the cover slip. This technique of cell imaging provides very 
high spatial resolution, allowing visualisation of individual actin filaments with no 
background fluorescence from the rest of the cell.  
Imaging sessions from both confocal and TIRF microscopy were saved in a movie format 







4.1. General localisation groups 
 
4.1.1. Strong cortical proteins 
 
The most important and interesting type of cellular localisation of the analysed proteins was a 
strong cortical localisation. Proteins in this localisation group were also the ones that showed 
the strongest translocation from the cytosol to the cortex upon cAMP stimulation. This group 
of proteins contained many of the known ABPs and regulatory factors selected for cloning 
(Fig. 4.1.). There were also 6 uncharacterised proteins showing strong cortical localisation, 
out of which 3 had identified actin binding domain. Most of the proteins in this group had 
comparatively big changes in the SILAC experiments, usually following actin type of 
dynamics.  
Proteins showing such a strong colocalisation with cortical actin are candidates for playing 
major roles in regulation and organisation of the actin cytoskeleton. Many of the cytoskeletal 
positive controls, such as coronins, AbpA, B and C, and myosin II fall into this group. There 
are 7 GEFs and 3 GAPs, as well as few other regulatory factors like PakB and PikF, 
exhibiting strong cortical localisation. All the unknown proteins belonging to this group 
represent a positive identification of novel cytoskeleton associated factors, which is a major 








Figure 4.1. Proteins exhibiting strong cortical localisation. A) Confocal images of four examples of proteins 
from this group. Images are taken at the peak of the first phase of the actin polymerisation response. B) All of the 
cloned proteins showing this type of localisation. Examples shown in A. are indicated in the heat-map by 
numbers on the left side. See also: Supplementary Materials \ Movies \ Strong cortical proteins. 
Strong cortical proteins 
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4.1.2. Weak cortical proteins 
 
Another important group of cloned proteins are the ones that show weak cortical localisation. 
These proteins show some colocalisation with cortical actin but are also found at high levels 
in the cytosol, even at the peak of their translocation to the cortex (Fig. 4.2.). Only proteins 
with stronger cortical than cytosolic signal are considered to be part of this group. Different 
weak cortical proteins show various ratios of cortical to cytosolic signal and therefore this 
group is composed of proteins showing different levels of cortical localisation. Many of the 
proteins showing this type of localisation are known actin binding factors. For some of them, 
such as talin TalA or formin ForH, it is easy to recognise their cortical translocation upon 
stimulation with cAMP. Some proteins however, like all of the cloned GTPases, show only 
very slight enrichment in the cortex or in cell protrusions, compared to the signals from the 
cytosol making it more difficult to detect their weak cortical localisation.  
There are a few possible explanations for their weak translocation to the cortex. Their affinity 
to actin filaments might be lower than that of strong cortical proteins, leading to lower ratio 
of cortical to cytosolic signal. It might also be caused by the limited availability of specific 
binding sites recognised by those proteins, which get easily saturated by the overexpressed 
GFP-tagged proteins, leaving big proportion of them to stay in the cytosol. Alternatively it 
might be related to the specific character of their function and regulation. This is the 
explanation for very weak cortical localisation of small GTPases, which are translocated to 
the cortex only at the activated state forming a small fraction of their whole cytosolic pool. In 
case of those major regulatory factors, it is not the overall protein localisation but rather the 
localised regulation of these proteins by GEFs and GAPs that determines their function.   
The strength of cortical localisation therefore does not necessarily indicate the importance of 
a protein’s function, but it might suggest that within a class of similar proteins, the ones with 
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strong cortical localisation play a more substantial role than the ones with weak localisation. 
Based on this assumption we speculate that both GEFs and GAPs from strong cortical 
proteins group are more likely to be the main regulators of the cytoskeleton, compared to the 
proteins of the same families showing weak cortical localisation. 
Most of the proteins in this group show actin-like dynamics patterns in the SILAC results, 
with amplitudes similar to and sometimes higher than those of the strong cortical proteins. 
Roco7 shows weak cortical localisation, but it has very strong enrichment detected with the 
SILAC experiment reaching 2.6 L/H in the 4 s time point, which is higher than most of the 
proteins with strong cortical localisation. Also within the group of strong cortical proteins 
there are several components, such as examples 1 and 2 from Figure 4.1., showing the same 
level of translocation to the cortex on confocal imaging analysis, but differing significantly 
with the levels of enrichment in the SILAC results. This illustrates that there is no direct 
quantitative correlation between the translocation dynamics measured with the proteomic 
assay and with in vivo imaging analysis.  
These two approaches detect slightly different aspects of protein dynamics. The SILAC 
experiment measures differences in the amount of protein that is bound to the cytoskeleton 
after cAMP stimulation, which might represent different proportion of the soluble fraction 
that is not detected in this assay. It might also detect changes in the type of interactions, 
which do not generate protein translocation. For example the cortical fraction of the protein 
might change interaction partners and binding stability after cAMP stimulation, but it does 
not have to lead to recruitment of proteins from the cytosol. In this situation the SILAC 
experiment would detect changes in dynamics which would not be observable with 
microscopy analysis. Indeed there are few proteins showing similar differences between the 





Weak cortical proteins 
Figure 4.2. Proteins exhibiting weak cortical localisation. A) Confocal images of four examples of proteins from 
this group. Images are taken at the peak of the first phase of the actin polymerisation response. B) All of the 
cloned proteins showing this type of localisation. Examples shown in A. are indicated in the heat-map by 
numbers on the left side. See also: Supplementary Materials \ Movies \ Strong cortical proteins. 
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The cellular imaging on the other hand, can detect proteins present in both cortical and 
cytosolic fractions and it measures translocation between those two compartments. This 
translocation has to be mediated by some interactions, but they are not necessarily identical 
with changes in binding to the cytoskeleton detected by the SILAC experiments. In some 
cases the cytosolic fraction contains the majority of protein present in the cell, making it 
difficult to analyse the dynamics of translocation to the cortex.  
The fact that the SILAC experiments are performed on the wild type strain while the cells 
used for imaging are overexpressing the proteins of interest is also likely to generate some 
differences between the outcome of those two analysis methods. 
It is important to state here, that the levels of cytosolic background exhibited by different 
proteins are gradual and the separation of those proteins into strong and weak cortical groups 
is arbitrary. Indeed all of the proteins from both groups showed some level of cytosolic 
localisation in unstimulated cells, which was then depleted to various extents after cAMP 
stimulation. There were few factors taken into account for dividing proteins into strong and 
weak cortical localisation groups. The first and most important factor was the level of 
cytosolic signal depletion coupled with the increase of cortical signal during the first phase of 
actin polymerisation. The other factors were the width of cortical band and colocalisation 
with actin structures. Narrow bands of cortical signal, which showed high contrast to the 
cytosolic fluorescence and colocalised closely with actin structures were considered as 
characteristic to strong cortical group. Proteins showing broad and somewhat diffused bands 
of cortical signal, which showed only partial overlapping with cortical actin cytoskeleton, 
were classified as members of the weak cortical proteins group. 
Both of those groups together contain most of the known cytoskeletal proteins which were 
selected for cloning. All of the known actin binding proteins as well as the cytoskeletal 
regulatory factors fall into one of those localisation classes.  
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In general terms, all the proteins showing cortical localisation and any level of translocation 
to the cortex upon cAMP stimulation, provide a positive validation of proteomic results from 
the SILAC experiments.  
All of the unknown proteins, which were shown to localise to the cell cortex and respond to 
cAMP stimulation are validated novel cytoskeletal components identified in this study. These 
proteins need to be further investigated in order to determine their role in the regulation of 
cytoskeleton functions. Some of them exhibit very strong translocation to the cortex and 
other interesting characteristics. Most of these newly identified cytoskeletal proteins, together 
with several known structural and regulatory factors will be described in greater detail in the 
following chapter. 
 
4.1.3. Microtubular proteins 
 
Three of the unknown proteins were showing a localisation suggesting that they colocalise 
with microtubules (Fig. 4.3). Microtubular cytoskeleton is not in the main focus of this study; 
nevertheless it is interesting to see few novel microtubular proteins identified with this assay. 
Microtubules are known to interact with the cell cortex in a dynein/dynactin dependent 
fashion [234, 235]. It has been reported that microtubules play an important role in force 
generation at the cortex and that microtubular plus-ends connections at the cortex are 
essential for nucleus transport within the cell [236, 237]. A Dictyostelium ortholog of human 
protein LIS1, involved in those interactions was found and reported to mediate cross-talk 
between microtubules and cortical cytoskeleton [238]. Nevertheless the exact contribution of 
microtubules to the regulation of acto-myosin cortical cytoskeleton and cell movement in 








Two of the newly identified microtubules associated proteins (DDB_G0290619 and 
DDB_G0282471) were localised along their whole length and were easily observed with 
TIRFM, indicating that microtubules are present in the outer cortical region of the cell. The 
third protein classified as microtubular – DDB_G0289705, showed a different type of 
localisation. On confocal images it is associated with part of the nuclear envelope and 
Figure 4.3. Proteins exhibiting microtubular localisation. A) Confocal (top) and TIRFM (bottom) images of 
proteins from this group. B) SILAC results for all the proteins shown in A with this type of localisation. See 




structure of irregular shape in close proximity to the nucleus. This could be either a 
centrosome with short fragments of microtubules anchored to it, or a part of the Golgi 
apparatus. Confocal images do not provide enough detail to identify the precise localisation, 
but the star-like shape of those structures visible in some of the cells suggests that the protein 
is associated with a microtubule organising centre. Images obtained with TIRFM reveal more 
details of this structure showing a bundle of short filaments going out of one central point in 
all directions. They also reveal that some fraction of this protein, visible as single spots on 
the image shown above, moves along the microtubules. This dynamic character of interaction 
with microtubules is best noticeable in the movie format. The most likely interpretation of 
those imaging results is that this protein is dynamically associated with microtubules 
primarily at their minus-ends where they are anchored to the centrosome, except for the 
microtubules enfolding the nucleus, on which it localises further along the nuclear envelope.  
Localisation of the first two proteins, which are uniformly distributed along the microtubules, 
does not tell us anything about their potential functions. On the other hand, the localisation 
observed for the third protein suggests, that it might be involved in anchoring microtubules to 
the centrosome and linking the whole structure to the nuclear envelope. 
Even though both of the uniformly localised microtubular proteins share low actin-like 
biphasic dynamics in the SILAC experiment, none of the imaging data revealed any 
translocation or increase in the signal intensity following cAMP stimulation. This suggests 
that the dynamics observed in proteomic analysis might have been caused by the trapping 
mechanism described earlier. This would mean that the detected patterns are simply a 
representation of the variable efficiency, with which microtubular network is trapped in the 
cortex of intact cells in different time points, which is directly related to the thickness of the 
cortical actin cytoskeleton. None of those proteins has any identified domains and there are 
no known orthologs of those molecules in higher organisms. BLAST searches against human 
database revealed only short regions of medium similarity.  
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4.1.4. Contractile vacuole proteins 
 
Another unexpected but interesting type of cellular localisation discovered among the cloned 
proteins, is the association with membranes of contractile vacuole system (Fig. 4.4.). 
The contractile vacuole (CV) system is an osmoregulatory organelle which consists of 
tubules and vacuoles. It plays an essential role of maintaining the water balance in free-living 
cells exposed to hypotonic stress, by accumulating and expelling excess water out of the cell 
[239]. Membranes of the CV network are populated with vacuolar ATPases (V-ATPases), 
generating a proton gradient required for transporting other ions into CVs, which drives the 
inward flux of water [240]. V-ATPases are proton pumps present on many vacuolar and 
vesicular structures, and they consist of two individual subcomplexes: trans-membrane V₀ 
complex and peripheral catalytic V₁ complex, both of which contain several subunits [241]. 
Two components of the V₁ complex, subunits B and C, are known to have high affinity to 
actin filaments [242, 243]. This interaction between V-ATPases and actin cytoskeleton was 
found to be essential part of regulating lysosome neutralization and V-ATPase recycling 
from the lysosomes, driven by WASH (Wasp And Scar Homologue) dependent actin 
polymerisation [244].  
In our results from the SILAC experiments several subunits of V-ATPases were showing 
strong enrichment in the insoluble fraction, mostly during the second phase of actin 
polymerisation, reaching L/H amplitudes of about 3. This type of enrichment pattern is very 
similar to myosin II dynamics and therefore is unlikely to be caused by the described 
trapping mechanism, which can only mimic the actin profile. The response shown by V-
ATPase complex is presumably a result of direct interaction with actin filaments mentioned 
above. Two of V-ATPase subunits, VatA belonging to V₁ subcomplex and VatM which is a 







Figure 4.4. Proteins exhibiting localisation to contractile vacuole system. A) Confocal images of proteins from 
this group. Images were taken with different magnifications. B) SILAC results for all the cloned proteins with 
this type of localisation. See also: Supplementary Materials \ Movies \ Contractile vacuole proteins. 
Contractile vacuole proteins 
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None of those proteins revealed any noticeable translocation or signal intensity changes upon 
stimulation with cAMP during confocal microscopy imaging (Suplementary Materials \ 
Movies \ Contractile vacuole proteins). Interestingly 5 of the unknown proteins also showed 
this type of localisation, and shared similar dynamics patterns to V-ATPase subunits in the 
SILAC experiment (Fig. 4.4. B). 
One of those proteins – DDB_G0278773, has two domains identified as MSP (Major Sperm 
Protein) and VAP (Vesicle-Associated membrane Protein). This is a conserved protein with 
orthologs present in many higher organisms including human. Three other proteins: 
DDB_G0270390, DDB_G0291600 and DDB_G0290371, contain various transmembrane 
domains, the one in DDB_G0291600 being a multi-pass domain with 3 transmembrane 
regions. (all the information regarding protein domains and orthologs were obtained from 
http://dictybase.org/). 
 
4.1.5. Vesicular proteins 
 
Another collection of proteins with distinctive localisation, which contained the largest 
number of unknown proteins selected for cloning, was the vesicular proteins group (Fig. 
4.5.). This group is also one of the most variable in appearance from all the types of cellular 
localisation found in these analyses. This observation is based on different characteristics, 
such as size, number and behaviour of vesicles labelled with different GFP-tagged proteins.  
This implies that many of the proteins in this class belong to different types of vesicular 
components of the cell. They might represent phagosomes, lysosomes at various stages of 
maturation, exosomes, different endosomes or even components of the Golgi network and 
possibly other unknown structures. The true identity of those vesicles cannot be determined 
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based on the confocal images and it will require additional co-staining with different 
vesicular markers.  
There are 16 unknown proteins exhibiting vesicular localisation, most of which are 
comparatively small molecules, with only two proteins above 70kDa. None of those newly 
identified vesicular proteins contains any characterised domains and only two have orthologs 
in higher organisms: DDB_G0277011 and DDB_G0280801.  
A couple of known proteins were also classified as vesicular. Prominent among those are 
clathrin heavy chain ChcA and its adaptor protein Ap2a1-1. A few proteins such as 
ponticulin related protein PonC3 and cell adhesion molecule CsaA unexpectedly were also 
found in vesicular structures. Both of these proteins are associated with membranes and those 
vesicles may be involved their membrane trafficking or recycling. Alternatively this may be 
an aberrant cellular localisation caused by the interference of the GFP tag. 
Most of the vesicular proteins show biphasic dynamics with 10 s time point being the lowest 
point separating the two phases and the second peak having generally higher amplitudes than 
the first one. The average enrichment of those proteins was around 1.7 L/H and only two of 
them exceeded 2 L/H in their peaks. There are few possible explanations for this response 
shown by vesicular proteins. The trapping mechanism described earlier cannot be excluded, 
but due to small size and presumably low resistance to Triton X-100 lysis of those vesicles, 
trapping is not the most likely scenario.  
A different approach would suggest that enrichment of those proteins observed in proteomic 
analysis is a result of their interaction with the components of the cytoskeleton. It is known 
that many types of vesicles exhibit actin-dependent movement inside the cell and that certain 
factors present in vesicular membranes, such as the previously described V-ATPase, bind to 
actin filaments. It is therefore possible that some of these proteins represent novel factors 







Figure 4.5. Proteins exhibiting vesicular localisation. A) Confocal images of 6 examples of proteins from this 
group. Images were taken with different magnifications. B) SILAC results for all the cloned proteins with this 




4.1.6. Nuclear proteins 
 
The final group of proteins showing a distinct cellular localisation is formed by nuclear 
proteins (Fig. 4.6.). This group also contains substantial part of all the unknown proteins 
analysed. There are 12 uncharacterised proteins that fall into this class, providing a variety of 
novel nuclear markers. It is interesting to note that most of those proteins are not 
homogenously spread within the nucleus, but are rather confined to specific structures within 
the nucleus with variable background levels in the nucleoplasm. Many of those structures 
resemble nucleoli but some, such as the one revealed by DDB_G0267882 (Fig. 4.6. A3), do 
not match the typical nucleoli characteristic shown by DDB_G0289345 (Fig. 4.6. A5).  
None of the unknown nuclear proteins contains any identified domains. Two proteins, 
DDB_G0289345 and DDB_G0284587, have orthologs in humans.  
There are two previously characterised proteins that showed nuclear localisation. The first 
one is a heat shock protein HspC, which is a known nuclear factor and was selected for 
cloning to validate the dynamics measured in the SILAC experiment. The second one is a 
guanine nucleotide binding protein Gnl3, which is annotated as an intracellular protein (Gene 
Ontology annotation). 
The SILAC results for most of the proteins in this group show only a weak increase in 
abundance after cAMP stimulation with peaks usually at 10 s and 3 min time points, and 
some proteins show depletion during the first minute after stimulation. Only one protein – 
DDB_G0283697, follows closely actin dynamics with the first peak reaching almost 2.5 L/H.  








Figure 4.6. Proteins exhibiting nuclear localisation. A) Confocal images of 6 examples of proteins from this 
group. Images were taken with different magnifications. B) SILAC results for all the cloned proteins with this 
type of localisation. See also: Supplementary Materials \ Movies \ Nuclear proteins. 
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To summarize this general description of in vivo imaging analysis of selected proteins, there 
were 6 groups of distinct cellular localisation described: strong cortical, weak cortical, 
microtubular, contractile vacuolar, vesicular and nuclear. Out of 109 proteins successfully 
tagged with GFP and analysed by fluorescence microscopy, 55 were showing at least partial 
cortical localisation and were classified into one of the first two groups. Most of those 
proteins were known or suspected cytoskeletal components and were cloned for validation of 
the SILAC experiments results and for a further detailed analysis of cortical actin dynamics. 
Out of 54 unknown proteins tagged with GFP, 12 showed a clear cortical localisation and 
translocation triggered by cAMP. 4 proteins contain identifiable actin binding domains, 2 
contain a GEF or GAP domain, and 6 are truly novel cytoskeletal factors identified for the 
first time as associated with the cytoskeleton in this study. 
All the other analysed proteins fell into one of the remaining groups. There are 3 novel 
microtubular proteins identified, 5 novel proteins localising to the contractile vacuole system, 
16 novel proteins localising to various types of vesicles and also 12 novel nuclear proteins 
with various subnuclear localisations. The remaining 6 unknown proteins analysed by 
fluorescence microscopy were showing very weak signal with homogenous cytosolic 
localisation, suggesting that their stability and localisation may have been affected by the 
GFP tag (data not shown).  
Even though many of those proteins represent potentially very interesting functions, for the 
purpose of this project all the proteins showing other than cortical localisation will not be 
described in any further detail.  
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4.2. Detailed characterisation of selected individual 
proteins 
 
Selected proteins showing cortical localisation and cAMP dependent translocation are 
introduced and described in a greater detail. For each protein confocal images of GFP alone 
and merged GFP and RFP fluorescence are shown from 4 time points corresponding to pre-
stimulation phase, peak of the first phase, depolymerisation phase and peak of the second 
phase of actin response to cAMP stimulation. A quantification of those confocal imaging 
series is also provided.  
Confocal images were quantified as described in Materials and Methods by selecting a region 
of interest (ROI) covering a fragment of the cell cortex and reslicing the average signal 
intensity of those ROIs as a function of time. The intensity profile was generated giving a 
temporal dynamics for both GFP and RFP signals within this fragment of the cortex. This 
type of local quantification of cortical signals provides a good indication of translocation 
timing and colocalisation of both proteins but is limited by a great variability of response on 
such a local level. The actin response to cAMP stimulation is very reproducible at the level 
of cell populations and even at the level of the whole cell, but less so at the subcellular level. 
While the first global phase of actin polymerisation is distinguishable on most of the 
quantifications, the second localised phase shows great variability in timing and intensity 
between different cells and parts of the cortex selected for quantification. Different levels of 
protein expression between the analysed cells also contribute to the big variability in 
quantifications. This type of analysis is also disturbed by cells moving out of or into the ROI 
during the course of imaging session. For all these reasons the quantifications were not 
combined, and instead two separate quantifications are presented for each protein. For 
proteins showing strong colocalisation with actin structures both GFP and RFP signals will 
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be following the same temporal dynamics at those quantifications, while proteins with 
weaker colocalisation will display greater mismatch between those two signals.   
TIRFM images are also presented for each analysed protein. These images show much 
greater detail of the cortex than confocal microscopy and many proteins reveal a clear 
filamentous structure of the actin cortical meshwork. Sequences captured only for GFP 
fluorescence with constant rate of 2 fps were also quantified with ROIs selected in the middle 
of visualised cells. These quantifications were generally found to be much more reproducible 
and informative than the ones performed on confocal imaging series. Nevertheless there was 
still significant variability in signal intensities between the cells and in individual character of 
the late response to cAMP stimulation, therefore three independent measurements are 
represented in one graph instead of an averaged profile.  
Quantification graphs for both confocal and TIRFM sequences show time plots of 
fluorescence signal intensity, which in confocal 8-bit images has a maximum value of 255 
and in TIRFM 16-bit images has a maximum value of 65,025 and for the purpose of graph 
spatial organisation it is divided by 1000. In all the graphs the time point of cAMP 
stimulation, which is around 7-10 s from the beginning of imaging session, is clearly 
distinguishable by strong shift in signal intensity. Unfortunately the TIRFM sequences 
captured for both green and red channels simultaneously turned out to be incompatible with 
fast temporal analysis and these sequences are not quantitatively analysed.  
Finally, all the proteins described have their dynamics profiles from the proteomic analysis, 
represented as a time plots of L/H values from two combined SILAC experiments with 
standard error bars, and whenever available also separate profile from the results of cross-
linked SILAC. All the figures in jpeg format and both confocal and TIRFM imaging sessions 
in avi movie format for each protein described below are presented on the attached CD : 




4.2.1. Structural components of the cytoskeleton 
 
4.2.1.1. Coronin A; CorA 
 
Coronins are a highly conserved family of multifunctional actin binding proteins, which was 
originally discovered in Dictyostelium discoideum and named after its localisation to crown-
like protrusions within the cell cortex [18]. It was later identified in all eukaryotes examined, 
and it is always involved in the cytoskeleton regulation.  
Coronins form two distinct subfamilies, short coronins subfamily including CorA and the 
long subfamily, which is represented in Dictyostelium by CorB. All coronins contain a core 
domain of WD40 repeats, but members of the first subfamily contain only one such domain, 
while the long coronins contain two [245]. The WD40 domain is a versatile motif acting as a 
platform for simultaneous protein-protein interactions in a wide range of proteins, including 
several important cytoskeletal components. Proteins containing WD40 repeats often serve as 
mediators of interaction between other factors in diverse cellular processes including signal 
transduction, transcriptional regulation, remodeling of the cytoskeleton and vesicular 
trafficking [246]. 
Coronins were characterised as cross-linkers of actin filaments and also as factors binding to 
Arp2/3 complex in mammalian cells [247] and in yeast [248]. This direct interaction was 
found to have an inhibitory effect on Arp2/3 driven actin polymerisation, by stabilising this 
complex in an inactive open conformation [249]. 
Two coronins found in Dictyostelium are involved in processes controlling cytoskeleton 
function but instead of acting in a redundant fashion, they seem to have antagonistic effects. 
While CorA is proposed to be involved in actin filament disassembly [250] and act as a 
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negative regulator of actin polymerisation [251], the reported function of CorB is prevention 
of actin depolymerisation by stabilising the filaments [252]. Dictyostelium cells lacking CorA 
protein exhibited aberrant cytokinesis and cell morphology and decreased motility rate [253], 
while CorB knock-outs had aberrations in phagocytosis, increased lateral pseudopod 
formation and cell-substrate adhesion [252]. 
Our results confirm cortical localisation of CorA and indicate the strong translocation of this 
protein to the cortex in both phases of actin polymerisation (Fig. 4.7.). Only small fraction of 
the signal comes from the cytosol in unstimulated cells and in 5 s time point after stimulation 
it is almost completely depleted, which coincides with the increase of cortical signal 
thickness and intensity. Cells overexpressing CorA-GFP constructs seemed to have aberrant 
morphology on confocal images, compared to more round shaped WT cells, which is also 
indicated by very rough profiles of cortical signal quantification of those cells (Fig. 4.7. A, 
B). TIRFM images of those cells also reveal strong translocation of CorA to the cortex upon 
stimulation. They also indicate that CorA distribution within the cortex is not homogenous 
but rather concentrated within defined regions (Fig. 4.7. C, D). 
Coronin A is one of the most abundant proteins detected in the SILAC experiments and 
shows more than 4 times higher abundance than CorB. The translocation dynamics measured 
for this protein is therefore very reliable and reproducible between both standard SILACs and 
is also well conserved in the cross-linked SILAC experiment. CorA exhibits the general 
actin-like dynamics with the first peak reaching about 1.6 L/H and the second peak about 1.3 
L/H in the standard and 1.6 L/H in the cross-linked SILAC (Fig. 4.7. E). This protein is one 
of several positive controls, which served to validate the SILAC results with in vivo analysis 







Figure 4.7. Results for CorA protein. A) Confocal images of 4 stimulation time points with GFP alone (top) and 
merged GFP and RFP signals (bottom). B) Quantifications of both GFP (green) and RFP (red) intensity 
dynamics from two separate fragments of the cortex in confocal images. C) TIRFM images of GFP signal at 4 
stimulation time points. D) Signal quantification for 3 separate ROIs within cells from TIRFM images. E) 




4.2.1.2. Subunit of actin capping protein Cap32/34; AcpA 
 
Cap32/34 is a heterodimeric actin capping protein composed of two subunits, a 32kDa AcpA 
and 34kDa AcpB proteins. Cap32/34 binds to fast growing barbed ends of actin filaments 
only in heterodimeric conformation and in a MgATP dependent manner [62]. This inhibitor 
of actin polymerisation was previously found to enter the cytoskeleton and follow the 
biphasic actin dynamics after chemoattractant stimulation [60]. 
There have been several regulatory interactions with other factors described for this protein. 
A 70kDa heat shock cognate protein (Hsc70) was copurified with Cap32/34 and found to act 
as a chaperone stimulating refolding of the denaturated subunits of the capping protein [254, 
255]. There is some controversy regarding Hsc70 interaction with the capping activity of the 
Cap32/34 complex, since one research group described that Hsc70 significantly increased 
this activity during in vitro assays [254], while the other group reported that it had no 
influence on Cap32/34 dependent inhibition of actin polymerisation [256]. 
PI(4,5)P2, which is a highly abundant factor on the inner side of the cell membrane, was 
demonstrated to inhibit Cap32/34 activity and therefore protect the very peripheral actin 
filaments from being capped [62]. Another important inhibitor of this capping protein is a 
different actin binding protein – coactosin (CoaA). This protein has no effect on dynamics of 
actin polymerisation alone, but was found to almost completely counteract the inhibitory 
effect of Cap32/34 on actin filament elongation [257].  
Interestingly, CoaA was detected in our SILAC experiments and showed a strong enrichment 
above 3 L/H in the earliest 1 s time point. It then decreases to about 1.5 L/H until the second 
phase, when it rises reaching the same level above 3 L/H at 3 min (Fig. 4.8.). This first short 
peak was conserved in the cross-linked SILAC with amplitude about 2 L/H, and the second 
phase also reached similar level at the 3 min time point. This result suggests that CoaA 
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inhibits Cap32/34 protein in the very beginning of the first phase of actin polymerisation, 
maintaining undisturbed elongation of all the newly formed filaments, but then rapidly leaves 
the actin structures allowing Cap32/34 to inhibit the filaments elongation. This result 
indicates that coactosin plays important role in actin dynamics regulation also during the late 






Our imaging results of AcpA protein tagged with GFP confirm that Cap32/34 shows strong 
translocation to the cortex upon cAMP stimulation (Fig. 4.9. A). There is still a substantial 
level of signal coming from the cytosol even at the peak of translocation, which might come 
from the excess of AcpA protein generated by overexpression that could not be dimerised 
with AcpB subunit present at the endogenous levels.  
Cap32/34 translocation during the first phase is very transient and virtually the whole cortical 
signal retreats to the cytosol during depolymerisation phase, and then reappears at the local 
actin-rich protrusions during the second phase. 
 
Figure 4.8. SILAC results showing translocation dynamics of CoaA protein to the cytoskeleton. Standard 
SILAC (blue) and cross-linked SILAC (red) experiments show similar patterns with the highest enrichment at 
1 s time point. Cross-linked SILAC results have lower amplitudes, which is a very common difference 





Figure 4.9. Results for AcpA protein. A) Confocal images of GFP alone (top) and merged GFP and RFP signals 
(bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity dynamics. C) 
TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) Translocation dynamics 
measured in the standard SILAC (blue) and cross-linked SILAC (red) experiments. 
Subunit of the Cap32/34 complex; AcpA 
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The SILAC results for both subunits of Cap32/34 were described earlier. Both of those 
proteins follow closely the profile of actin dynamics in both types of SILAC experiments. 
TIRFM imaging reveals the same character of strong and rapid translocation in the first phase 
of response to cAMP stimulation (Fig. 4.9. C, D). The second phase of response is generally 
not well represented in this type of microscopy. This is most likely caused by the very 
limited pseudopod formation at sites of contact with the substrate. This means that cells do 
not extend protrusions in the direction of the cover slip, which makes the second phase 
hardly detectable by TIRFM imaging.  
In order to obtain quantifiable results, these images were taken only for the GFP signal and 
therefore lack direct reference to the actin dynamics. Actin response was measured separately 
with TIRFM and quantified (Fig. 4.10.). This measurement of actin dynamics shows few 
unexpected features, which do not correlate exactly with the results from confocal 
microscopy and proteomic analysis. The peak of this response is around 10 s after cAMP 
stimulation, which is about two times slower than the actin response measured with confocal 
microscopy. The rising slope of this actin dynamics profile shows a distinct breaking point 
forming a plateau at about one third of the peak’s amplitude.  
This characteristic is conserved within all the cells quantified in this measurement, but has 
never been reported or detected in any other assay for actin dynamics. This observation 
might be related to the fact that the cells, in which the actin dynamics was measured were 
overexpressing the actin bundling protein alpha actinin, AbpA. This protein present in a great 
abundance could have affected the polymerisation dynamics in response to cAMP 
stimulation generating this distinct pattern. Nevertheless, in the absence of any more 
reproducible actin measurement from TIRFM analysis, this profile of actin dynamics will be 








4.2.1.3. Myosin II heavy chain; MhcA 
 
Myosin II is a major component of cortical cytoskeleton and it is involved in a variety of 
cellular processes such as cytokinesis, uropod and pseudopod retraction, cell polarisation and 
organisation of the actin cytoskeleton. It is an actin-based ATP-dependent motor molecule 
capable of generating force needed for the mentioned functions. Myosin II is a hexamer 
consisting of 2 myosin heavy chains (MHC), 2 regulatory light chains (RLC) and 2 essential 
light chains (ELC). These myosin II complexes spontaneously assemble into bipolar 
filaments made of 10-20 hexamers, which is the only form in which they can perform their 
cellular functions (reviewed  in [72]). 
Myosin II filament assembly is negatively regulated through MHC phosphorylation by 
MHCKs [73], and induced by dephosphorylation performed by MHC phosphatase PP2A 
Figure 4.10. Actin dynamics measured with TIRFM. 
A) TIRFM images of 4 stimulation time points with 
RFP signal coming from RFP-lifeact F-actin probe. 
B) TIRFM signal quantification for 3 separate ROIs 




[74]. Myosin II filaments are assembled in the cytosol and then translocated to the cortex by 
two separate and independent mechanisms [75]. Myosin II function and motor activity are 
controlled by cGMP signalling pathway [76, 77] and other factors, such as p-21 activated 
kinase PakA [78, 79]. 
Our imaging results for the GFP tagged Dictyostelium MHC, MhcA protein, generally 
confirm the results of proteomic analysis. All the components of myosin II, as described 
earlier, shared similar biphasic dynamics with the first transient peak at 1 s and the main 
peak, with 3 L/H values, lasting from 1 min to 3 min time points (Fig. 4.11. E). This result is 
in agreement with previously published data, which describe the same pattern of 
translocation dynamics for myosin II in response to cAMP stimulation [258].  
Confocal imaging confirms this behaviour, showing that the highest enrichment of MhcA at 
the cortex, occurs during the late response to cAMP stimulation (Fig. 4.11. A, B). TIRFM 
imaging provides much greater detail and reproducibility of myosin II dynamics analysis. It 
also reveals one unexpected characteristic of myosin II dynamics, showing sudden drop in 
fluorescence intensity directly following cAMP stimulation, which then returns to pre-
stimulation levels and follows the canonical pattern of myosin II translocation. Except for 
this initial drop of signal intensity, the rest of the TIRFM signal time plot resembles closely 
the results from the SILAC experiments. It shows a small and transient first peak of myosin 
II translocation followed by the disassembly phase and then gradual constant increase in 
cortical localisation, forming a strong and long lasting peak in the late response to cAMP 
stimulation (Fig. 4.11. C, D). 
This sudden drop of fluorescence intensity is only observed by TIRFM and, as it will be 
described later, it is shared by several other proteins analysed. The most likely explanation is 
that it represents a TIRFM specific phenomenon, related to the very unusual way by which 
cells are visualised with this method. To understand it, we need to imagine the processes that 





Figure 4.11. Results for MhcA protein. A) Confocal images of GFP alone (top) and merged GFP and RFP 
signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 
Translocation dynamics measured in the standard SILAC (blue) and cross-linked SILAC (red) experiments. 
Myosin II  
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In unstimulated cells we are observing a relatively stable network of cytoskeletal components 
existing in a dynamic equilibrium, with constant endogenous fluctuations of different factors. 
At the point of cAMP stimulation this whole equilibrium collapses and an explosion of actin 
polymerisation is triggered, generating massive amount of new actin filaments. Those new 
filaments are generated within the first 3 – 5 s almost exclusively at the outer cortex, and are 
equivalent of more than all the filamentous actin present in those cells before stimulation. 
This new F-actin population has to form a thick layer at the outer part of the cortex, pushing 
the old cortical structure deeper inside the cell.  
The average length of actin filaments was previously determined to be constant throughout 
the whole response to cAMP stimulation and was calculated as about 350 nm ±100 nm [60]. 
Taking into account that TIRFM is efficiently illuminating a layer of only about 200 nm of 
the cell cortex, it is easy to understand that proteins which do not associate instantly with 
freshly formed ATP-rich actin filaments, will be pushed away from the cortex periphery and 
at the same time from the illumination field of TIRFM. This mechanism could explain the 
sudden drop of fluorescence intensity, which correlates with the burst of actin 
polymerisation, and then the following slow recovery of this fluorescence would indicate the 
gradual loss of this new outer layer of actin filaments during the depolymerisation phase.  
The alternative explanation, that proteins exhibiting this type of behaviour are actually 
depleted from the cortex instantly after the stimulation, is not supported by any other 
available data. 
 
4.2.1.4. Kinesin Family member; Kif5 
 
Kinesins are molecular motors which move along microtubules driven by ATP hydrolysis, in 
the direction of the plus end, which means that they travel from the centre of the cell to the 
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cell periphery. These proteins are involved in diverse cellular processes such as vesicles and 
organelles transport and chromosome segregation. Dictyostelium genome encodes 13 
members of this superfamily, given the acronym ‘kif’ followed by a number [259].  
Kif5 is a kinesin-1 family protein and it is a very interesting member of this superfamily. It 
contains a conserved head domain at the N-terminus, central coiled coil region and a C-
terminal tail domain. This protein has already been studied by Iwai et al. (2004) and found to 
colocalise with actin at the cortex [260]. The motor domain was shown to have ATP-
dependent affinity to microtubules and the C-terminal domain was shown to bind directly 
and bundle actin filaments [260]. Based on those findings it has been proposed, that Kif5 
might function as a cross-linker between actin filaments and microtubules associated with 
cortical structures. 
Our results confirm cortical localisation of this protein and add interesting feature to its 
characteristic. In our study Kif5 was found to be localised predominantly at the uropod of 
polarised cells (Fig. 4.12. A). It actually showed only limited colocalisation with cortical 
actin, which was mainly present at the front of those cells. The reason why this uropod 
localisation was not reported in the previous study might be due to the fact, that those 
analysis were performed on vegetative cells by immunofluorescence microscopy, while our 
data represent in vivo imaging of GFP-tagged proteins in developed polarised cells. 
Confocal microscopy revealed that this protein was translocated from the cytosol to the 
cortex after stimulation, but this translocation only slightly increased the initially strong 
cortical signal. In addition to cortical localisation, Kif5 was also present on short fragments 
of the microtubules around the centrosomes, which gave a visible signal from the centre of 
the cells. TIRFM imaging revealed a very homogenous distribution of Kif5-GFP fusion 
proteins within cortical filamentous structure, which also confirms a specific binding of this 
protein to actin filaments. These filamentous structures visualised with TIRFM showed very 





Figure 4.12. Results for Kif5 protein. A) Confocal images of GFP alone (top) and merged GFP and RFP signals 
(bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity dynamics. C) 
TIRFM images of merged GFP and RFP signals. D) Translocation dynamics measured in standard SILAC (blue) 




expected for kinesin protein (Supplementary Movies). It is important to indicate that even 
though both C-terminal and N-terminal GFP fusions were localised to the cortex, the N-
terminal construct generated stronger fluorescence, suggesting that it was more stable, and it 
was the only one to stain microtubules close to the centrosome.  
SILAC results for Kif5 show biphasic response with the first peak at 10 s and about 1.4 L/H, 
the second phase peaking at 60 s shows big variability between two experimental replicas. 
Results from the cross-linked SILAC are not consistent with the standard experiment. 
 
 
4.2.2. Regulatory components of the cytoskeleton 
 
4.2.2.1. Unconventional Rac GEFs; DocA and DocB  
 
Both DocA and DocB are Rac GEFs which activate Rac GTPases by catalysing dissociation 
of GDP from those proteins, allowing binding of GTP and switching to an active form. Both 
of those proteins are related to human Dock180 protein and belong to evolutionarily 
conserved family of unconventional Rho GEFs containing CZH (CDM-zizimin homology) 
domain [261, 262]. They feature two CZH domains, CZH1 which can bind phospholipids 
such as PI(3,4,5)P3 [263], and CZH2 which is responsible for activation of GTPases [264]. In 
addition to those two CZH domains DocA also contains N-terminal SH3 (Src homology 3) 
domain, which makes it closer homolog to human Dock180, than DocB [138].  
There are 4 Dock180-related proteins in Dictyostelium. Two of them, which show highest 
homology to human ortholog, DocA and DocD, were previously investigated and 
characterised as having redundant functions [138]. Cells lacking either of those proteins were 
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showing reduced cell motility, which was further impaired in double knock-out. Morover, 
overexpression of DocD was shown to enhance actin polymerisation leading to increase in 
membrane protrusions. This protein was also described to translocate to the cortex after 
cAMP stimulation in a PI3K dependent fashion, which suggests its role in signal transduction 
from PI(3,4,5)P3 accumulation to activation of the Arp2/3 complex [138]. 
Standard SILAC experiment detected only DocA and DocB members of Dock180-related 
proteins, which both shared interesting translocation dynamics and were selected for further 
investigation. Imaging analysis also revealed very similar characteristic of those two proteins 
(Fig. 4.13. and 4.14.). Both of them showed very rapid and transient translocation to the 
cortex in the first phase of response to cAMP stimulation, and then partially colocalised with 
actin structures during the second phase of response. Both types of SILAC experiments 
revealed that they have enrichment specific for the first phase of cAMP-induced actin 
polymerisation (sections E).  
Both SILAC and TIRFM analysis reveal very rapid character of DocA and DocB 
translocation, reaching their peaks around 1 s after stimulation, except for the cross-linked 
SILAC with the firs peak between 4 – 10 s time points for both proteins. Interestingly, these 
proteins show relatively uniform localisation within the filamentous cortical structure 
visualised by TIRFM imaging (sections C; Suplementary Movies). Another important feature 
detected by imaging analysis, is that cells overexpressing each of those GFP-tagged proteins 
showed enhanced levels of cortical actin polymerisation leading to increased membrane 
protrusions and abnormal motion characteristic, which can be described as hectic and over 
agitated (sections A, B; Suplementary Movies). These observations are in agreement with 
phenotypes reported for cells overexpressing DocD-GFP fusion protein [138] and indicate 






Figure 4.13. Results for DocA protein. A) Confocal images of GFP alone (top) and merged GFP and RFP 
signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 






Figure 4.14. Results for DocB protein. A) Confocal images of GFP alone (top) and merged GFP and RFP 
signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 




The fact that those two proteins have very high sequence similarity and share virtually the 
same characteristics in all the types of analyses performed, suggests that they also have 
redundant functions acting in the same processes.  
The very rapid translocation to the cortex and higher enrichment during the first than the 
second phase of actin polymerisation would make those proteins a strong candidates for 
specific activators of fast actin response to cAMP stimulation. On the other hand, their 
translocation to the cortex is likely to be PI3K dependent, based on the previously mentioned  
study of their close homolog – DocD, which would exclude them from the list of potential 
factors mediating the PI3K independent response during the first phase. 
 
4.2.2.2. Zizimin-related protein; ZizA 
 
ZizA is a Zizimin-related protein which belongs to the same CZH family of unconventional 
Rho GEFs as Dock180-related proteins and it also contains two characteristic domains: 
CZH1 and CZH2. The difference between Dock-related and Zizimin-related proteins in 
humans is that they regulate different subfamilies of Rho GTPases. Dock proteins activate 
proteins belonging to the Rac subfamily while Zizimins activate the Cdc42 subfamily of the 
Rho GTPases [261]. Interestingly, Dictyostelium has 4 Zizimin-related proteins while there 
are no members of the Cdc42 family of Rho GTPases found in this organism [101]. Zizimins 
present in Dictyostelium are thought to be involved in development but not in chemotaxis to 
cAMP [261].  
Our results of ZizA analysis give somehow inconsistent picture of this protein’s dynamics. 
On one hand the standard SILAC experiment indicates that ZizA follows the generic actin 
dynamics with a first peak of 1.8 L/H at the 4 s time point, going down the to pre-stimulation 





Figure 4.15. Results for ZizA protein. A) Confocal images of GFP alone (top) and merged GFP and RFP signals 
(bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity dynamics. C) 
TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) Translocation dynamics 




This result is generally supported by the confocal imaging, showing weak cortical 
localisation with a lot of cytosolic signal, but also clear colocalisation with actin structures 
and cAMP-induced translocation (Fig. 4.15. A, B). On the other hand the cross-linked 
SILAC shows only mild enrichment after stimulation with no prominent pattern noticeable, 
which does not generate a major inconsistency alone, as there are many proteins with no 
correlation between the two types of SILAC experiments.  
The major discrepancy comes from the TIRFM imaging analysis, showing a rapid and strong 
drop of fluorescence intensity after stimulation, which then recovers slowly reaching pre-
stimulation levels after about 30 s (Fig. 4.15. C, D). This type of behaviour was described 
earlier for MhcA and it indicates that this protein is not present at the newly generated 
peripheral part of the cell cortex, consisting of actin filament formed in the first phase of 
actin polymerisation.  
The most likely overall interpretation of those results is that ZizA is enriched in actin 
structures at the cortex and does respond to cAMP stimulation, but it translocates only to the 
old pre-existing network of actin filaments and does not bind to newly polymerised ones. 
This interpretation would suggest that ZizA plays some role specific only to pre-existing 
structure of cortical actin filaments, such as stabilisation or reorganisation of those filaments. 
 
4.2.2.3. Ras-like GTPase; Roco7 
 
Roco7 belongs to a superfamily of multidomain proteins containing a Ras-like GTPase 
domain called Roc (Ras of complex proteins) followed by a characteristic COR (C-terminal 
of Roc) domain. This superfamily was first identified in Dictyostelium [265] and later 
members of Roco family were detected in many other organisms including humans, where 
one of them (LRRK2) was found to be involved in development of Parkinson disease [266].  
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There are 11 members of Roco family in Dictyostelium, all containing a kinase domain 
belonging to MAPKKK subfamily of kinases, which follows directly the COR domain. Many 
of those proteins also contain other domains such as WD40, LRR or Rho GEF and Rho GAP 
domains [14, 265]. These proteins were described to play important roles in various cellular 
processes such as organisation of myosin II filaments, chemotaxis and development [14, 
267]. Interestingly, it has been shown that the GTP binding to Roc domain is necessary for 
activation of the MAPKKK domain kinase activity, suggesting that these proteins may act as 
independent signal transduction units, performing tasks which normally require several 
proteins [268, 269]. 
Roco7 is the only roco protein in Dictyostelium which does not contain LRR (Leucin-Rich 
Repeat) domain at the N-terminus. Apart from the 3 common domains shared by all the 
members (Roc, COR and MAPKKK) it contains only WD40 repeat domain at the C-
terminus, which makes it one of the most simple proteins in this family [265]. Expression of 
this protein is developmentally regulated and, similarly to many other proteins involved in 
chemotaxis, it shows the highest expression levels after 4 hours of starvation corresponding 
to the aggregation stage of development (http://www.ailab.si/dictyexpress/). Knock-out cells 
lacking roco7 gene did not display any major developmental defects, neither did most of 
other roco single knock-out strains [267].  
Our SILAC experiments detected 4 members of the Roco family, Roco5, Roco7, Roco9, and 
Roco10, most of which followed the basic actin dynamics with Roco7 showing the highest 
amplitude in the first phase (Fig. 3.5.). First three of them were selected for tagging with 
GFP, but because of the very big sizes of the genes encoding those proteins, only Roco7 was 
successfully cloned. This is unfortunate because Roco5 and Roco9 are more complex and 
potentially more interesting regulators of the cytoskeleton containing additional Rho GEF 






Figure 4.16. Results for Roco7 protein. A) Confocal images of GFP alone (top) and merged GFP and RFP 
signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 




The SILAC results for Roco7 protein revealed an interesting dynamics pattern with rapid 
translocation reaching peak of about 2.6 L/H at 4 s after stimulation. In the standard SILAC it 
then followed actin dynamics decreasing linearly to slightly below pre-stimulation level at 60 
s time point and was enriched during the second phase to around 1.3 L/H. The cross-linked 
SILAC experiment also revealed rapid translocation with a peak of 2.6 L/H at 4 s time point, 
but here instead of falling down it stayed at this level until 20 s and then gradually decreased 
to about 1.5 L/H at 2 and 3 min time points (Fig. 4.16. E).  
This difference between dynamics patterns detected in two types of SILAC preparations can 
be easily explained for such a big and compex protein. As a multidomain factor, Roco7 is 
presumably involved in different interactions with several other proteins. The standard 
SILAC experiment can only detect translocation dynamics mediated through stable protein-
protein interactions, while cross-linked version of the sample preparation is capable of fixing 
and maintaining also the weaker interactions. This type of difference in the SILAC results as 
observed for Roco7 might illustrate the fact that this protein changes interaction 
characteristic and partners in the course of response to chemoattractant stimulation.  
In spite of this promising SILAC result showing strong enrichment, confocal imaging 
showed only weak cortical localisation of this protein (Fig. 4.16. A). This is one of the 
examples illustrating that those two assays measure slightly different aspects of protein 
dynamics and do not always correlate with each other. 
TIRFM imaging results have higher correlation to the dynamics detected with the SILAC 
experiment. In TIRFM analysis Roco7 shows comparatively uniform distribution in the 
cortex and a rapid enrichment upon cAMP stimulation, with relatively long lasting effect 
(Fig. 4.16. C, D). These combined results indicate that Roco7 is involved in regulation of the 




4.2.2.4. p21-activated protein kinase; PakB 
 
PakB belongs to a conserved family of p21-activated protein kinases, which are important 
regulators of the cytoskeleton and cell motility in a diverse range of organisms. This family 
of kinases is characterised by the presence of two domains, a PBD (p21-binding domain) and 
a C-terminal Ser/Thr protein kinase domain. In the inactive conformation the PBD inhibits 
the kinase activity of the catalytic domain, and this autoinhibitory effect is disrupted by 
interaction with active forms of Rac GTPases [270].  
PakB from Dictyostelium was found to interact directly with Rac1a/b/c, RacA, RacB, RacC 
and RacF1 [99, 101]. PakB was originally identified as an activator of unconventional type I 
myosin – MyoD, which is phosphorylated by this kinase at a site located in the motor domain 
[271]. MyoD is a single-headed non-filamentous myosin, which is localised to the cell 
leading edge [272]. MyoD contains a membrane binding domain at the C-terminus and 
therefore may function as a cross-linker between actin filaments and cell membrane and it 
could also move those two structures relatively to each other [273, 274].  
PakB has been previously investigated including in vivo localisation analysis and was shown 
to be enriched at the cell cortex and in a phagocytic cup structures, which is consistent with 
its role in regulation of MyoD [275]. PakB-null cells did not display any significant 
phenotypes, but overexpression of constantly active PakB resulted in cytokinesis defects and 
higher rates of phagocytosis and pinocytosis [275]. 
Our imaging results of GFP-tagged PakB confirm the cortical localisation of this protein. In 
fact this construct was showing one of the strongest translocation and colocalisation with 
actin structures after stimulating with cAMP (Fig. 4.17. A, B). What is noticeable, the GFP 







Figure 4.17. Results for PakB protein. A) Confocal images of GFP alone (top) and merged GFP and RFP signals 
(bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity dynamics. C) 
TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) Translocation dynamics 




fluorescence in the cortex (Fig. 4.17. B), while most of the other cortical proteins showed 
weaker fluorescence than the F-actin probe. 
TIRFM imaging also reveals increase in cortical signal intensity following cAMP stimulation 
and lasting for about 20 s (Fig. 4.17. C, D). Both types of microscopy analyses provide a 
good validation of the SILAC results, which show that PakB follows closely actin dynamics 
in both native and cross-linking conditions (Fig. 4.17. E). 
MyoD was also detected in the SILAC experiments and it displayed a different dynamics 
pattern than PakB, showing no response in the early time points and then slow and gradual 
enrichment with a peak at the second phase of actin polymerisation. This pattern was 
consistent between both standard and cross-linked SILAC results (Fig. 3.8. 22nd profile from 
the bottom). The fact that PakB follows actin dynamics very closely, which is not shared by 
its main known substrate – MyoD, suggests that this kinase might also participate in the 
regulation of other cytoskeletal components upon cAMP stimulation. 
 
4.2.2.5. Rac GAP; GacR 
 
GacR (GTPase activating factor for Rac) is a Rho GAP domain containing protein. It 
activates the intrinsic catalytic activity of Rac GTPases leading to hydrolysis of GTP into 
GDP and thus inactivating those molecular switches. The family of Rho GAPs has generally 
attracted much less attention than the activators of those small GTPases, Rho GEFs. Only 
very few proteins containing Rho GAP domain were individually investigated and therefore 
the interaction partners for most of them remain unknown [100]. GacR has not been yet 
individually characterised with functional analysis. 
GacR apart from Rho GAP domain also contains a BAR domain at the N-terminus. This type 
of domain is responsible for dimerisation, lipid binding and membrane curvature sensing. 
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BAR domains form dimers that bind to membranes and can induce or detect membrane 
bending and curvature, they may also be involved in protein-protein interactions [276]. This 
domain composition makes this protein an interesting molecule, which might be involved in 
local cytoskeleton regulation at sites of specific membrane structures, such as actin based 
protrusions or invaginations.  
SILAC results show rapid enrichment of this protein after stimulation. It reaches a peak of 
about 1.5 L/H at 1 s, which then slowly decreases. The 60 s time point is missing but at 120 s  
it indicates protein abundance below the pre-stimulation level, which then goes up to 1.4 L/H 
in 180 s time point (Fig. 4.18. E). This protein was not detected in the cross-linked SILAC 
experiment.  
Confocal imaging reveals a primarily cytosolic localisation in unstimulated cells and a strong 
translocation to the cortex after cAMP stimulation. GacR exhibits strong colocalisation to 
actin cortical structures in both phases of actin polymerisation (Fig. 4.18. A, B). 
TIRFM imaging also indicates very rapid and strong enrichment of this protein at the 
peripheral cell cortex after stimulation, with characteristic biphasic dynamics, which is rather 
unusual for TIRFM analysis. The first rapid phase peaks only about 2-3 s after stimulation 
and the second lower peak comes at about 12-15 s (Fig. 4.18. C, D), which does not correlate 
with the two phases of actin response, but might represent a specific character of this 
protein’s dynamics. It is also noticeable that GacR is not uniformly distributed, but rather 
concentrates locally at distinct patches throughout the cell cortex.  
All the acquired results suggest, that this Rac GAP might play an important role in both 
phases of actin polymerisation. Based on the very strong translocation of GacR to actin 





Figure 4.18. Results for GacR protein. A) Confocal images of GFP alone (top) and merged GFP and RFP 
signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 




4.2.2.6. Rho GAP; GacA 
 
GacA is another example of a Rho GAP domain containing protein. It is a relatively simple 
and small (37kDa) protein, which does not have any additional identified domains and has 
not been previously investigated. 
Results from the standard SILAC experiment show initial depletion after stimulation, 
followed by enrichment to about 1.2 L/H at 20 s, which corresponds to the beginning of the 
depolymerisation phase. Indeed, this protein was selected for cloning as a potential factor 
involved in triggering actin depolymerisation at the end of the first phase. This pattern was 
not reproduced in the cross-linked SILAC experiment, which revealed instant enrichment 
after stimulation with a peak of 1.8 L/H at 20 s going down to below pre-stimulation level at 
120 s and rising again to 1.3 L/H at 180 s (Fig. 4.19. E). This profile resembles the actin 
biphasic dynamics with a certain time delay and correlates with the imaging analysis much 
better than the standard SILAC results.  
Confocal imaging shows strong translocation from the cytosol to the cortex triggered by 
cAMP stimulation. GacA exhibits partial colocalisation with actin structures leaving some of 
the cortical actin without GFP signal and staining some parts of the cortex with no actin 
present (Fig. 4.19. A). Cells overexpressing GacA showed greatly reduced second phase of 
actin polymerisation, which is in agreement with its function as an inhibitor of Rac 
signalling. TIRFM imaging also indicates cAMP dependent increase in cortical localisation 
of GacA corresponding to actin dynamics (Fig. 4.19. C, D). 
These results show that GacA is another Rac GAP which follows actin dynamics after cAMP 
stimulation and the overexpression phenotype observed for this protein suggests, that it is 






Figure 4.19. Results for GacA protein. A) Confocal images of GFP alone (top) and merged GFP and RFP 
signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 




It is interesting to observe those two Rho GAPs being translocated to the cortex after cAMP 
stimulation with very similar timing to that displayed by Rho GEFs. This indicates that both 
activators and inhibitors of small GTPases signalling are working with the same temporal 
and spatial dynamics.  
 
4.2.2.7. Rho GEF / Rho GAP; XacB 
 
XacB (Exchange and activating factor for Rac) is a complex 143kDa multidomain protein. It 
is one of three proteins in Dictyostelium containing both Rho GEF and Rho GAP domains. 
Its Rho GEF domain belongs to the canonical family comprised of DH (Dbl-homology) 
domain followed by PH (Plecstrin-homology) domain acting as a membrane anchor and as a 
mediator of interactions with other signalling components [100]. Those two subdomains 
belonging to the classical Rho GEF domain are followed by the Rho GAP domain at the C-
terminus. The Rac GTPases which are controlled by each of those domains has not been 
identified and the XacB protein has not been yet functionally characterised.  
Even though this protein domain composition seems to belong to the big repertoire of 
Dictyostelium specific cytoskeletal components, it does have identified orthologs in human 
and mouse (http://dictybase.org/gene/DDB_G0278417). XacB gene expression is like many 
other cytoskeletal factors developmentally regulated and it is most highly transcribed in the 
slug stage of development after 16 h of starvation. 
XacB measured in the SILAC experiments exhibits biphasic dynamics with shifted timing 
relative to actin profile. The first peak of about 1.4 L/H ends at 20 s time point and then the 





Figure 4.20. Results for XacB protein. A) Confocal images of GFP alone (top) and merged GFP and RFP 
signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 




Confocal imaging reveals strong translocation from the cytosol to the cortex in the first phase 
of actin response. This cortical enrichment is almost completely reversed into the cytosol 
during the depolymerisation phase and then occurs again in the actin-rich cortical structures 
during the second phase (Fig. 4.20. A). Cells overexpressing XacB construct had both phases 
of actin polymerisation well represented and did not show any obvious aberrant phenotypes 
related to this overexpression. XacB shows comparatively uniform distribution along 
filamentous structures in the cortex of unstimulated cells, which is then followed by more 
localised enrichment after cAMP stimulation as visualized by TIRFM imaging, which also 
confirms the translocation triggered by this chemoattractant (Fig. 4.20. C, D).  
These results indicate that XacB is involved in the chemotactic response to cAMP 
stimulation. The fact that it contains a PH domain suggests that the translocation of this 
protein might be driven by PI(3,4,5)P3 accumulation at the membrane. It is not clear from the 
results which of the two domains, Rho GEF or Rho GAP, plays a primary role in the cellular 
functions of this protein, since both of those classes of regulatory factors share the same type 
of actin-like dynamics. 
 
4.2.3. Uncharacterised cytoskeletal factors 
 
4.2.3.1. DDB_G0283827; WASP-related protein 
 
DDB_G0283827 is one of two WASP-related proteins found in Dictyostelium in addition to 
the conventional WASP. It contains a CRIB (Cdc and Rac Interactive Binding) domain at the 
N-terminus and a WH2 (WASP homology 2) domain at the C-terminus. The CRIB domain 
suggests that this protein is a putative effector of Rho GTPases signalling. Proteins 
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containing CRIB domains usually exist in a folded inactive conformation which has an 
autoinhibitory effect on its function. This conformation is disrupted by interaction with 
activated GTPases exposing the catalytic domain or allowing formation of further 
interactions with other proteins [48]. The WH2 domain is a monomeric actin binding motif, 
which facilitates the assembly of actin monomers into filaments, but by itself is not sufficient 
to establish interactions with F-actin or the Arp2/3 complex [49, 277].  
This protein, together with the other WASP-related protein, was recently investigated and 
both were found to colocalise with clathrin coated vesicles, which suggests their potentially 
redundant function in the clathrin based endocytosis [50]. 
The standard SILAC experiments show a moderate increase of this protein’s abundance 
during the first phase with a level of about 1.3 L/H at the 4 s and 10 s time points. It then 
goes down to prestimulation level at 20 s, and  increases again up to 1.3 L/H at the last 3 min 
time point (Fig. 4.21. E). Results from the cross-linked SILAC are inconsistent with the 
standard experiment and show less coherent translocation profile.  
This WASP-related protein shows very strong translocation to the cortex upon cAMP 
stimulation as observed with confocal imaging. It colocalises with most of the actin cortical 
structures in both phases of cAMP stimulated actin polymerisation response (Fig. 4.21. A, 
B). Apart from the cell cortex it also localises to circular structures resembling a phagocytic 
ring, which is best visible at the confocal images from the 60 s time point. This observation 
suggests that DDB_G0283827 might be also involved in the process of phagocytosis.  
TIRFM imaging also reveals a strong translocation to the cortex after stimulation. This 
enrichment shows non-homogenous distribution and is present throughout the whole duration 
of the first phase of actin polymerisation (Fig. 4.21. C, D). 
All the results show that this WASP-related protein colocalises strongly with actin structures 
in response to cAMP stimulation. This indicates a potential role in the regulation of the 






Figure 4.21. Results for DDB_G0283827 protein. A) Confocal images of GFP alone (top) and merged GFP and 
RFP signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 
Translocation dynamics measured in the standard SILAC (blue) and cross-linked SILAC (red) experiments. 
DDB_G0283827; WASP-related protein 
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4.2.3.2. DDB_G0295683; ADF-H dcp 
 
DDB_G0295683 is a big 190kDa protein containing two conserved domains: one ADF-H 
(Actin Depolymerising Factor Homology) domain and one LIM type Zinc finger domain.  
ADF-H domain can bind both actin monomers and filaments and is found in three distinct 
classes of ABPs. A single ADF-H domain is found in ADF/cofilins which bind both G-actin 
and F-actin and promote rapid filament turn-over by depolymerising/fragmenting actin 
filaments. Twinfilins, which are actin monomer sequestering proteins, contain two ADF-H 
domains [278]. Drebrins, proteins that bind to actin filaments, but do not promote actin 
depolymerisation, contain one ADF-H domain followed by a C-terminal SH3 domain [279]. 
It therefore appears that the ADF-H domain mainly acts as an actin binding domain, but that 
it is not enough to specify a protein’s function, since it is found in a diverse range of proteins 
playing very different roles in actin dynamics. 
The LIM domain consists of two zinc finger motifs, which can coordinate one or more zinc 
atoms. This is a versatile domain which can mediate various interactions such as binding to 
nucleic acids or other proteins. It is found in factors involved in a wide range of cellular 
functions including gene expression, cytoskeleton organisation and development [280]. 
Protein BLAST search also revealed a region at the N-terminus, which shows similarity to 
several ATPases including V-ATPase, few bacterial SMC (structural maintenance of 
chromosomes) chromosome segregation ATPases and DNA repair ATPase SbcC. Its domain 
composition makes this protein a complex and potentially interesting ABP. The gene 
encoding this protein has a relatively low endogenous level of expression, which does not 
change significantly during development. 
The standard SILAC results show enrichment of about 1.4 L/H at the 10 s time point, which 
then stays at this level almost constantly for the remaining time-points.  The cross-linked 
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experiment shows a peak of 1.4 L/H at 10 s, but then shows depletion to 1.1 L/H at 60 s 
followed by a second lower peak at the 2 min time point (Fig. 4.22. D). This protein was 
among the most abundant factors detected in the SILAC experiments, which suggests that it 
might have a significant role in the cytoskeleton dynamics. 
The GFP-tagged DDB_G0295683 protein displays a strong translocation to the cortex after 
cAMP stimulation as visualised by confocal microscopy, but interestingly it is localised only 
to the rear and sides of chemotaxing cells and it is virtually absent from the leading edge. It 
shows limited colocalisation with actin structures and appears to be enriched in cortical 
regions depleted of F-actin (Fig. 4.22. A).  
TIRFM imaging was performed for both green and red channels simultaneously, which 
means that there is no accurate quantification of the translocation dynamics available, as 
explained before. Nevertheless it still provides useful information, visualising a clearly 
filamentous structure labelled uniformly with this construct. It also reveals stronger labelling 
of this structure by GFP construct than by the RFP-lifeact probe (Fig. 4.22. C).  
The fact that both types of microscopy show a certain degree of exclusion between regions of 
GFP and RFP signal localisation suggests that the DDB_G0295683 protein might be 
involved in actin filament depolymerisation in accordance with the presence of an ADF-H 
domain. The very strong uropod localisation of this protein implies that it might be playing 







Figure 4.22. Results for DDB_G0295683 protein. A) Confocal images of GFP alone (top) and merged GFP and 
RFP signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of merged GFP and RFP signals. D) Translocation dynamics measured in the 
standard SILAC (blue) and cross-linked SILAC (red) experiments. 
DDB_G0295683; ADF-H dcp 
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4.2.3.3. DDB_G0277615; ADF-H dcp 
 
DDB_G0277615 is another ADF-H domain containing protein (dcp). It actually contains 
three of those domains, each about 150 amino acids long, covering almost the entire 
sequence of this 56kDa protein. This type of domain architecture is not found in any of the 
protein families containing ADF-H domains described earlier and this particular protein does 
not have any clear orthologs in higher organisms  
The gene shows very high levels of expression, which is developmentally regulated and 
reaches the highest level at the last stage of development, when it shows about 100 times 
higher gene expression than DDB_G0295683 described before. Interestingly, the detection of 
these two proteins in the proteomic data reveals a reversed abundance. The proteomic 
abundance factor was calculated as the total peptide count for each protein in the whole 
experiment divided by the size of this protein in kDa, to avoid overrepresentation of large 
proteins. Even with this normalisation to the protein size the DDB_G0295683 protein shows 
about 4 times higher abundance than the DDB_G0277615, which is more than 3 times 
smaller molecule and shows between 20 and 100 times higher levels of mRNA with 800 – 
4000 counts detected by RNA sequencing (http://www.ailab.si/dictyexpress/).  
DDB_G0277615 protein has been previously detected by proteomic analysis of the purified 
phagocytic vesicles [281] and also centrosomes [282], which suggests that it displays 
interactions with various cellular components. 
Our image analysis does not confirm any centrosomal or vesicular localisation, but instead 
reveals a cAMP dependent translocation to the cortex and colocalisation with actin-rich 
structures. It is localised to the distinct and narrow cortical band, which determined its 
classification as a strong cortical protein, even though there is a substantial part of the signal 





Figure 4.23. Results for DDB_G0277615 protein. A) Confocal images of GFP alone (top) and merged GFP and 
RFP signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 
Translocation dynamics measured in standard SILAC (blue) and cross-linked SILAC (red) experiments. 
DDB_G0277615; ADF-H dcp 
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The interesting and unusual characteristic of its translocation is its timing. DDB_G0277615 
protein enrichment at the cortex is triggered at the same time as actin polymerisation but it 
seems to stay in the cortex still after the peak of the first phase when actin is being 
depolymerised. This is best noticeable in the quantification of the confocal images (Fig. 4.23. 
B) and in the movie format (Supplementary Materials \ Movies \ Individual Proteins \ 
DDB_G0277615). TIRFM imaging also reveals a strong translocation to the cortex after 
cAMP stimulation (Fig. 4.23. C, D). This analysis lacks the internal actin reference, but 
comparison to the actin dynamics measured for other cells does not indicate any significantly 
prolonged residence of this protein at the cortex. 
The translocation to the cortex and colocalisation with actin observed by imaging analysis 
correlates with the standard SILAC results. In this experiment DDB_G0277615 protein 
follows closely the actin dynamics with the first peak reaching about 1.9 L/H at 4 – 20 s 
followed by depletion to prestimulation levels at 60 s and rising to 1.6 L/H at 2 and 3 min 
time points (Fig. 4.23. E). The cross-linked SILAC experiment does not reproduce this 
pattern and is less consistent with the imaging analysis.  
The translocation dynamics of DDB_G0277615 validates this protein as an actin binding 
protein responsive to cAMP stimulation. The prolonged cortical localisation in comparison to 
actin polymerisation during the first phase, which was detected with confocal microscopy, 
suggests that this protein might be playing role in a disassembly of the actin filaments in the 
depolymerisation phase, in line with its domain architecture of three ADF-H motifs.  
 
4.2.3.4. DDB_G0267974; CH dcp 
 
DDB_G0267974 is an uncharacterised protein containing a single CH (Calponin Homology) 
domain at the N-terminus followed by three subsequent coiled coil regions. CH domains are 
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found usually as tandem repeats in cytoskeletal proteins and in signal transduction factors. 
There are several types of CH domains and some of them are functioning as actin binding 
modules, while others have no detectable affinity to actin [283].  
The CH domain found in DDB_G0267974 protein belongs to the CH3 type, which is 
characteristic of many signalling factors such as Rho GEFs and is thought to be unable to 
bind actin [283]. There are no other conserved domains identified in the sequence, which 
makes the single CH domain insufficient to predict any potential function of this protein. 
The SILAC results from both standard and cross-linked experiments show very similar 
biphasic response with the first peak reaching about 1.3 L/H and lasting for 10 s. The 20 s 
time point shows depletion to about the prestimulation level and is followed by a gradual 
enrichment rising to about 1.5 L/H in the last time point (Fig. 4.24. E).  
Confocal imaging shows strong cortical localisation even in unstimulated cells. This cortical 
signal is enriched after stimulation by the cytosolic fraction of the protein translocating to the 
cortex (Fig. 4.24. A). It partially colocalises with actin structures, but noticeably the strongest 
enrichment of this protein is found at the uropod cortical regions, which show only limited 
amount of F-actin making a GFP signal almost excusive at those sites. In contrast in the 
leading edge of chemotaxing cells the RFP signal dominates over the weak GFP 
fluorescence. The imaging sequence shown below shows that this region of strong GFP 
fusion protein localisation is first established in the middle of the elongated cell at the 5 s 
time point, which then becomes the uropod of this cell as it retracts the left part of the body 
and moves rightwards at 60 s after stimulation (Fig. 4.24. A). The uropod localisation of this 
protein is most noticeable in the movies and also in another confocal image sequence 
discussed later.  
TIRFM imaging reveals that this is one of the proteins showing a sudden drop of 
fluorescence after stimulation. Interestingly, it displays only partial signal recovery, never 





Figure 4.24. Results for DDB_G0267974 protein. A) Confocal images of GFP alone (top) and merged GFP and 
RFP signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 
Translocation dynamics measured in the standard SILAC (blue) and cross-linked SILAC (red) experiments. 
DDB_G0267974; CH dcp 
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On the other hand, TIRFM also clearly shows that this protein does bind to actin filaments, 
which is best visible at the protrusions of cells in the centre of TIRFM images (Fig. 4.24. C). 
These observations indicate that DDB_G0267974 is an actin binding protein, which is not 
binding to the freshly polymerised actin filaments and during the translocation it localises 
only to the inner part of the cell cortex. This result together with the uropod localisation of 
this protein suggests that it might be another factor involved in actin depolymerisation or in 
inhibition of pseudopod formation at the back of the cell, rather than play a role in the 
process of cAMP dependent actin polymerisation. 
This protein clearly binds to actin filaments either directly or indirectly, but the domain that 
mediates this interaction remains elusive. The CH3 domain found in this protein has been 
shown to be unable to bind F-actin [283, 284] 
 
 
4.2.3.5. DDB_G0284825; Rap/Ran GAP dcp 
 
DDB_G0284825 is a 186kDa protein containing one Rap/Ran GAP domain at the C-
terminus and one ARM (armadillo) domain at the N-terminus. It has orthologs identified in 
higher organisms including human and mouse. Rap/Ran GAP domain is involved in the 
negative regulation of the Rap and/or Ran GTPases signalling. Ran GTPases are the major 
regulators of transport between the nucleus and the cytosol [285]. The Rap subfamily is 
involved in a wide range of cellular functions. Rap1 is the only Rap GTPase found in 
Dictyostelium and it was reported as an important regulator of cytoskeletal dynamics, 
chemotaxis, cell adhesion and phagocytosis [286-288]. It was found to be rapidly activated at 




The ARM domain is a versatile motif involved in protein-protein interactions found in a large 
variety of proteins including beta-catenins, importins, clathrin heavy chain and the regulatory 
subunit of V-ATPase [290].  
Confocal imaging reveals only very weak cortical localisation and cAMP mediated 
translocation, with the majority of the protein being present in the cytosol (Fig. 4.25. A).  
TIRFM analysis show very uniform distribution with no sign of binding to any type of 
filamentous structures. It does however reveal an increase in cortical localisation after cAMP 
stimulation. This enrichment is relatively small and has very sharp and narrow peak, lasting 
only about 3-4 s after which the signal drops to prestimulation level and does not show any 
further fluctuations apart from photobleaching (Fig. 4.25. C, D). This rapid translocation to 
the cortex detected by TIRFM confirms the SILAC results for this protein. Both types of 
experimental preparations indicate very early peak of enrichment after stimulations. Standard 
SILAC shows peak of 1.4 L/H at 1 s and 4 s, which drops down at 10 s followed by a second 
peak reaching 1.5 L/H at 60 s. Cross-linked SILAC shows lower amplitudes with the first 
peak of 1.2 L/H at 1 s and the second peak with the same level at 20 s (Fig. 4.25. E).  
All the results obtained for the DDB_G0284825 protein indicate that it translocates to the 
cortex after cAMP stimulation, but it presumably does not bind to actin filaments directly. 
Based on the dynamics observed with TIRFM, it is likely to be involved in the very early 
events following detection of cAMP by the membrane receptors. The domain architecture of 
this protein suggests that it plays a role in regulation of Rap1 signalling, which is an 






Figure 4.25. Results for DDB_G0284825 protein. A) Confocal images of GFP alone (top) and merged GFP and 
RFP signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 
Translocation dynamics measured in the standard SILAC (blue) and cross-linked SILAC (red) experiments. 
DDB_G0284825; Rap/Ran GAP 
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4.2.3.6. DDB_G0275305; Fry homolog 
 
DDB_G0275305 is a very big protein with molecular weight over 320kDa. The only 
conserved domain identified in this protein is an ARM repeat, but based on the sequence 
homology it has predicted kinase activity. Expression of the gene encoding this protein is 
developmentally regulated and reaches the highest levels of transcription after 8 hours of 
starvation and does not decrease substantially until the end of development 
(http://dictyexpress.biolab.si/). This protein is an ortholog of a Fry (furry) protein and has 
two long regions of 800 and 500 amino acids showing very high similarity and one region of 
200 amino acids with lower similarity to Fry protein and its homologs in fruit fly and human.  
Furry is a conserved protein, which was first discovered in Drosophila and later found in 
many higher eukaryotes. It is proposed to play a key role in generating and maintaining 
extensions of polarised cells during morphogenesis of multicellular organisms [117] and is 
also involved in patterning dendritic fields of sensory neurons by limiting dendritic branching 
[118]. It performs those functions during development by regulating the actin cytoskeleton 
[291, 292]. The original Fry protein found in fly was reported to regulate the Trc 
(tricornered) Ser/Thr kinase and to localise to the cell cortex [293].  
Our imaging results indicate that this protein has a very distinct localisation. It is localised at 
the cell boundary and only at the attachment sites with the substrate. This localisation is best 
analysed by TIRFM imaging (Fig. 4.26. A, D). The confocal imaging with Z-sectioning 
revealed that there is hardly any signal coming from the cortex at the upper part of the cells 
above the cover slip surface and confirmed the exclusive localisation of this protein to the 
cell boundary at the bottom of the cell (data not shown).  
TIRFM analysis also showed that the DDB_G0275305 protein is enriched at those sites after 
stimulation with cAMP. It revealed an initial minor depletion of the fluorescence intensity 
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followed by gradual increase in protein abundance. This translocation displayed rather slow 
kinetics reaching its peak at about 40 s after stimulation (Fig. 4.26. B). 
Interestingly, this type of dynamics is shared only with the cross-linked SILAC results 
showing the main enrichment of about 1.9 L/H during the late response to cAMP stimulation. 
The standard SILAC results indicate a different pattern with an early enrichment peak of 
around 1.4 L/H lasting until 20 s and then staying at the level of 1.2 L/H (Fig. 4.26. C).  
 




Figure 4.26. Results for DDB_G0275305 protein. A) TIRFM images of GFP fluorescence alone. B) TIRFM 
signal quantification for 3 separate ROIs. C) Translocation dynamics measured in standard SILAC (blue) and 
cross-linked SILAC (red) experiments. D) TIRFM images of merged GFP and RFP fluorescence. Cells were not 
stimulated with cAMP. 
DDB_G0275305; Fry homolog 
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Another session of TIRFM imaging for both GFP and RFP fluorescence revealed another 
characteristic of this protein’s localisation. This imaging analysis was performed on 
developed and polarised cells which were not stimulated with the chemoattractant and were 
performing a random walk. In these cells it is apparent that the cortical localisation of 
DDB_G0275305 is confined mainly to the back and sides of moving cells and almost absent 
from the leading edge (Fig. 4.26. D). In a few occasions when the localisation spot does 
occur at the front of the cell it is noticeable that it is not displaced by the protruding 
pseudopods, but instead the membrane protrusions have to go around it in order to move 
forward. This behaviour is best visible by watching a movie of this imaging sequence 
(Supplementary data \ Movies \ Individual proteins \ DDB_G0275305).  
There is also another striking characteristic of this cortical localisation observed by TIRFM. 
Even though it does not colocalise with actin filaments it shows a protrusion-like rough 
pattern at the cell boundary. This is rather unusual, compared to other proteins showing 
cortical localisation at the uropod, which always form smooth band of signal detection.  
All these results suggest that this protein is involved in establishment of the cell-substrate 
adhesion at the cell boundary. This localisation shows also certain similarity to the one 
observed for other protein involved in focal adhesion – paxillin PaxB [294]. The major 
difference between those two proteins is that PaxB was found not only at the cell boundary, 
but also in the focal points located throughout the whole cell surface touching the substrate. It 
will therefore be interesting to investigate this possibly specialised form of cell-substrate 






4.2.3.7. DDB_G0292230  
 
DDB_G0292230 is another very big protein of unknown function. This 334kDa protein is 
annotated as a hypothetical kinase based on the sequence homology analysis. The expression 
of this gene reaches its highest level of transcription after 8 hours of starvation and then 
slowly decreases during the remainder of development. 
BLAST analysis of the protein sequence against human database revealed three regions of 
low similarity to various proteins. The longest fragment is less than 200 amino acids at the 
N-terminus and it shows similarity to several Rho GAPs. The second fragment of about 80 
amino acids has homology to TRP (tetratricopeptide repeat) domain, which is responsible for 
protein-protein interactions in various proteins such as protein phosphatases and mediates 
binding of the heat shock protein hsp90 to a series of proteins containing TRP domain [295, 
296]. The last region is about 50 amino acids long and it shows similarity to several isoforms 
of Ca²⁺ transporting ATPase type 2C. This composition of homology regions indicates that it 
might be an interesting multidomain factor potentially involved in cytoskeleton regulation 
through Rho GTPase activity and calcium signalling.  
The standard SILAC experiments show with high reproducibility that DDB_G0292230 
follows closely actin dynamics with the first peak reaching 1.6 L/H at 4 s followed by 
depletion to about 0.8 L/H at 60 s time point and the second phase of enrichment to 1.2 L/H 
at the last two time points (Fig. 4.27. E). The cross-linked SILAC did not reproduce this 
result showing a depletion of this protein after stimulation with incoherent and noisy pattern, 
which indicates that interactions formed by this protein are disrupted rather than cross-linked 






Figure 4.27. Results for DDB_G0292230 protein. A) Confocal images of GFP alone (top) and merged GFP and 
RFP signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) TIRFM signal quantification for 3 separate ROIs. E) 




Confocal imaging analysis shows that this protein displays weak cortical localisation with 
hardly noticeable translocation to the cortex after cAMP stimulation. Most of the protein was 
present in the cytosol and the cortical fraction seems to almost completely disappear in the 
late phase of response to cAMP stimulation represented by a 60 s time point (Fig. 4.27. A, 
B). Interestingly, this weak enrichment at the cortex is mainly observed at the uropod of 
moving cells. TIRFM imaging reveals a comparatively uniform localisation to a filamentous 
structure at the cell cortex. The DDB_G0292230 GFP construct shows rapid depletion of 
fluorescence intensity after cAMP stimulation in TIRFM analysis. This initial depletion is 
followed by a relatively fast and transient recovery to the prestimulation level at around 10 s 
time point and then by a second phase of depletion, which does not recover during the 
experiment (Fig. 4.27. C, D). The first rapid depletion is an indication that the analysed 
protein belongs to the class of factors, which do not bind to newly polymerised actin 
filaments and the recovery could indicate a role in actin depolymerisation. The secondary 
depletion however, is a more unusual characteristic and presumably represents an actual loss 
of this protein from the cortical cytoskeleton, which is in agreement with the confocal 
imaging data but not with the SILAC results.  
The proteomic data indicating an actin-like dynamic of this protein are generally not 
reproduced by the in vivo localisation analysis. The cortical enrichment during the first phase 
is hardly detectable on the confocal imaging and not possible to analyse by TIRFM due to the 
absence in the freshly generated periphery of the cortex. The enrichment in the second phase 
detected by the standard SILAC experiment is in contradiction to both types of imaging data, 
which indicate depletion of the cortical signal during the late response to the cAMP 
stimulation. The discrepancy between those results is another indication that the proteomic 
and the microscopy analysis are measuring different characteristics of protein translocation 
dynamics and do not necessarily correlate with each other. The dynamics measured by the 
SILAC experiments represent changes in type and stability of the protein-protein 
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interactions, which might involve only a fraction of the entire protein pool and might not 
always be detectable in the overexpression system used for in vivo localisation analyses.  
Even though the imaging analyses do not confirm the type of dynamics indicated by the 
SILAC results, they do validate that DDB_G0292230 is a cytoskeleton interacting protein. 
The confocal microscopy shows cortical enrichment mostly at the uropod, while the TIRFM 
imaging shows binding of this protein to the filamentous structures at the cortex. All these 
results together indicate that DDB_G0292230 is a cytoskeletal factor most likely involved in 
the negative regulation of the actin polymerisation, which is also supported by the sequence 




DDB_G0293032 is a 180kDa protein which has two conserved domains identified in its 
sequence. It contains an AAA+ (ATPase Associated with a wide variety of cellular 
Activities) domain and a WD40 repeat domain. It has orthologs present in higher eukaryotes 
including human. It shows low level of gene expression, which is not increased during 
development. 
The AAA+ superfamily represents an ancient group of ATPases belonging to the P-loop 
NTPase fold characterised by the conserved alpha-beta-alpha core domain and the Walker A 
and B motifs. The AAA+ ATPases function as molecular chaperons, ATPase subunits of 
proteases, helicases or nucleic-acid-stimulated ATPases. Several eukaryotic members of this 
family have adaptations related to cytoskeletal functions [297].The WD40 repeat, as 
described before, is a versatile domain acting as a platform for simultaneous protein-protein 







Figure 4.28. Results for DDB_G0293032 protein. A) Confocal images of GFP alone (top) and merged GFP and 
RFP signals (bottom). B) Two separate quantifications of confocal GFP (green) and RFP (red) cortical intensity 
dynamics. C) TIRFM images of GFP signal. D) Translocation dynamics measured in the first (green) and the 




The translocation dynamics pattern of the DDB_G0293032 protein showed substantial 
differences between the two standard SILAC experiments. The first experiment, which was 
used for selection of the proteins for cloning, showed a rapid first peak of 1.4 L/H at 1 s time 
point followed by depletion until 20 s and then enrichment to about 1.5 L/H at the rest of the 
time points. The second standard SILAC experiment also revealed a biphasic response to 
cAMP stimulation, but with different timing. In those results the first phase had a peak of 2.7 
L/H at 10 s, the lowest depletion point at 60 s and the second peak reaching 1.6 L/H at 3 min 
time point (Fig. 4.28. D).  
Confocal imaging revealed that this protein is mainly present in the cytosol, but it colocalises 
with actin at the tips of pseudopodia in unstimulated cells and during the second phase of 
actin polymerisation, and shows weak translocation to the whole cortex in the first phase of 
response to cAMP stimulation (Fig. 4.28. A). 
TIRFM imaging was performed for both GFP and RFP simultaneously and therefore could 
not be quantified afterwards, but it indicated cortical localisation similar to filamentous 
structures visualised with other actin binding proteins. The individual filaments are not as 
easily distinguishable in the merged images as with some other constructs, but they become 
noticeable when observed in the GFP fluorescence images (Fig. 4.28. C). 
These results suggest that DDB_G0293032 is one of the novel cytoskeletal factors identified 
in this study, but they do not provide enough information to speculate about the potential 









Chemotaxis is a fundamental cellular process playing a key role in a big variety of biological 
phenomena. It is involved in nearly all aspects of unicellular organisms, such as nutrient 
finding and avoidance of environmental stress. It also plays a crucial role during the 
development of multicellular organisms and in adult life in wound healing and the immune 
response. Chemotaxis also plays a key role in several pathological processes, e.g. the 
metastasis and invasion of cancer cells. 
Chemotaxis is a highly conserved process and the principal mechanisms of cellular 
movement in gradients of chemical signals are virtually identical in all eukaryotes. This 
allows us to investigate this process in a simple model organism, which is genetically and 
biochemically tractable, and then translate key findings to a better understanding of this 
process in higher organisms. Dictyostelium discoideum is an ideal organism in which to 
investigate chemotaxis, indeed many crucial cytoskeletal components and regulatory factors 
were first discovered in this organism and subsequently identified in higher eukaryotes.  
Even though chemotaxis has been studied for a few decades, there are still many fundamental 
aspects of this process that are not fully understood. There are several signalling pathways 
known to be involved in regulation of chemotactic movement, but none of them has been 
fully analysed and the cross-talk between them still needs to be delineated. All of those 
signalling pathways work in parallel and make different contributions to the regulation of this 
complex process.  
One of the major aspects of this process that is still poorly understood is the biphasic 
character of the actin polymerisation in response to chemoattractant stimulation. This is a 
universal characteristic, which can be detected with certain variability in both Dictyostelium 
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amoebas and human cells such as neutrophils and fibroblasts. It is thought that the existence 
of the initial rapidly excitable actin polymerisation can enhance the spatial detection of the 
source of stimulation, but the exact physiological relevance of this type of dynamics remains 
unclear. It has been shown that those two phases of actin polymerisation have different 
characteristics and are independent to a certain extent, but a differential regulatory 
mechanism has not yet been identified. 
 
There has been recently a great improvement of various techniques used in the quantitative 
proteomics, driven mainly by advancements in technology of the MS analysis. Orbitrap is a 
new type of mass spectrometer performing mass determinations with a very high resolution 
and accuracy and a large dynamic range. This allowed development of a new method for 
global quantitative proteomic analysis, based on a Stable Isotope Labelling by Amino acids 
in Cell culture. This relatively straightforward yet powerful procedure has been successfully 
used in many areas of research, mainly for analysis of protein expression dynamics in 
response to various treatments and for discovering interaction partners of investigated 
factors. 
 
We have adapted this versatile technique to analyse fast protein translocation dynamics of the 
cytoskeletal components in response to stimulation with chemoattractant. This approach was 
focused on the quantitative examination of changes in the composition of the cytoskeletal 
fraction, in response to cAMP stimulation. Our experimental procedure was based on the 
crude purification of the Triton X-100 insoluble cytoskeletal fractions from various time 
points after cAMP stimulation, followed by the quantitative MS proteomic analysis.  
We have performed two biological replicas of the standard SILAC experiment using native 
cell lysis conditions and one cross-linked SILAC experiment with formaldehyde fixation 
during lysis, followed by the thermal reversal of the cross-linking. Merged results from the 
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standard SILAC experiments form a main dataset of this proteomic analysis of fast 
translocation dynamics, while the cross-linked SILAC results serve as a complementary 
dataset.  
 
5.1. SILAC allows simultaneous quantitative 
measurements of translocation dynamics for 
hundreds of proteins 
 
The standard SILAC experiments have detected over 1800 proteins with a minimum 
detection of two peptides per time point in at least 4 out of 8 time points taken. It revealed 
that the analysed insoluble fraction of the cell lysate was composed, apart from the 
cytoskeletal factors, of proteins belonging to many different cellular compartments including 
nucleus, mitochondria, cell membranes, ribosomes and phagocytic vesicles. There was also a 
big fraction of uncharacterised proteins with no function determined, which contained about 
a quarter of all the identified proteins. Most of the proteins from those different groups 
exhibited some changes in abundance with various amplitudes and pattern persistency.  
 
There are more than 200 known cytoskeletal proteins composing 11% of the whole number 
of identified proteins and they make up 17% of the total protein abundance detected in those 
samples. These 200 proteins contain members of different classes of effectors including all 
known families of actin binding proteins as well as regulatory factors such as Rho GTPases, 
GEFs, GAPs and various kinases. Nevertheless they represent only a fraction of all the 
known cytoskeletal factors. Based on the Gene Onthology annotation there are almost 800 
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proteins with a cytoskeletal annotation, including regulatory factors, in Dictyostelium 
discoideum.  
This partial detection of about 25% of all the cytoskeletal proteins present in this organism is 
a result of several factors. The most important factor is protein abundance determining the 
likelihood with which a protein will be identified by MS analysis. Proteins with a low 
abundance have much lower probability of detection and are usually represented by only few 
peptides, which makes their measurement less reliable. Many of those low abundant proteins 
are detected only in a few time points, making their patterns not informative enough to be 
used in our analysis. In fact the total number of cytoskeletal factors identified in those 
experiments is more than 300, but about one third of them had L/H ratios in less than 4 time 
points or had no ratios available at all (proteins detected with a single peptide) and were 
therefore deleted from the final dataset. This detection rate could have been improved by 
further fractionation of protein samples decreasing the complexity and dynamic range of 
individual samples. Presumably using two different types of fractionation in parallel on the 
same samples and analysing them separately with several technical replicas on the MS, 
would generate much better coverage and reliable quantification of all the proteins. 
Unfortunately this ideal experiment would require much more MS runs and would exceed the 
resources available for this project.  
A crucial factor influencing the protein detection in our experiments, besides abundance of 
expression, is the stability of the interactions formed with other cytoskeletal proteins. Only 
proteins which maintain their interactions after cell lysis and during the whole preparation 
procedure will be present in the final samples. The ones that form only transient interactions 
will be lost during purification and therefore not represented in the final results. The 
importance of this behaviour is illustrated by the number of cytoskeletal proteins detected 
only in the cross-linked SILAC experiment. This type of experiment was performed 
especially to detect those weakly binding proteins, which could not be detected in the 
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standard procedure. It showed a generally slightly higher detection of proteins, but the 
cytoskeletal fraction was the most strongly enriched in comparison to the standard 
experiment. 90 additional cytoskeletal components were detected, some of which are known 
to play key roles in chemotaxis, such as activators of the Arp2/3 complex, the Scar and 
WASP proteins. 
 
These observations indicate that the proteins identified in the SILAC experiments represent 
mostly abundant proteins, which form stable interactions through direct or indirect binding to 
the cytoskeletal core components. Even though these characteristics imply that our analysis is 
limited to a subset of all the cytoskeletal proteins, it will still be very informative and give 
insights in their relative performance and regulation.  
The stability of interactions formed by detected proteins can be to a certain extent assessed 
by comparing the results from the standard and cross-linked preparations. Proteins forming 
weak interactions are likely to show better or even exclusive detection in the cross-linked 
SILAC experiment. Some of the most prominent components that share this characteristic are 
unconventional myosins. There are 4 unconventional myosins that were detected in both 
types of SILAC experiment and these were: MyoA, MyoD, MyoI and MyoJ. Another 5 
members of this family were detected only in the cross-linked preparation, including MyoB, 
MyoC, MyoE, MyoF and MyoK, suggesting that their binding to actin filaments is relatively 
unstable. This might be related to the ATP-depended character of this binding, which will be 
disrupted by dilution of the ATP after cell lysis.  
 
For proteins belonging to the same class of cytoskeletal factors, which share similar function 
and are involved in the same process, we can assume that the ones present in a greater 
abundance are more likely to have higher significance for this particular process. Based on 
this correlation between protein’s abundance and its relative importance, we can speculate 
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that the components detected in our SILAC experiments are likely to play more significant 
roles than members of the same families, which are not present in the final results. We can 
only discuss this relative contribution during the early development in which the cells were 
analysed. 
Based on these assumptions, 3 out of 8 formins found in Dictyostelium, ForA, ForB and 
ForH are the most likely to mediate the cellular function of this family in the stage analysed. 
Formins belong to the class of actin nucleators, which elongate actin filaments at the barbed 
ends in contrast to Arp2/3, which is present at the pointed end. The only members of this 
family detected in the standard SILAC experiments were ForB and ForH showing low 
abundance, while ForA was detected only in the cross-linked experiment. These results also 
indicate that formins play only minor role in cAMP-induced actin polymerisation, compared 
to the Arp2/3 complex which is present at much higher abundance and shows stronger 
enrichment.  
Similarly, we have detected only 4 out of 7 PI3 kinases identified in Dictyostelium. PikA and 
PikH were showing the highest abundance factors, while PikB and PikF were detected at 
lower levels. The remaining PikC, E and G proteins were not detected, which suggests that 
they have less significant contribution to the PI(3,4,5)P3 signalling during the aggregation 
stage of development.  
Following the same logic we suggest, that among the whole battery of GEFs and GAPs 
present in Dictyostelium cells, the ones that were detected through the proteomic analysis of 
the cytoskeletal fractions are potentially the most important regulators of the cytoskeleton 
dynamics during the early stage of development.  
This approach of using the very fact of protein detection as an indicator of protein abundance 
and therefore significance in comparison to other undetected homologs, can only be used 
with limited confidence due to the big number of factors that can influence this detection 
rate. It can be affected by different protein composition of individual fractions, variable 
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efficiency of tryptic digest for different proteins or variable efficiency of peptide extraction 
from different parts of a gradient gel.  
 
The abundance factor calculated for all the detected proteins is another way of comparing the 
relative contribution of different components to the function of the cytoskeleton. It was 
determined for each protein as the ratio of total number of peptides detected and the protein 
size in kDa. It is not the same as the absolute protein quantification but it represents an 
estimation of protein abundance. It is also affected by the variable character of several 
aspects described before and, similarly to the L/H quantifications, it is more reliable for the 
most abundant proteins.  
One interesting outcome of the abundance factors analysis for all the cytoskeletal proteins is 
the list of factors showing the highest association with the cytoskeletal fraction (Table 5.1.). 
This list includes all the major structural components of the acto-myosin framework such as 
actin, myosin II complex, Arp2/3 complex, Cap32/34 complex, and several ABPs.  
This list represents the key structural constituents of the cytoskeleton and the most abundant 
effectors regulating cytoskeletal dynamics. It is important to notice that the differences of the 
abundance factors exhibited by the subunits of the same complex do not necessarily represent 
a real variability in their abundance, but might just indicate the error levels of this estimation. 
The largest difference shown by components of myosin II complex is also likely caused by 
the very big difference in the size of those subunits, which results in different numbers of 
generated tryptic peptides and influences the relative representation of those proteins. 
It is interesting to observe that one of the most abundant actin binding proteins is a 
translational elongation factor EfaAII, which is also a known actin bundling protein. This 
protein did not show any translocation dynamics in response to cAMP stimulation, 
displaying virtually identical L/H values in all the time points (data not shown). It is therefore 
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a good indication that the most abundant proteins are resistant to the noise fluctuations 


















Another important characteristic is that most of the highly abundant ABPs detected in those 
experiments are involved in actin filament disassembly. This includes cofilin, short coronin 
and also DDB_G0295683. This is a previously uncharacterised protein, which was analysed 
in this study and was found to localise to the cortex at the uropod and sides of moving cells. 
This observation illustrates the significance of the endogenous actin turn-over cycle in the 
maintenance of the cytoskeletal functions.  
 
 
• Actin (34); 
• Myosin II subunits : MHC (7.7), RLC (3.7), ELC (2); 
• Arp2/3 subunits : ArcB (4.3), ArpB (3.5), ArcD (3.2), ArpC (2.5), ArcE (2.4),  
ArcA (2), ArcC (1.6); 
• Cap32/34 subunits : AcpA (2.4), AcpB (1.6); 
• EfaAII (10) – elongation factor, ABP involved in F-actin bundle assembly; 
• CorA (4.4) – coronin A, ABP, cross-linker of actin filaments, negative regulator 
of actin polymerisation also involved in F-actin disassembly; 
• ComA (3) – comitin A, ABP connecting actin filaments to the Golgi apparatus; 
• DDB_G0295683 (2.7) – uncharacterised protein containing ADF-H and LIM 
domains, potential factor involved in F-actin depolymerisation; 
• CofB (2.2) –  cofilin identical with CofA, F-actin depolymerising factor; 
• MhkA (1.6) – MHC kinase A, promotes myosin II filament disassembly. 
 
Table 5.1. The list of the most abundant proteins detected in the standard SILAC experiments. Abundance 
factors were calculated as a ratio of a total peptide count divided by protein MW in kDa and then normalised to 
the average of all the abundance factors. Values shown in brackets are representation of two combined 
abundance factors from the standard SILAC experiments. 
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The translocation dynamics patterns revealed by the highly abundant structural components 
of the cytoskeleton form the most reliable part of the SILAC results. These patterns represent 
the global dynamics of the myosin and actin filaments and the major direct regulators of F-
actin polymerisation in response to cAMP stimulation (Fig. 5.1.).   
Even though there is certain variability between the individual subunits of the protein 
complexes forming the described structures, these complexes can be analysed as a whole 
unities, which is the best representation of their endogenous mode of action (Fig. 3.4.).  
The biphasic actin dynamics is followed by both Arp2/3 and Cap32/34 complexes. There is 
however a substantial difference in the profiles displayed by those two components. While 
the capping protein shares almost the same levels of enrichment as actin in both phases of 
polymerisation, the Arp2/3 complex shows significantly higher levels of translocation during 
the first phase. Actin and Cap32/34 both reach the amplitude of about 2.4 L/H at the peak of 
the first phase and the Arp2/3 complex is enriched to about 3.2 L/H at the same time. This 
means that the increase in F-actin amount and Cap32/34 attached to it during the first phase 
of actin polymerisation equals to only 75% of the enrichment shown by the nucleator of actin 
filaments – the Arp2/3 complex.  
To fully understand the profound implications of this observation we need to recall the 
characteristic of F-actin polymerisation reported previously. It has been shown in two 
independent studies, that the actin filament length distribution does not change during the 
whole process of chemoattractant induced actin polymerisation, but that the number of actin 
filaments increases [60, 298]. The average length of actin filaments was determined in both 







This means that the 2.4 fold increase in F-actin in the first phase of chemotactic response 
actually represents the increase in the number of actin filaments generated during this 
process. Obviously the Arp2/3 and Cap32/34 enrichment also directly represents the numbers 
of those complexes bound to actin filaments. This finally means that we can analyse those 
enrichment factors as direct and proportional indicators of relative amounts of each of those 
components, including actin filaments.  
With this feature established, we can now interpret these results and see the implications. The 
first implication is that all of the actin filaments, generated by the Arp2/3 complex during the 
first phase of polymerisation, are capped by the Cap32/34 complex. Another important 
conclusion is that there is about 25% excess of the Arp2/3 complex molecules in relation to 
the newly generated actin filaments. This implies that about one quarter of all the 
incorporated Arp2/3 complexes do not trigger actin polymerisation.  
This could be related to some specific regulatory mechanism which has not yet been 
described, or might be a result of the whole process reaching the maximum capacity of actin 
Figure 5.1. Translocation dynamics of the main structural components of the cytoskeleton measured in the 
standard SILAC experiments. Patterns are representation of combined results for all the subunits of the protein 
complexes: actin (red); Arp2/3 complex (green); Cap32/34 complex (violet); myosin II complex (blue).  
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filament generation. There are several possible limiting factors that could be depleted during 
the first phase of actin polymerisation, the most obvious one being actin monomer 
availability.  
 
The two activities exhibited by the Arp2/3 complex, binding actin filaments and filament 
nucleation, have been shown to be tightly coupled and perhaps inseparable events [39, 43], 
but the exact mechanism linking those activities in vivo has not been determined. 
A different interesting observation is the faster depletion rate of F-actin compared to capping 
protein during the depolymerisation phase. This is clearly visible at the 20 s time point where 
F-actin level is almost in the middle of the falling slope, while Cap32/34 is still close to the 
peak level. This is related to the character of actin depolymerisation process and it illustrates 
that actin filaments are still capped at the barbed ends, and also interconnected with other 
filaments by cross-linking factors, while being depolymerised from the pointed ends.  
All of those actin structures, which were generated during the first 10 s after stimulation with 
cAMP, are completely disassembled during the next 50 s and all of the structural components 
of actin filaments reach almost the pre-stimulation levels at 60 s time point. During the 
second phase of actin polymerisation all of those components share virtually the same 
enrichment levels. This indicates that during this slow and localised phase each Arp2/3 
complex nucleates one actin filament, which is then capped by the Cap32/34 complex.  
 
The majority of the cytoskeletal factors detected in the SILAC experiments can be divided 
into three groups, based on their translocation dynamics profiles.  
The most commonly found group shows a typical actin-like biphasic incorporation profile in 
response to cAMP stimulation. This pattern is shared by a diverse range of proteins from 
different classes of cytoskeletal factors including effectors and both positive and negative 
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regulators of actin polymerisation. It is displayed with variable amplitude and sometimes 
slightly different timing by all those proteins.  
This type of profile can represent a passive dynamics exhibited by many ABPs, which have 
constant affinity to F-actin and their incorporation levels simply mirror the amount of actin 
filaments. It can also represent an active type of translocation dynamics, characteristic for 
many regulatory components and mediators of the signalling pathways, which bind to the 
cytoskeleton after activation following the cAMP stimulation. Due to this generic character, 
this profile alone is not informative enough to indicate protein’s function or specificity. 
The other two groups are formed by proteins that show exclusive or primary enrichment 
during either the first or the second phase of actin polymerisation. These types of patterns are 
much less common, but are more informative as they indicate the specific role of the protein 
in one of the two phases.  
Proteins from the first group show strong translocation during the rapid phase and are almost 
absent during the second slow phase of actin polymerisation (Table 5.2.). Some of the 
proteins in this group reach the highest point of enrichment in the earliest 1 s time point after 
cAMP stimulation, which strongly suggests their involvement in the earliest events following 
detection of this chemoattractant. This characteristic is shown by two Dock180-related Rho 
GEFs, DocA and DocB, and also by coactosin CoaA. This inhibitor of the Cap32/34 complex 
activity shows strong enrichment in both phases of actin polymerisation, but was classified in 
the group of early factors due to its distinct peak at the 1 s time point. This observation 
indicates CoaA dependent inhibition of actin filaments capping during the initiation of the 
first phase of cAMP mediated actin polymerisation, promoting elongation of actin filaments. 
It is very striking that nearly all of the factors showing unambiguous specificity to the first 
phase are the activators of small GTPases signalling. This however does not necessarily 
mean, that they all induce only the positive regulation of actin polymerisation, since Ras 













All of the Rho GAPs detected in the SILAC experiments were showing certain enrichment 
during the late response to cAMP stimulations and therefore were not classified into this 
group. Nevertheless few of them had much stronger translocation during the first phase or 
reached the first peak in the 1 s time point, suggesting their involvement in the earliest 
events. These factors included two Rac GAPs, GacR and GacV, and one putative Rap/Ran 
GAP protein – DDB_G0281809.  
 
The second group of proteins showing translocation specific to the second phase of actin 
polymerisation was poorly represented in the standard SILAC experiments. The most 
prominent component of the cytoskeleton exhibiting this type of dynamics is myosin II. This 
major F-actin based molecular motor is responsible for force generation during several 
cellular processes including uropod retraction and cytokinesis. It is also involved in 
inhibition of the pseudopod formation at the uropod of chemotaxing cells. There were only 
two regulatory factors characterised by this type of dynamics detected in the standard 
experiments:  Rho GEF – GxcQ, and Rho GAP – GacHH (Table 5.3.).  
 
 
• DocA – Dock180-related Rac GEF from unconventional CZH family; 
• DocB – Dock180-related Rac GEF from unconventional CZH family; 
• GxcD – DH family Rac GEF, contains CH and VHP domains; 
• ZizC – Zizimin-related Rac GEF from unconventional CZH family; 
• GefA – Ras GEF (Aimless) involved in chemotaxis and activation of ACA; 
• GefR – Ras GEF, gefR null cells do not exhibit any observable phenotype; 
• CoaA – coactosin, ADF-H domain containing inhibitor of Cap32/34 complex. 
Table 5.2. The list of proteins showing incorporation to the cytoskeletal fraction specific to the first phase of 





















The cross-linked SILAC experiment on the other hand, revealed a large group of proteins 
detected only in this type of preparation, which exhibited incorporation to the cytoskeleton 
exclusively during the late response to cAMP stimulation. Some of those proteins are 
regulatory factors and some are effectors involved in cytoskeletal dynamics.  
One of the most interesting members of this group is a RacC protein. This Rac GTPase was 
found to be a functional equivalent of mammalian Cdc42 in Dictyostelium, responsible for 
direct activation of WASP leading to stimulation of actin polymerisation [299]. Importantly, 
the incorporation dynamics detected by our SILAC analysis showed specific enrichment 
during the second phase of actin response, which is in agreement with the previous studies of 
 
• GxcQ – DH family Rac GEF, contains PH domain; 
• GacHH – Rac GAP, contains Kelch repeat domain; 
• Myosin II – conventional filamentous myosin, actin based molecular motor 
involved in stabilisation and retraction of the cell uropod; 
 
Proteins detected only in the cross-linked SILAC 
• RacC – Rac GTPase, direct activator of WASP, involved in PI3K activation and 
translocation to the cortex in response to cAMP stimulation; 
• GxcC – DH family Rac GEF, contains PH and ARM domains; 
• RdiA – Rho GDI, negative regulator of Rac GTPases; 
• PLC – involved in PIP2 depletion, negative regulator of chemotaxis; 
• PTEN – responsible for PIP3 hydrolysis, involved in chemotaxis and cell polarity; 
• CadA – responsible for establishment of calcium-dependent cell-cell adhesion; 
• SevA – severin responsible for calcium-dependent F-actin fragmentation; 
• MyoK – class I myosin regulating cortical tension and phagocytosis; 
• CtxB – cortexilin II involved in cytokinesis and cell morphogenesis. 
 
Table 5.3. The list of proteins showing incorporation to the cytoskeletal fraction exclusively during the second 
phase of actin polymerisation. These factors are the most likely candidates involved specifically in the formation 
of localised  protrusions in the late response following cAMP stimulation. 
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this protein. Cells with a disrupted racC gene have been reported to show almost wild type 
level of the first phase of actin polymerisation, but have completely lost the second peak 
following cAMP stimulation [299]. This result therefore confirms the previous findings of 
RacC specificity to the second phase and reversibly, also serves as a validation of this 
dynamics pattern detected with the cross-linked SILAC experiment.  
RacC was also reported in the same study to be involved in activation and translocation of 
PI3K to the cortex after cAMP stimulation [299]. This activity also links RacC to the second 
phase of actin polymerisation, which contrary to the first phase is dependent on PI3K 
signalling. This regulation of PI3K activity by RacC could also to some extent explain the 
lack of the second phase of actin polymerisation observed in racC null cells. 
There are also two other factors classified to this group, which are related to the PI3K 
signalling. PLC and PTEN are both involved in the metabolism of phosphatidylinositol and 
are negative regulators of PI(3,4,5)P3 accumulation at the membrane [125, 133, 300]. Both of 
those proteins are associated with the membrane, which explains their absence from the 
standard SILAC results, and both of them show enrichment only during the second phase in 
the cross-linked SILAC. 
There are also few proteins involved in the organisation and turn-over of the actin 
cytoskeleton, which show this type of late enrichment in response to cAMP stimulation. 
These include: severin involved in actin filament fragmentation [301, 302]; cortexilin II 
belonging to the alpha-actinin superfamily of actin bundling proteins [303]; calcium-
dependent cell-adhesion molecule CadA playing role in Ras mediated cell-cell adhesion 
formation [304, 305]; class I unconventional myosin MyoK with characterised actin filament 
cross-linking activity affecting cortical tension and involved in phagocytosis [306, 307]. 
 
Our SILAC results provide for the firs time a basic characterisation of the cytoskeletal factors 
and mediators of the signal transduction, specific for each of the two phases of cAMP 
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induced actin polymerisation. It does not fully delineate the differential regulation of those 
processes, but it contributes significantly to the identification of the components determining 
the independent character of the fast and slow phases of actin polymerisation.  
These factors need to be further investigated and functionally characterised in order to verify 
their involvement in the specific regulation of those two phases of cytoskeletal dynamics. 
 
 
5.2. In vivo microscopy analysis validate the SILAC 
results and provide additional characterisation of 
the cytoskeletal components translocation dynamics  
 
In order to validate the dynamic patterns detected with the SILAC experiments and further 
analyse the translocation dynamics of the cytoskeletal proteins, 55 suspected components of 
the cytoskeleton were tagged with GFP and visualised in vivo. Each of the cloned proteins 
was tagged with GFP on both C-terminus and N-terminus separately and coexpressed with 
RFP-lifeact F-actin probe from a single extrachromosomal vector. Dictyostelium cells 
overexpressing those constructs were developed in suspension and imaged by confocal and 
TIRF microscopy.  
The majority of analysed proteins showed expected localisation consistent with the previous 
findings and with the reported or expected function of those components. Most of them 
exhibited cortical localisation classified as either strong or weak, based on the level of cAMP 
dependent translocation from the cytosol to the cortex. The dynamics of this translocation 
observed in vivo was generally in agreement with the proteomic data, although the results 
from those two types of assays were not always directly correlated.  
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Some of the proteins with strong enrichment in the SILAC results, such as Roco7, was 
showing only weak translocation in the imaging analysis, while some proteins with small 
changes in proteomic analysis, for example GacR, was found to strongly translocate to the 
cortex in vivo. This is related to the different character of those two assays, which detect 
slightly different aspects of protein translocation dynamics. The SILAC results are based on 
the changes in protein-protein interactions and their stability in the insoluble cytoskeletal 
fraction only, while the imaging analysis are based only on protein localisation and can 
detect the protein in all cellular compartments.  
Nevertheless, all of the analysed known cytoskeletal factors, which followed the actin-like 
profile of enrichment in the SILAC experiments, were found to colocalise with actin 
structures at the cortex, providing a positive validation of the quantitative proteomic analysis.  
The imaging data also provide a characterisation of the cellular localisation and translocation 
for the proteins that have not previously been visualised in vivo, such most of the GEFs and 
GAPs investigated in this study.  
 
The strength of cAMP induced translocation from the cytosol to the cortex observed with the 
confocal analysis is an indication of protein’s binding affinity and availability of its binding 
sites in the cytoskeletal structures. This factor alone cannot determine the importance of 
protein’s function, but it can be used as a basis for comparison of proteins from the same 
class of cytoskeletal factors.  
We postulate that for proteins playing similar function in the regulation of the cytoskeletal 
dynamics, the strength of cortical translocation is a good indication of their relative 
importance. Therefore, within the group of all the GEFs and GAPs analysed in this study, the 
ones showing strong incorporation to the cortex during cAMP induced actin polymerisation 
are likely to play more significant role in this process than the ones displaying weak 
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incorporation. The list of those potentially most important regulatory factors includes 6 
GEFs, 3 GAPs and one protein containing both GEF and GAP domains (Table 5.4.). 
Most of those were not individually investigated before. GxcA is the only conventional Rac 
GEF from this group, that was functionally characterised. It was shown to activate RacB 
during chemotaxis and to colocalise with sites of actin polymerisation at the cortex [308]. 
RapGAP1 is the only GAP from this group that was previously investigated. It has been 
shown to regulate cell adhesion at the front of moving cells via Rap1 signalling and to 
translocate to the cortex after cAMP stimulation [286].  
Both of those proteins were found to have significant effect on actin polymerisation process 
and cells lacking one of them or overexpressing the mutant forms of those components were 

















GEFs showing strong cortical localisation 
• GxcW – DH family Rac GEF, contains PH and FYVE zinc finger domains; 
• KxcB – DH family Rac GEF, contains PH and STE group kinase domains; 
• GxcBB – DH family Rac GEF, contains PH and CH domains; 
• GxcA – DH family Rac GEF, contains PH and CH domains; 
• XacB – DH family Rac GEF, Rac GAP, contains PH domain; 
• DocA – CZH family Dock180-related Rac GEF, contains SH3 domain; 
• DocB – CZH family Dock180-related Rac GEF; 
 
GAPs showing strong cortical localisation 
• GacR – Rac GAP, contains BAR domain; 
• GacA – Rac GAP; 
• RapGAP1 – Rap/Ran GAP, inhibitor of Rap1 signalling; 
Table 5.4. The list of GEFs and GAPs showing a strong translocation to the cortex after cAMP stimulation. 
These regulatory factors of the small GTPases are likely to play the most significant roles in the regulation of the 
cytoskeletal dynamics during response to cAMP stimulation. 
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The interaction partners for the rest of those regulatory factors have not yet been determined. 
The significant role of those proteins in the regulation of the actin cytoskeleton is also 
indicated by the fact, that in this study cells overexpressing most of those factors were 
displaying observable aberrations in actin dynamics compared to the wild type cells.   
A common tendency was that cells overexpressing the proteins with Rac GEF activity were 
exhibiting enhanced actin polymerisation at the cortex, leading to increase in membrane 
protrusions and somewhat motile behaviour. On the other hand, overexpression of Rac GAPs 
was correlated with decrease in actin polymerisation and protrusion formation, leading to less 
prominent second phase of chemotactic response and generally calm cortical dynamics. 
These observations are in agreement with the expected roles of those regulatory components, 
but will need to be further characterised. 
 
TIRFM imaging provided much better spatial and temporal resolution of protein localisation 
and incorporation dynamics. Components binding F-actin were clearly visible in the cortical 
filamentous structures, while others associating for instance with PI(3,4,5)P3 at the 
membrane or with other cortical compartments, did not exhibit filamentous patterns.  
One of the most informative contributions of the TIRFM analysis and the great advantage 
over the confocal microscopy was the ability to precisely measure the timing of the cAMP 
induced translocation to the cortex in a reproducible and easily quantifiable way. This 
allowed identification of the fastest responding regulatory factors and determination of the 
precise duration of their association with the cortex. All of the regulatory proteins analysed 
quantitatively by TIRFM, which showed enrichment at the cortex after cAMP stimulation, 
could be divided into two distinct groups based on the translocation dynamics (Fig. 5.2.).  
The first group consists of proteins, which show very rapid translocation to the cortex 
periphery, reaching their peaks at about 1-2 s after cAMP stimulation. These proteins are also 
very rapidly depleted after the peak of translocation and most of them return to the pre-
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stimulation levels within 10 s from the starting point, even before actin reaches its peak of 
polymerisation (Fig. 5.2. A). 
The second group contains proteins which show the same rate of translocation as the initial 
actin dynamics and reach their peaks at about 3-5 s after cAMP stimulation. These 
components are characterised by slow depletion from the cortex and most of them reach the 
pre-stimulation levels at the same time or slightly after actin does at 20 s (Fig. 5.2. B).  
It is important to note that the actin dynamics profile used in this analysis was measured in 
cells overexpressing alpha actinin – AbpA, and shows some unusual characteristics. It has a 
distinct plateau at a rising slope of polymerisation phase and reaches the peak at 10 s after the 
cAMP stimulation, which is about two times slower than the dynamics measured by the 
confocal microscopy, showing the first peak at 5 s for almost all the clones analysed.  
This characteristic is most likely related to the overexpression of AbpA or alternatively to 
some other unidentified phenomenon. It is presumably not the best representation of the 
universal actin dynamics for TIRFM imaging, but due to the time constrains these 
measurements could not be repeated. Nevertheless, despite the nonuniversal character of this 
actin polymerisation profile, it can still serve as a good reference of incorporation timing for 
other proteins, allowing separation of the fast and slow factors.  
Each of those groups contains both positive and negative regulators of actin polymerisation. 
The first group includes two GEFs – DocA and DocB, and two GAPs – GacR and 
DDB_G0284825 Rap/Ran GAP.  
DocA and DocB display almost the same timing of association, which is consistent with their 
dynamics patterns measured in the SILAC experiments. They reach the peak of enrichment at 
1.5 s after stimulation, which is followed by a rapid depletion reaching pre-stimulation levels 
at around 7 s time point. This result indicates that those two unconventional Rac GEFs are 
the earliest responding activators of the actin polymerisation after cAMP stimulation, 








Figure 5.2. Translocation dynamics of the cytoskeletal regulatory components measured by the TIRFM analysis. 
Graphs represent a time plots of the GFP fluorescence intensity changes following cAMP stimulation. Each 
curve is an average of three measurements of different cells from a single imaging session. Individual 
measurements for each construct were first normalised to their average, then combined and finally normalised to 
the prestimulation period. Standard errors were calculated adequately to these normalisations. A) Proteins 
showing the fastest response to the cAMP stimulation. They reach the peak of enrichment at 1.5-2 s followed by 
a rapid depletion. B) Proteins showing slower rate of incorporation, equal to the actin dynamics. They reach the 




induced actin polymerisation. This very rapid character of translocation dynamics displayed 
by the Dock proteins is in agreement with the observations made by a different research 
group (Douwe Veltman and Robert Insall, personal communications). 
DDB_G0284825 Rap/Ran GAP shows even more transient translocation to the cortex. It 
reaches peak at the same time as Dock proteins, but it shows much lower intensity and is 
completely depleted at 4 s. GacR shows slightly slower pace of incorporation reaching the 
peak at 2 s after stimulation, which lasts longer and has slower depletion rate the other 
proteins from this group. It displays biphasic dynamics, which is unusual for TIRFM 
analysis. It reaches close to pre-stimulation level at 12 s followed by a minor second peak at 
16 s and then the final depletion lasting till the end of the measurement.  
 
Proteins from the second group show slower enrichment kinetics, which matches the initial 
actin polymerisation rate. They reach the peak of translocation at 3-5 s after cAMP 
stimulation and exhibit a relatively long lasting occupation at the cortex, covering the whole 
period of the first phase of actin polymerisation. All four proteins belonging to this group of 
translocation dynamics represent cytoskeletal regulatory factors, but only two contain GEF or 
GAP domains.  
Roco7 is a multidomain complex protein acting as a complex signal transduction unit. It 
contains Ras-like GTPase domain called Roc, which regulates the activity of the protein 
kinase domain sitting further downstream on this protein. The downstream effectors of this 
kinase have not been identified. This regulatory factor shows the lowest enrichment and 
shortest occupancy at the cortex from all the proteins in this group (Fig. 5.2. B). Its depletion 
starts at 6 s and reaches the pre-stimulation level at 20 s after cAMP stimulation, which 
correlates with the actin depolymerisation phase also reaching the pre-stimulation level.  
PakB is another protein kinase showing this type of translocation dynamics. It belongs to the 
family of p21-activated protein kinases, which are regulated by the Rac GTPases. It is known 
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to interact directly with several Rac GTPases in Dictyostelium and to regulate activity of 
class I myosin MyoD [101, 271]. This protein reaches the peak of incorporation at 3 s and 
shows a plateau lasting until 12 s and its depletion matches exactly the timing of actin 
depolymerisation (Fig. 5.2. B). Another protein forming a very similar plateau is XacB, 
containing both Rac GEF and Rac GAP domains. The unusual characteristic of this protein’s 
translocation is the slow rate of depletion. Even though the depletion phase starts at the same 
time as for PakB – around 13 s after stimulation, it lasts much longer than for any other 
protein in this group and reaches the pre-stimulation level at around 40 s, which is much later 
than the actin depolymerisation phase has finished. 
GacA is the last protein from this group and it shows the highest amplitude of enrichment in 
response to cAMP stimulation. This Rac GAP reaches the peak of incorporation at 5 s and 
has relatively short occupation period in the cortex. Interestingly, this protein shows slightly 
biphasic depletion phase, similar to that of GacR in the first group discussed earlier. It is first 
depleted to about 1.5 of pre-stimulation signal intensity at 12 s and then shows very small 
secondary peak around 16 s, which is then followed by the final depletion lasting till the end 
of the measurement (Fig. 5.2. B). This second peak is much less prominent than the one 
showed by GacR, but it has the same timing corresponding to actin depolymerisation phase. 
This indicates that those two inhibitors of Rac signalling and potentially also XacB, showing 
prolonged occupation at the cortex relative to actin, are likely to play role in regulating actin 
depolymerisation phase and therefore adaptation of the cytoskeletal response to cAMP 
stimulation.  
Proteins from this group, showing translocation timing correlating with actin polymerisation 
during the first phase, are most likely to be involved in maintenance of actin cytoskeleton 
dynamics and some of them in promoting a shift from polymerisation to depolymerisation 




There are few interesting insights into the nature of the first phase of cAMP-induced actin 
polymerisation coming from these observations. The first and most general one is that the 
regulatory factors can be divided into two distinct groups of translocation dynamics. The 
ones showing very rapid and transient incorporation into the cortical cytoskeleton are most 
likely responsible for triggering the actin polymerisation response. The ones showing slower 
and long lasting translocation are supposedly involved in regulating persistence and timing of 
this response. We have investigated only a fraction of all the regulatory factors functioning in 
this process and presumably many others would fall into one of those groups after this type 
of analysis.  
Another important observation, which may help to understand the character of the first phase, 
is the presence of both activators and inhibitors of small GTPases in each of the groups 
showing different translocation dynamics. In the first group of early regulators there are two 
Rac GEFs – DocA and DocB, and two GAPs – Rac GAP GacR and Rap/Ran GAP 
DDB_G0284825. This indicates that both excitatory and inhibitory reactions are triggered at 
the same time and the response observed in actin polymerisation is the outcome of balancing 
those two contrary activities.  
An intuitive way to understand the detailed process of chemoattractant mediated actin 
polymerisation is by describing the response profile in terms of an excitation adaptation 
mechanism. The first phase of actin polymerisation represents the primary response to cAMP 
stimulation followed by adaptation to this signal, which allows the secondary phase to occur 
and drive the chemotactic movement. This type of excitation response coupled with the 
adaptation to the stimulus is a common characteristic of the majority of signal induced 
reactions. In general the excitatory pathways generating the response are easier to investigate 
and therefore much better understood, while the inhibitory counterparts necessary for the 
adaptation remain elusive in most systems analysed.  
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One of the best established models describing this type of response coupled with adaptation 
is shown in Figure 5.3. It involves simultaneous activation of reactions leading to excitation 
and inhibition of the process. The excitation kinetics rises rapidly in response to the 
instantaneous change in signal and reaches a plateau level determined by the signal strength. 
The adaptation is characterised by a slower kinetics eventually reaching the same level as the 
excitation. The resulting actin polymerisation is proportional to the difference between 






This model of adaptation has been proposed for several cellular processes. One of the best 
described is the adaptation of the adenylyl cyclase (ACA) during cAMP relay response in 
Dictyostelium. In this process both positive and negative regulators of ACA are thought to be 
activated by the same signal of PI(3,4,5)P3 accumulation at the membrane, generated by 
PI3K after cAMP stimulation, and regulate ACA activity with different kinetics [309].  
 
Figure 5.3. General model of the response perfect adaptation to stimulus. Both excitation and inhibition of the 
response are triggered at the same time by stimulation. These two processes have different kinetics and 
excitation reaches the plateau level much faster activating the response reaction. The inhibition rises slowly 
influencing the response level. When the inhibition reaches the same level as excitation the response is finished. 
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Our analysis of the translocation dynamics partially supports this model of adaptation of 
actin polymerisation response. We detect both activators and inhibitors of Rac signalling, 
regulating the actin polymerisation response, enriched at the cortex in almost the same time. 
We need to note again, that the translocation observed in our assay does not equal the activity 
of those components, which can differ in regulatory kinetics even when sharing the same 
incorporation dynamics.  
Nevertheless, we can safely assume that the regulatory effect of one factor cannot exceed its 
occupancy at the site of the process being regulated, which in this case is the cell cortex. This 
generates a discrepancy between our results and the proposed model. All of the regulatory 
factors showing the fastest response to cAMP stimulation, display only transient 
incorporation to the cortex and therefore cannot provide the regulatory effect throughout the 
whole process of actin polymerisation. This indicates, that if this model of response 
adaptation is correct for this system, it requires the excitation function to be transferred from 
the earliest  responding factors that initiate the response to the other factors, which are 
present at the cortex during the whole period of actin polymerisation and maintain the 
response. The inhibitory factors, GacR and GacA, might also exhibit similar type of temporal 
differentiation of activity. Even though they show a larger overlap of occupancy at the cortex 
than the excitatory components, the main peak of GacR is almost finished at 5 s which is 
when GacA reaches the peak of translocation. So these factors could also together provide a 
continuous inhibitory activity counterbalancing the excitatory reactions.  
 
An alternative way of explaining the process of cAMP induced actin polymerisation on a 
different, more mechanistic level does not necessarily require the constant presence of 
excitatory reactions. It is plausible, that a single short peak of excitation generating a global 
activation of the Arp2/3 complex throughout the cell cortex, could initiate the process of 
formation of new filaments, which would then continue elongating and thereby increase the 
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mass of polymerised actin until inhibited by the capping protein, without the need of 
continuous excitation. In this model the excitation could be only transient and followed 
almost directly by the inhibition, which correlates closely with our results (Fig. 5.4.).   
There is also another characteristic of actin polymerisation, which makes the adaptation of 
this response more complex processes. In actin polymerisation response, similarly to ACA 
activation, it is not enough to switch off the activity to generate the adaptation. During the 
cAMP relay response the cAMP produced needs to be removed, which is done by the 
constitutively active cAMP phosphodiesterases. In similar manner actin filaments, once 
polymerised, need to be actively depolymerised. This means that the perfect adaptation of the 
actin polymerisation response requires involvement of a different set of components, which 
will reverse the effects of this process. This depolymerisation process could be mediated by a 







Figure 5.4. Mechanistic model of the perfect adaptation in the actin polymerisation response. Both excitation 
and inhibition of the Arp2/3 complex are transiently triggered at the same time by stimulation. These two 
processes have different kinetics and excitation reaches the peak level faster then inhibition, generating a short 
period of Arp2/3 activation and incorporation. This triggers the actin polymerisation process, which continues as 
an independent spontaneous reaction until inhibited by the capping protein. The adaptation of this system is 
mediated by the actin depolymerisation process, which is driven by ADFs. The activity of ADFs could be 
constitutive or could also be triggered by the initial signal and show slower kinetics.  
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The standard SILAC results did not detect any profound enrichment of cofilin, which is the 
major and most abundant ADF, during the depolymerisation phase (data not shown). The 
cross-linked SILAC experiment detected slightly higher incorporation of cofilin at 20 s 
corresponding to the depolymerisation phase, than at the peak of the first phase. This might 
suggest specific activation during the depolymerisation phase, but these data need to be 
further validated. 
 
It is important to note that is a mechanistic model based on the results of the translocation 
dynamics analysis. The reactions responsible for excitation and inhibition of the Arp2/3 
complex and excitation of ADFs represented in this model, are themselves regulated by some 
upstream regulatory reactions. This means that the translocation and activation of the 
components leading to downstream regulation of the actin polymerisation response, such as 
DocA, DocB or GacR, are all individually regulated responses to cAMP stimulation with 
their own excitatory and inhibitory reactions. All of those responses display their own 
adaptations (cortical enrichment of those proteins is followed by depletion reaching pre-
stimulation levels) and it is likely, that their individual regulatory mechanisms follow the 
general model for response adaptation described before.  
In this way of looking at the process of cAMP induced actin polymerisation, there is a whole 
layer of different individual responses to this stimulus, all showing different timing and 
adaptations, which function as regulatory reactions controlling all the aspects of actin 
polymerisation. The regulation of Arp2/3 will have its own activation and inhibition 
reactions, Cap32/34 will presumably be also individually regulated and similarly, all the 
factors involved in actin depolymerisation. From this point of view, the first phase of cAMP 
induced actin polymerisation emerges on a higher level from a multitude of individually 
controlled responses of different regulatory components to this global stimulation. 
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The model presented in the Figure 5.4., which requires only transient excitation of the Arp2/3 
complex to drive the whole process of actin polymerisation, is based on the TIRFM imaging 
analysis of the translocation dynamics of different regulatory factors, especially DocA, DocB 
and GacR. It is also in agreement with the spontaneous character of the actin filament 
elongation following the nucleation by Arp2/3.  
On the other hand this model is not supported by the SILAC analysis, which reveals gradual 
incorporation of the Arp2/3 complex during the whole period of the first phase, following 
similar dynamics as the changes of F-actin abundance. This model would predict an early 
peak of the Arp2/3 enrichment, forming a plateau until the depolymerisation phase.   
 
This indicates that the whole process is more complex and that this simple model needs to be 
supplemented with additional regulatory levels. DocA and DocB do not activate the Arp2/3 
complex directly, but this stimulation needs to go through Rac GTPases to NPFs, such as 
Scar and WASP, to eventually reach the actin nucleator. It is possible that this transient 
activity of Dock proteins detected by TIRFM analysis is capable of generating a long lasting 
activation of downstream NPFs, which will then activate Arp2/3 until the peak of the first 
phase. Alternatively, this activation can be maintained by other regulatory factors after the 
initial triggering ones have been depleted, as speculated before. 
It is clear that these analyses are just a starting point of the long process of elucidating the 
mechanisms regulating the actin polymerisation response to cAMP stimulation. Many more 
components need to be individually investigated in order to provide further insight and feed 
the models of this process.  
Nevertheless, we can already say which of the components are most likely to play certain 
roles during the cAMP induced actin polymerisation. DocA and DocB are the strongest 
candidates for the initial triggering of the response. XacB, PakB and Roco7 are likely to be 
involved in maintaining the regulatory signals and potentially contributing to the shift from 
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polymerisation to depolymerisation reactions. Finally, GacR and GacA are the most likely 
components involved in the inhibition of Rac signalling, switching off the whole excitation 
and allowing for the adaptation to take place.  
 
The TIRFM imaging revealed that several of the analysed proteins were showing very 
distinct incorporation dynamics. These factors did not exhibit an increase in signal intensity 
upon cAMP stimulation, but instead they showed sudden drop of fluorescence to about 75% 
of the pre-stimulation level. This loss of the fluorescence intensity was typically followed by 
a gradual recovery showing different timing and dynamics patterns (Fig 5.5.). 
The most likely explanation of this unusual behaviour is related to the specificity of this type 
of microscopy. TIRFM illuminates effectively only the very outer layer of about 200 nm of 
the cell cortex, which generally corresponds in scale to the cortex periphery newly generated 
during the first phase of actin polymerisation. This means that the proteins, which are 
incorporated to the cortical cytoskeleton but do not translocate to the newly polymerised 
fraction, will be pushed inside the cell and move partially out of the TIRFM illumination 
field, resulting in this type of fluorescence intensity decrease.  
This interpretation is supported by the fact that the drop of signal intensity shows a very 
similar timing in all of those proteins, and it correlates with the initial actin polymerisation 
response. The recovery of this signal in case of ZizA is clearly correlated with actin 
depolymerisation at the end of the first phase, and it is one of two proteins that actually fully 
recover to the pre-stimulation level. The second one is MhcA, which is the only protein in 
this group showing strong enrichment in the late response following the initial drop of signal. 
In the other three proteins, this recovery is followed by a secondary fluorescence depletion, 
which does not recover and might represent a protein specific translocation dynamic required 
for a specific funtion.  
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Interestingly, all of components showing depletion were found to localise to cortical 
filamentous structures as observed by TIRFM and all of them showed actual translocation to 
the cortex revealed by the confocal imaging and also the SILAC analysis.  
This leads to some interesting implications. All of those proteins apparently translocate to the 
cortex after cAMP stimulation and bind to actin filaments, but they are incorporated 
exclusively to the pre-existing cortical structures and do not localise to the very periphery of 
the cortex generated during the first phase of actin polymerisation. This indicates that these 
factors are playing role in processes that are specific to the pre-existing actin cytoskeleton 





This type of differential mechanisms working on those cortical actin structures of distinct 
origin have not yet been reported. It is likely caused by the fact that it is very challenging to 
distinguish in vivo between actin filaments that existed before and those generated after 
cAMP stimulation. The observation that this TIRFM based assay can indirectly distinguish 
Figure 5.5. Translocation dynamics of the cytoskeletal components measured by the TIRFM analysis. These 
proteins revealed sudden drop of fluorescence intensity after cAMP stimulation, correlating with the burst of 
actin polymerisation. Graphs representing a time plots of the GFP fluorescence intensity changes following 
cAMP stimulation were averaged from three measurements and normalised as described for Figure 5.2.  
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between those two types of actin structures was purely coincidental and it enabled the 
discovery of this novel class of cytoskeletal factors interacting or modulating specifically 
pre-existing cortical structures. 
 
Three out of five proteins in this group share another interesting characteristic, which might 
relate to their specific functions. MhcA and two of the unknown proteins classified in this 
group, DDB_G0292230 and DDB_G0267974, are all found to localise to the uropod of 
moving cells as observed with the confocal analysis. Proteins showing this type of 
localisation are likely to be involved regulation of cell polarity and/or stabilisation of the 
cytoskeleton at the uropod and play a role in inhibition of pseudopod formation in this part of 
the cortex. They might also be involved in actin turn-over or in regulation and localisation of 
other components fount in this compartment such as myosin II filaments.  
All of those potential functions are interesting candidates for processes that would need to be 
carried out specifically at the inner cortex composed of pre-existing cytoskeletal structures. 
The fact that those two proteins of unknown function show the same type of localisation as 
MhcA to the inner cortex at the cell uropod, suggests that they might be involved in some 
aspect of control of myosin II filament dynamics. 
 
Another possibly important function of proteins from this group is the regulation of stability 
of the cytoskeletal structures. As discussed before, the regulation of the actin 
depolymerisation process during the response to cAMP stimulation is not well understood 
and we do not find reliable data elucidating this process in our analyses. One readily 
detectable, but not necessarily intuitive observation of this process shows that it brings the F-
actin abundance back to pre-stimulation exactly at the end of the first phase. This suggests 
strongly that only the newly generated filaments are depolymerised, while the pre-existing 
filaments are not affected by this process. It is not clear why this global actin 
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depolymerisation phase occurring at the whole cortex would leave the old structures intact, 
while degrading the newly synthesised ones, rather than disassembling all of them.  
Such character of depolymerisation specific only to the new filaments is also not in 
agreement with the general view of the ADF/cofilin dependent actin turn-over. This major 
depolymerising factor shows high affinity to older ADP-rich actin filaments and drives their 
depolymerisation, while fresh ATP-rich actin filaments are not processed by this protein [36]. 
This would suggest that the inner cortical structures based on older actin filaments, should be 
more susceptible to the actin depolymerisation process. 
Nevertheless, our SILAC results reveal that all of the major structural constituents of the 
actin filaments, including Arp2/3, Cap32/34 and actin itself, are brought down to pre-
stimulation levels, which is a strong indication that only the pre-existing structures are left 
intact. TIRFM analysis of the components localised to the inner cortex generally supports 
this notion. Firstly the structures labelled by the above described proteins do not show 
dramatic changes in shape, which would be noticeable if they were disassembled. Secondly 
by the correlation of the signal recovery for some of those proteins with the actin 
depolymerisation phase. 
All these observations imply that there is some specific regulation during the 
depolymerisation phase, targeting this process to the freshly polymerised filaments and 
protecting the older structures. This function could be performed by this novel class of 
cytoskeletal components translocating specifically to the inner cortex. These proteins could 
stabilise the pre-existing actin filaments preventing their depolymerisation, or they could 
otherwise locally inhibit the factors responsible for actin filament disassembly. Alternatively, 
they could locally promote the depolymerisation process to occur on the border of pre-




To summarise the whole picture of the biphasic process of the chemoattractant induced actin 
polymerisation, which emerges from these wide analysis of protein translocation dynamics, 
we will go through the major detected events. 
Stimulation with cAMP triggers several signal transduction pathways, which lead to 
activation of the major actin nucleator the Arp2/3 complex. There are many positive 
regulators that show incorporation to the cortex during the first phase of actin polymerisation. 
The ones that exhibit the fastest translocation, and therefore are the most likely to act as the 
initial activators, are DocA and DocB Rac GEFs. These proteins show very transient 
incorporation to the cortex and they are followed by another set of regulatory factors, 
including XacB, PakB and Roco7, which show slower kinetics and longer occupancy lasting 
until the end of the first phase.  
Activation of the Arp2/3 complex drives the whole process of actin polymerisation, leading 
to about 2.4 fold increase in F-actin abundance, which is proportional to the number of actin 
filaments. At the same time the Arp2/3 complex shows 3.2 fold enrichment, this indicates 
that about 25% of those nucleators incorporated to the cytoskeleton do not generate new actin 
filaments. This might be a regulated feature or result from some factors such as the actin 
monomers becoming limiting. 
The major capping protein – Cap32/34, is likely to be inhibited at the very beginning of the 
first phase by CoaA, which then dissociates from the cytoskeleton before the peak of actin 
polymerisation, allowing the Cap32/34 complex to terminate filament elongation. Virtually 
all of the actin filaments are capped by the Cap32/34 complex and the entire polymerisation 
process stops after about 5 s at room temperature and 10 s at 12°C. At this point the 
excitatory reactions are switched off by Rac GAPs. Out of all the GAPs analysed in this 
study, GacR and GacA seem to be playing the most significant role in this process. 
This rapid increase in the amount of actin filaments results in binding of a multitude of 
proteins associated with those structures, including many ABPs and regulatory factors.  
 
- 207 -
The burst of actin polymerisation is then followed by the reverse reaction driving the 
disassembly of the generated filaments. The regulation of this depolymerisation phase is not 
well understood and there are not very many new insights into this process coming from our 
analysis. Depolymerisation appears predominantly to affect the newly generated filaments, 
leaving the older pre-existing actin structures intact. Such a specific targeting of this reaction 
could be mediated by the proteins translocating only to those pre-existing structures at the 
inner cortex Five proteins were discovered to exhibit this type of localisation in this study, 
including MhcA, RapGAP1, ZizA and two previously uncharacterised proteins 
DDB_G0292230 and DDB_G0267974.  
At the end of the depolymerisation phase the whole actin cytoskeleton reaches perfect 
adaptation, which means that it has essentially the same composition as before cAMP 
stimulation. From this point onwards the process of cAMP induced actin polymerisation is 
taken over by a very different regulatory machinery. There are several regulatory factors that 
show specific enrichment during this phase, including RacC, GxcC, PLC and PTEN. This 
phase is thought to be mainly dependent on the PI3K signalling, which leads to local 
accumulation of PI(3,4,5)P3 at the membrane guiding other components driving actin 
polymerisation.  
Actin polymerisation during this phase is also driven by the Arp2/3 complex, but it leads to a 
completely different outcome. In this slow and long-lasting phase actin is polymerised only 
at local sites at the cortex, generating membrane protrusions and driving the actual 
chemotactic cell movement. Most of the proteins translocated to the cortex during the first 
phase are now colocalising with those local actin-based structures. 
The regulatory network involved in this part of chemotactic response has been well 
characterised and it is very similar to the one operating at the pseudopod formation during a 
random walk in the absence of any chemoattractant stimulation [143]. Therefore it is 
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adequate to describe this phase of actin polymerisation as a guided regulation of a random 
motion.  
The fact that the response is long lasting and low amplitude is the result of the process of 
pseudopod formation is only loosely coupled to the initial stimulus and happens at discrete 
times in different cells giving rise to slow, low amplitude kinetic in the population average. 
In individual cells the response is fast as shown in several experiments. The time delay may 
reflect the pseudopod cycle (3/minute) that occurs independently of cAMP stimulation and 
may be part of the random movement response. 
 
 
5.3. In vivo microscopy analysis validate the 
dynamics of several novel cytoskeletal components 
detected in the SILAC experiments 
 
Apart from a detailed study of the translocation dynamics of many proteins simultaneoulsy in 
the same experiment this project was also aimed at identification of novel cytoskeletal 
components.  
About 25% of all the proteins identified in the SILAC experiments, were proteins of 
unknown function. Most of those unknown proteins were showing changes in abundance 
following cAMP stimulation. 54 of those proteins, showing the strongest and most reliable 
patterns of translocation dynamics, were tagged with GFP and analysed by confocal and 
TIRFM imaging. 
Most of those proteins revealed localisation to different cellular compartments and did not 
show any colocalisation with the cortex. This analysis led to identification of 3 novel 
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microtubule-associated proteins, 5 novel proteins localising to the contractile vacuole 
network, 16 novel vesicular proteins and 12 novel nuclear markers. There are few possible 
reasons for the changes in abundance of those factors detected by the SILAC analysis. Some 
of them might represent a real interaction with the cytoskeleton and some might be related to 
an unspecific co-purification for instance through trapping in the insoluble fraction.  
 
There were also 12 proteins, which showed either strong or weak cortical localisation (Table 
5.5.). 4 of those proteins had previously identified actin binding domains by sequence 
homology analysis, and 2 other proteins were identified as GAPs. The remaining 6 proteins 
have not been previously characterised as potential cytoskeletal factors.  
6 of those proteins showing strong translocation to the cortex are most likely to play 
significant roles in the cytoskeleton dynamics. There are two proteins in this group 
containing ADF-H domains, suggesting that they might be involved in actin 
depolymerisation. Another factor showing strong cortical localisation is a WASP-related 
protein, which might be involved in activation of the Arp2/3 complex.  
One of the most interesting proteins identified as cortical components is the homolog of Fry 
proteins. This family is suspected to play important roles during development of higher 
organisms, including humans, but the mechanism of action is poorly understood. We have 
found that Fry homolog is localised at the cell boundary at substrate attachment sites. This is 
presumably a multi-pass transmembrane protein. It is mostly enriched at the uropod of 
polarised cells and is clearly involved in establishing cell attachment to the substrate.  
Two other proteins from this group were also showing localisation to the uropod. These were 
the factors discussed earlier as members of the characterised group of proteins translocating 
specifically to the inner cortex after cAMP stimulation.  
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The list of components showing weak cortical localisation includes two proteins containing 
GAP domains. One of them, DDB_G0284825 with Rap/Ran GAP domain, belongs to the 




















All of the unknown proteins with this type of localisation were showing uniform distribution 
at the cortex. On the other hand, surprisingly large proportion (4 out of 6) of the unknown 
proteins showing strong translocation to the cortex were found to localise to the uropod in 
polarised cells (Fig. 5.6.). Another protein, which was unexpectedly found to accumulate at 
 
Novel cytoskeletal components showing strong cortical localisation 
• DDB_G0283827 – WASP-related protein, contains WH2 and CRIB domains; 
• DDB_G0277615 – contains 3 ADF-H actin binding domains; 
• DDB_G0295683 – contains ADF-H and LIM domains, localised at the uropod; 
• DDB_G0275305 – Fry homolog, localised at the uropod bottom cell boundary; 
• DDB_G0267974 – contains CH3 domain, localised at the uropod inner cortex ; 
• DDB_G0292230 – contains regions of similarity to Rho GAPs and calcium   
transporting ATPases, localised at the uropod inner cortex; 
 
Novel cytoskeletal components showing weak cortical localisation 
• DDB_G0279449 – contains VHP actin binding domain; 
• DDB_G0284825 – contains Rap/Ran GAP domain; 
• DDB_G0274211 – contains Ras GAP domain; 
• DDB_G0280261 – contains LisH/WD40 repeat domain; 
• DDB_G0293032 – contains AAA+ ATPase and WD40 domains; 
• DDB_G0293724 – contains regions of similarity to dynein heavy chains. 
 
Table 5.5. The list of proteins of unknown function showing a strong or weak translocation to the cortex after 
cAMP stimulation. Some of those proteins have identified actin binding domains or other domains potentially 
involved in interaction with the cytoskeleton.  
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the uropod, was Kif5. This protein was previously found to localise to the cell cortex and in 
this study we further characterised this localisation, showing that Kif5 is found at the uropod 






All those proteins associated with the uropod, are most likely involved in one of the cellular 
processes that would require this type of localisation. They might be involved in establishing 
or maintaining cell polarisation, in regulation of other component’s translocation or might 
play a role in stabilisation of the cytoskeleton and inhibition of lateral pseudopod formation.  
 
Figure 5.6. Protein showing cortical localisation at the uropod of polarised cells. Four of the unknown proteins 
were found to exhibit this characteristic localisation. Kif5 is a known protein, which was characterised as cortical 
protein and here we show that it is predominantly found at the uropod. All of the pictures represent confocal 
images, except for the DDB_G0275305 which was visualised by TIRFM. 
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In this study we have identified and briefly characterised a number of novel cytoskeletal 
components. They need to be further investigated individually by functional analysis in order 
to understand their roles in the cytoskeletal dynamics.  
The next step in this process will be generation of knock-out strains for each of those factors 
followed by developmental phenotype characterisation and quantitative analysis of actin 
dynamics. In order to identify their interaction partners and regulatory factors, a series of 
immuno-precipitation preparations coupled with proteomic analysis will be performed.  
Some of those factors might play a substantial role in the cytoskeleton, and their 
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